key: cord-0034640-o0vacxc2
authors: Hubálek, Zdenek; Rudolf, Ivo
title: Systematic Survey of Zoonotic and Sapronotic Microbial Agents
date: 2010-11-10
journal: Microbial Zoonoses and Sapronoses
DOI: 10.1007/978-90-481-9657-9_8
sha: 518b321d838209ce3ab92de7991f21f27ed7943b
doc_id: 34640
cord_uid: o0vacxc2

Viruses, bacteria, fungi, protozoa, and metazoa (parasitic worms and arthropods) are among the aetiological agents of zoonoses and sapronoses. Our survey only concerns the agents of microbial diseases (i.e., not the metazoan invasions and infestations), and is arranged according to systematic position. In addition, a new zoonotic disease caused by prions – variant of Creutzfeld-Jakob disease – is included.

BSL-1 -the agent does not usually cause any illness, and standard microbiological practices are required (work on open bench); BSL-2 -the agent can cause an illness and care is required to control aerosols and contamination (class I or II biosafety cabinets [BSC] are required for aerosol producing procedures; limited access); BSL-3 -the agent causes a serious illness and it can spread aerogenically; class II BSC required for all manipulations with infectious material; restricted access, air lock facility, controlled uni-directional air flow, exhaust air discharged away from building (with certain viruses via HEPA filtration); BSL-4 -the agent causes serious, life-threatening disease and it can spread aerogenically, there is no known effective therapy nor vaccination against it; the work with such agent necessitates rigorous containment of all manipulations, change of clothing and shower; class II BSC is adequate only when all laboratory personnel are immunized or insusceptible to the agent, otherwise class III BSC or hermetically closed positive pressure suits are required; the facility must be equivalent to a separate building with HEPA filtration of all exhaust air, and provided with a double-door autoclave.

For dangerous agents of the bio-containment grade BSL-3, the BSL-2 practices and facilities can be generally used for the less risky nonpropagative laboratory procedures such as serology with inactivated antigens or for staining of fixed (inactivated) impression smears, while BSL-3 practices and facilities have to be used for propagative techniques such as inoculation (and harvesting) of cell cultures, embryonated eggs or experimental animals, the necropsy of infected animals and manipulations with infected tissues. A more detailed information on BSL and risk groups of microbes is given below (CDC 2007 Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available (Moderate individual risk; low community risk). A pathogen that can cause human or animal disease but is unlikely to be a serious hazard to laboratory workers, the community, livestock or the environment. Laboratory exposures may cause serious infection, but effective treatment and preventive measures are available and the risk of spread of infection is limited Risk group 3

Agents that are associated with serious or lethal human disease for which preventive or therapeutic interventions may be available (high individual risk but low community risk) (High individual risk; low community risk). A pathogen that usually causes serious human or animal disease but does not ordinarily spread from one infected individual to another. Effective treatment and preventive measures are available Risk group 4

Agents that are likely to cause serious or lethal human disease for which preventive or therapeutic interventions are not usually available (high individual risk and high community risk)

A pathogen that usually causes serious human or animal disease and that can be readily transmitted from one individual to another, directly or indirectly. Effective treatment and preventive measures are not usually available Biosafety Level 1 is suitable for work involving well-characterized agents not known to consistently cause disease in immunocompetent adult humans, and present minimal potential hazard to laboratory personnel and the environment. BSL-1 laboratories are not necessarily separated from the general traffic patterns in the building. Work is typically conducted on open bench tops using standard microbiological practices. Special containment equipment or facility design is not required, but may be used as determined by appropriate risk assessment. Laboratory personnel must have specific training in the procedures conducted in the laboratory and must be supervised by a scientist with training in microbiology or a related science. Biosafety Level 2 is suitable for work involving agents that pose moderate hazards to personnel and the environment. It differs from BSL-1 in that (1) laboratory personnel have specific training in handling pathogenic agents and are supervised by scientists competent in handling infectious agents and associated procedures;

(2) access to the laboratory is restricted when work is being conducted; and (3) all procedures in which infectious aerosols or splashes may be created are conducted in BSCs or other physical containment equipment. Biosafety Level 3 is applicable to clinical, diagnostic, teaching, research, or production facilities where work is performed with indigenous or exotic agents that may cause serious or potentially lethal disease through inhalation route exposure. Laboratory personnel must receive specific training in handling pathogenic and potentially lethal agents, and must be supervised by scientists competent in handling infectious agents and associated procedures. All procedures involving the manipulation of infectious materials must be conducted within BSCs (preferably Class II or Class III), or other physical containment devices, other physical containment devices, or by personnel wearing appropriate personal protective equipment. The laboratory must be separated from areas that are open to unrestricted traffic flow within the building. Biosafety Level 4 is required for work with dangerous and exotic agents that pose a high individual risk of life-threatening disease, aerosol transmission, or related agent with unknown risk of transmission. Agents with a close or identical antigenic relationship to agents requiring BSL-4 containment must be handled at this level until sufficient data are obtained either to confirm continued work at this level, or re-designate the level. Laboratory staff must have specific and thorough training in handling extremely hazardous infectious agents. Laboratory staff must understand the primary and secondary containment functions of standard and special practices, containment equipment, and laboratory design characteristics. All laboratory staff and supervisors must be competent in handling agents and procedures requiring BSL-4 containment. Access to the laboratory is controlled by the laboratory supervisor in accordance with institutional policies. There are two models for BSL-4 laboratories:

(1) A Cabinet Laboratory where all handling of agents must be performed in a Class III BSC.

(2) A Suit Laboratory where personnel must wear a positive pressure protective suit. BSL-4 Cabinet and Suit Laboratories have special engineering and design features to prevent microorganisms from being disseminated into the environment. The BSL-4 cabinet laboratory consists of either a separate building or a clearly demarcated and isolated zone within a building. For BSL-4 containment agents, the BSL-3 laboratory procedures can be sometimes used when all personnel is effectively vaccinated against the disease and stringent laboratory protocols are applied (example: TBE virus).

Since 1986, an explosive epizootic of bovine spongiform encephalopathy (BSE) has occurred in the UK: about 166,000 cattle were affected up to 1997, with peak incidence between 1992 and 1993. According to the main symptom -loss of neuromuscular coordination -the syndrome has informally been called "mad cow disease". It originated from the use of ovine meat-bone meal added to the fodder of cattle; some of the source sheep cadavers had been infected with scrapie, another spongiform encephalopathy, known and described in Great Britain since 1732. Scrapie was widely dispersed in Britain by the mass use of a vaccine against louping ill (1938 and later) unintentionally contaminated with scrapie. In cattle a disease similar to scrapie was never observed before 1986; in the 1980s, scrapie obviously overcame the species barrier and adapted to cattle (a "host-jumping event"). The infectious agent in BSE and in similar "slow" or "unconventional" diseases, called generally transmissive spongiform encephalopathies (TSE), with an incubation period usually over 3 years in diverse mammals (mink, cat, deer) including man (Creutzfeld-Jakob disease, or kuru) are so-called prions (Stanley B. Prusiner 1982: "proteinaceous infectious particles", a modified acronym), causing vacuolisation of the brain tissue that looks like a sea sponge or an Emmental cheese. It is interesting that the prion PrP c is a physiological normal protein in the CNS, which however can change its conformation (spatial configuration) from the molecule with a prevailing α-helix structure to the pathogenic β-folded flat structure PrP Sc (the index Sc means scrapie). Following this structural rearrangement, the molecule becomes hydrophobic and resistant to disintegration. An accumulation of these PrP Sc prions in the CNS leads to the subsequent destruction of neurons. The pathological isoform of the prion posseses several other quite unusual characteristics: it is non-antigenic (no humoral antibodies are produced against the prion), resistant against proteases (this is why it accumulates in tissue not being metabolised), high temperature (it does not inactivate at 121 • C for 60 min nor at 240 • C for 1 min) and common disinfection liquids (peracetic acid, phenol, alcohols, formalin, ultraviolet and microvave irradiation), while undiluted sodium hypochlorite, 4% NaOH, or autoclaving at 134 • C for 60 min are effective.

Creutzfeld-Jakob disease (CJD) was described in 1920-1921. It is a rare, but absolutely fatal disease with a mean incidence of about 0.4 cases per 10 million population, usually hereditary but there is also a transmissible form e.g. during corneal transplantation or on application of hypophyseal growth hormone. A new variant of human CJD (abbreviated as "vCJD") has been observed in Britain since 1994, differing from classic CJD by a substantially shorter incubation period (months rather than years), a much higher incidence rate (the original inter-annual increase of the incidence was 20-30%) and in also affecting young people. This vCJD was detected disproportionately more often in families of farmers in areas where BSE was endemic and after contact with diseased cattle. There is a justified hypothesis that vCJD is, in fact, BSE transmitted to humans, it means a zoonosis. This hypothesis has been promoted by results of several experiments with BSE on animals (monkeys and mice). The CNS, bone marrow, neural ganglions, ileum, retina, and so-called mechanically-recovered meat (remnants of meat detached from backbone and ribs, used for preparation of hamburgers, sausages and minced meat in tins for humans and pet animals) are regarded as risky bovine tissues for consumption. Until August 2010, "only" 212 people had died of vCJD (against the originally expected many hundreds or thousands of victims), out of which 43 patients were from outside Great Britain (France 25 cases, Ireland 6, the Netherlands 2, Spain 1, Portugal 1, Italy 2, Canada 1, USA 3, Japan 1, and Saudi Arabia 1). The epidemic was efficiently controlled by drastic veterinary measures: culling, and the ban on feeding meat-bone meal to cattle.

Bio-containment: BSL-2. Diagnosis of transmissive spongiform encephalopathies is carried out using electroencephalography, CT, histopathology, immunohistochemistry, molecular biology (PCR), ELISA and WB.

Most zoonotic viruses have an RNA genome, although some zoonoses are also caused by DNA herpetic and pox viruses. Numerically most common viral agents of zoonoses are arboviruses. The acronym arbovirus (for "arthropod-borne virus", coined by W. M. Hammon in 1958) was suggested by W. C. Reeves, and recommended for general use by the WHO in 1960. Arboviruses do not constitute a taxonomic unit, but an ecological group with a common mode of transmission to vertebrates. Their existence in nature is conditioned by replication in blood-feeding (haematophagous) arthropods and by an interaction between these arthropods and vertebrates. It is important that transmission from the vector arthropod to the recipient vertebrate is biological, not mechanical. The ability of replication in two phylogenetically and physiologically diverse organisms -poikilothermic arthropods and homeothermic vertebrates -and, at the same time, at largely varying ambient temperatures, is a remarkable characteristic and one that is in other viruses unusual.

For the transmission of arboviruses by competent arthropod vectors the following conditions must be fulfilled:

(1) the vector is infected by feeding on a viraemic vertebrate host or during cofeeding with infected vectors, (2) the infectious dose must pass to the vector's gut lumen, (3) the virions are adsorbed on the membrane of epithelial gut cells, penetrate into them by endocytosis or fusion of the virion envelope with the cell membrane, and replicate intracellularly, (4) infectious virions disseminate from epithelial gut cells in the haemocel of the vector, (5) they further migrate into salivary glands, (6) the virions are transmitted in saliva by feeding of the vector on a susceptible host.

Nearly 500 arboviruses are registered (International Catalogue of Arboviruses) at present. They belong to 9 families: Bunyaviridae (52% of all arboviruses), Reoviridae (17%), Flaviviridae (12%), Rhabdoviridae (10%), Togaviridae (6%), Orthomyxoviridae, Poxviridae, Asfarviridae and Nodaviridae (the latter four all less than 1%). However, only about 100 arboviruses have been reported as pathogenic to humans.

The diagnosis of arbovirus and other virus infections is largely based on serological laboratory analysis, optimally by using paired blood serum samples taken at an interval of 2-3 weeks. Recent infection is said to be demonstrated when the patient seroconverts between the two intervals (i.e., the 1st sample is without antibodies, while the 2nd sample contains antibodies to a particular virus) or when there is an at least fourfold increase of antibody titre against the virus, as revealed in different serological tests, e.g. ELISA, HIT, CFT, VNT, IFA etc. (Lennette, Schmidt et al. 1974 ). If there is only one (convalescent) serum sample of the patient available, the differentiation of recent infection from a past one can be done by testing for IgM and IgG immunoglobulins -in recent infections IgM antibodies prevail over IgG. A very significant, but difficult and time-consuming technique is the isolation of the virus agent from the blood, CSF or bioptic samples of the patient using inoculation of suckling mice, cell cultures or chicken embryos. In the last decade, isolation techniques have started to be intensively replaced by molecular techniques detecting specific nucleic acids of particular viral agents: traditional or real-time PCR and RT-PCR, nested (RT-)PCR, RLB, sequencing, and others. These methods are excellent tools, although they also have some specific limitations (e.g., they do not show whether the nucleic acid fragments originate from a viable virus). Various immunohistochemistry techniques are also very convenient for the detection of viruses in the vertebrate tissues, and usually they are highly specific.

Specific therapy for viral diseases usually does not exist, and therefore symptomatic treatment, rest in bed, a sufficient supply of fluids, infusions and antipyretics are recommended; in certain cases antiserum (a specific immunoglobulin) may help, when applied immediately after infection. Only a few virus diseases can be treated with antivirals such as nucleotide analogues, e.g. ribavirin in RNA virus infections, or acyclovir in some DNA viruses. The optimum specific measure against virus infection is vaccination. Unfortunately, very few vaccines are available against zoonotic virus diseases at present: YF, JE, TBE, WEE/EEE/VEE, RVF, and lyssa.

Virions of the genus Alphavirus are spherical (60-70 nm), enveloped, contain one molecule of ss(+)RNA sized 10-12 kbp, and 2-3 surface glycoproteins E1, E2 (E3). Alphaviruses occurring in New and Old World differentiated phylogenetically some 2-3 thousands of years. The first virus of this group (WEE) was isolated from a dead horse in 1933. Venezuela and Columbia in 1962-1964 when about 30,000 persons were ill and 300 of them died, a smaller one in Mexico and Texas in 1971 (84 cases) , and a huge one in 1995 in Columbia and Venezuela with 75,000-100,000 cases. Bio-containment: BSL-2 (WEE, EEE), BSL-3 (VEE: a high risk of laboratory infections). Prevention: there are mono-, bi-and tri-valent inactivated vaccines (horse, human), their use is however limited (usually applicable for laboratory personnel). Geographical distribution: North, Central and South America. However, only the less virulent subtypes of VEE occur in North America (Tonate, Everglades). Rio Negro and Pixuna viruses are other subtypes of VEE, occurring in Argentina and Brazil, respectively. Brand new data indicate that EEE virus strains that circulate in Central and South America might represent a distinct species compared to North American strains, needing a possible reclassification of EEE (J. Virol. 84: 1014 .

Antigenically related with the next alphavirus; three genotypes of CHIK virus are differentiated: West African, and South/Central/East African, and Asian. In Svahili language, "chikungunya" means "something what causes people becoming bended".

Source of infection (natural host range): mammals (wild primates, bats), man. Animal disease: asymptomatic course. Transmission mode (Fig. 8 .3): culicine mosquitoes (Aedes aegypti, Ae. albopictus, Mansonia spp.). The natural cycles are: (a) sylvatic (gray vervet monkeys, baboons + canopy mosquitoes Ae. africanus, Ae. furcifer, Ae. taylori); (b) urban (synanthropic: man + Ae. aegypti, Ae. albopictus, Culex pipiens fatigans). Human disease: chikungunya fever with a sudden onset and chills, strong headaches, severe arthralgia, myalgia, backache, nausea, vomiting, erythema on face and trunk, up to maculopapular rash, lymphadenitis, photophobia, sometimes (e.g. with Asian strains) haemorrhages; fatality rate is very low, but arthralgia may develop into severe arthritis and persist for several months (even years). Epidemics of CHIK: 1952 CHIK: -1953 , first recognized outbreak in eastern Africa; 1955, another big epidemic in Africa; 1964 -1965 in India (at least half a million of cases) and Thailand; 2001 -2003 2004, an epidemic in Kenya; 2005 -2006 , a huge outbreak (about 280,000 cases including 213 fatalities) on islands of Indian Ocean which started on the Comoros and Réunion Island where 255,000 persons out of 775,000 inhabitants were infected (about 130 cases have been still reported in 2010); many additional cases were reported on the Seychelles archipelago (9,000), Mayotte (5,800), Mauritius rash, apathy, lymphadenitis, affection of kidneys (haematuria, glomerulonephritis), splenomegalia; fatalities have not been reported; persistent or recurrent arthralgia and arthritis (polyarthritis) and lethargy can occur for up to 6-12 months. Ross River fever is the most frequent arbovirosis in Australia, with a mean incidence of about 4,800 patients annually (for instance 47,500 cases were reported in the period [1991] [1992] [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] . Five big epidemics of RR occurred: in 1927 RR occurred: in /1928 during the 2nd WW; 1956; 1979 /1980 an explosive outbreak, with >65,000 persons affected on the Polynesian islands and archipelagos of Fiji, Samoa, New Caledonia, Cook and Tonga, and 2003/2004 (re-emergence on Fiji) . Diagnostics and treatment of patients with RR fever costs Australia annually 2.7-5.6 million dollars. Risk factors for outbreaks include among others heavy rainfalls and higher maximum tides, causing increased mosquito population densities. Bio-containment: BSL-2. Geographical distribution: Australia, New Guinea, Polynesia (Solomon Islands, New Caledonia, Fiji, American Samoa, Tonga, Cook Islands).

The virus was first isolated from mosquitoes in the Barmah Forest in Victoria, Australia, 1974. Source of infection (natural host range): mammals (e.g. kangaroo Macropus agilis), birds. Animal disease: inapparent course. Transmission mode: mosquitoes Aedes vigilax (competent vector), Culex annulirostris, Ae. funereus, Ae. camptorhynchus, Ae. normanensis, Ae. bancroftianus, Ae. eidsvoldensis, Cx. globocoxitus, Verrallina funerea (competent vector), Anopheles amictus, An. annulipes, and other species. Human disease: epidemic polyarthritis, with symptoms similar to those caused by Ross River virus -fever, headache, arthralgia, myalgia, rash (the rash more marked than in RR), apathy, lymphadenitis, affection of kidneys (haematuria, glomerulonephritis), splenomegalia; fatalities have not been reported; persistent arthralgia and polyarthritis occur for shorter time than in RR (a few months at maximum). First big epidemic of Barmah Forest arthritis was reported in 1993/1994 (but before, in 1992 , also a number of cases occurred), and a total of 1,084 cases were reported between 1992 and 1999 (at the same time, the number of Ross River fever patients attained 5,863); a major epidemic occurred in 2005/2006, with 1,895 reported cases. Bio-containment: BSL-2. Geographical distribution: Australia.

Virions of the genus Flavivirus [Lat. flavus, yellow] are spherical (40-50 nm), enveloped, they contain one molecule of ss(+)RNA sized 10-12 kbp, and surface proteins E and M. This genus involves 75 viruses of 9 antigenic groups, most of them being transmissible by arthropods (mosquitoes and ticks). The strains of YF virus can be divided in Ethiopian and Neotropical (Theiler and Downs 1973) , and according to sequencing analyses of genes for protein E in 3 genotypes: IA -West-African, IB -South-American, II -East-African. More detailed classifications differentiate even 7 genotypes.

Colobus, Cercopithecus, Erythrocebus, Cercocebus, baboons, probably also galagoes in Africa, while Alouatta, Ateles, Saimiri, Pithecia, and Callithrix in South America), other mammals of tropical forests, opossum (Didelphis marsupialis); man (the main amplifying host of the virus in the urban cycle). Animal disease: inapparent course (however, some species of New World monkeys die after experimental inoculation). Transmission mode ( In the sylvatic cycle, man acquires infection accidentally during occupational (e.g., hunters) or recreational (tourism) activities. In Africa, an intermediate (savannah) cycle involves transmission of YF from tree holebreeding Aedes spp. (e.g., Ae. opok, Ae. luteocephalus) to humans living or working in jungle border areas. For typical habitats of sylvatic YF, see Photos 5.1 and 5.2. Human disease: yellow fever -high fever with chills, headache, backache, vomiting (in severe cases black vomit containing blood), haemorrhages, necrotic hepatitis (YF virus reveals a marked hepatotropism) with icterus, nephritis, albuminuria, sometimes also encephalitis; fatality rate is 5-40%. YF was introduced in the Caribbean from western Africa during the slave trade (introduction of viraemic persons and infected Ae. aegypti mosquitoes on slave ships): the first extensive epidemic occurred here in 1647-1648 and involved Little Antilles (Barbados, St. Cristof, Guadeloupe), Yucatan and Cuba (in Havana one-third of citizens died); epidemics occurred frequently in Central America also in the eighteenth and nineteenth centuries. In 1741 and 1802-1803, big outbreaks of YF were reported in Portugal and Spain (80,000 victims -also an import on ships, with a consequent spread from seaports to inland); in 1793, 15% citizens of Philadelphia died on YF; in 1853, 8,000 persons from 29,000 infected died in New Orleans; 1900, Havana: Human disease: Japanese encephalitis with fever, headaches, myalgia, decreased consciousness, convulsions, pareses, aggravated breathing; fatality rate 20-40%; common are severe irreversible sequelae in 30-40% of patients (and even higher proportion among children). The first recorded extensive JE epidemic occurred in 1924, with 6,125 cases including 3,197 deaths. The present incidence in Asia is thousands of patients yearly: in the 1990s it was on average 45,000 (about 10,000 fatal), while in the last years 20-50 thousands annually, out of them 6,000-10,000 fatal (for instance, China reported a total of 38, 000 cases in 1990, about 15,000 in 1995, 8,100 in 1999, and 5,104 1950-1951, 1956, 1971, and 1974 . Outbreaks usually occur after heavy rains followed by extreme drought. Bio-containment: BSL-3. Geographical distribution: northern Australia, New Guinea.

Serologically it cross-reacts (in CFT) with distantly related WNV and JEV, being more closely related to Ntaya flavivirus. Interestingly Diagnosis: serology (ELISA, HIT, CFT, VNT), detection of IgM in early phase or seroconversion in paired serum samples; less common is the isolation of the virus from the blood or CSF in cell cultures (e.g., PS pig embryo kidney cells) or in mice, detection of the virus' RNA by using RT-PCR. Prevention: inactivated vaccine ("FSME-Immun" Immuno/Baxter; "Encepur" Behring); specific immunoglobulins (but effective only when applied immediately, i.e. within 1-2 days after infection, otherwise it could be even detrimental); repellents against ticks. 

Virions are spherical (80-120 nm), enveloped, containing segmented molecule of a ss(-)RNA (the three segments are labeled L, M and S) sized 11-19 kbp (genus Orthobunyavirus -12 kbp), with two surface glycoproteins G1 and G2, nucleoprotein N and transcriptase protein L. During a mixed simultaneous infection of cells in a vector or vertebrate host with different but related bunyviruses, reassortant (hybrid) virions can arise through incorporation of RNA segments from different viruses. Incidence of this disease is low. The disease with Ilesha (7 cases) and Bwamba (9 cases) viruses included fever with headache, myalgia and rashof the observed Ilesha cases, one was fatal. One encephalitic case caused by Tensaw virus was reported. Also these American species of rodents are not only the competent hosts of hantaviruses, but at the same time also the reservoir, due to their persistent infection combined with long-term excretion of the virus by saliva, urine and faeces. Animal disease: inapparent course. Transmission mode: aerogenic (dried particles of rodents' infectious excreta -urine, faeces, saliva), contact (rodent bite), and alimentary -food contaminated by infected rodents. Epidemiological cycle is analogical to that of the Old World hantaviruses. The main risk factor for acquiring HPS or HCPS is being a "male farmer seeing or killing rats in the fields or dwellings". Human disease: hantavirus pulmonary syndrome (HPS) -high fever, chills, headaches, myalgia, arthralgia, diarrhoea, nausea, sweat, thrombocytopenia, severe hypotension, cough, pneumonia (marked oedema of the lungs)intensive care including assisted ventilation is necessary, carditis (when also carditis is associated with the syndrome, the disease is called hantavirus cardio-pulmonary syndrome, HCPS); high fatality rate, 45-70%. Sin Nombre: 186 cases in USA, 1993 USA, -1998 . Andes virus has caused several epidemics with a high lethality; e.g., a total of 628 cases have been reported in Chile, with a mean fatality rate of 30-35%. 

Virions spherical (60-100 nm), they contain 10-12 segments of dsRNA with a total size of 19-21 kbp; reoviruses do not have lipoprotein envelope, and thus are insensitive to diethyl ether contrary to other arboviruses. They also do not produce haemagglutinin (HIT cannot be used in diagnostics). Due to the highly segmented genome, they are genomically (and phylogenetically) markedly variable.

Virions (60-80 nm) contain 12 segments of dsRNA with a total size of 21 kbp. 

This reovirus, a prototype species of the genus Seadornavirus, with a dsRNA genome consisting of 12 segments, is considered an emerging mosquito-borne virus in eastern and southeastern Asia. It was first isolated in China (Yunnan province) in 1987. Two groups (A, B) and subgroups (A1, A2) have been disclosed occurring in different areas.

Source of infection (natural host range): pig, cattle. Animal disease: CNS affection in pigs. 

Virions of this genus of the family Reoviridae are spherical (80-100 nm), not enveloped, with 11 segments of dsRNA sized 19 kbp.

Source of infection (natural host range): cattle, pig (some genotypes of the serotype C of swine rotaviruses are obviously zoonotic; also zoonotic are some strains of serotype A which causes disease in small children under 5 years old), dog; man. Animal disease: diarrhoea in calves and piglets. Transmission mode: alimentary (this is, of course, not an arbovirus). Human disease: gastroenteritis. Bio-containment: BSL-2. Geographical distribution: worldwide.

Virions are rod-like [Greek ραβδoς (rhabdos) = rod or rivet] with a characteristic bullet shape, about 100-500×45-100 nm, enveloped, containing one molecule of ss(-)RNA sized 11-12 kbp.

Virions are 100-430×45-100 nm, the molecule of RNA has 11 kbp.

Source of infection (natural host range): equids, cattle, pig, wild mammals. Animal disease: vesicular stomatitis of cattle and horses. Transmission mode: percutaneous, through conjunctiva, aerogenic, and also by haematophagous diptera (mosquitoes, sandflies [Lutzomyia trapidoi: TOT in VSI], biting midges, tabanids, blackflies). Non-viraemic transmission of VSV by co-feeding was experimentally demonstrated among blackflies. Human disease: vesicular stomatitis -a short-term flu-like disease with myalgia, occasionally with vesicules in the oral and nasal cavities. Chandipura virus can cause encephalitis in children in India. America the dog prevails as the source of human infection ("dog rabies": the proportion is 75% and more), followed by domestic ruminants and man, while in North America, similarly as in Europe, wild mammals (76.5%).

According to the source of human infection we can distinguish:

(1) "urban (canine) rabies": main source are stray dogs; this form is dominating in Asia, Africa and South America, with mortality 11-83 human cases per 1,000 cases of rabies in animals; (2) sylvatic (wildlife) rabies: main source are wild mammals; dominating in Europe and North America, with mortality <1 (0.3-0.5) human cases per 1,000 cases of rabies in animals.

Animal disease: lyssa, rabies -paralysis, aggressive behaviour. Rabies was also occasionally diagnosed in cattle, donkey, cat, roe deer, rabbit, and some rodents (squirrel, kangaroo rat, cotton rat, vole, hamster). Transmission mode: percutaneous -biting of an infected mammal (virus in saliva), transplantation of cornea (8 cases), liver and kidneys (2 cases in Germany, infection of the donor originated in India). Human disease: rabies (lyssa) -encephalomyelitis with excitation, aerophobia (patient cannot stand breath of air over face), hydrophobia, anxiety, hallucinations and bizzare aggressive behaviour, eventually followed by paralysis, coma and terminating with death at full consciousness (without treatment, the fatality rate is 100%). Acute neurologic disease is divided into furious and paralytic (dumb) forms. Incubation period is long, 10 days to 6 months. The disease was known already in the Old Babylon, Egypt, Israel, India, China, ancient Greece and Rome. According to WHO, about 50,000-60,000 human deaths from rabies are estimated to occur annually, most often in Asia: e.g., about 20,000 cases in India (the Buddhist and Hindu ethics forbid culling the stray dogs; also in Thailand the killing of stray dogs is prohibited). Bio-containment: BSL-2/3. Diagnosis: anamnesis (animal bite); observation of the captured biting animal for the period of 5-10 days by a veterinarian, or post-mortem examination of the animal (histological slides of the brain and salivary glands -detection of antigen by the technique IF, Negri bodies or intracerebral inoculation of mouse); in the human patient, IF microscopy of corneal, mucosal and bioptic samples; also isolation on mice. Treatment: post-exposure prophylaxis (PEP) is an immunization with several doses of vaccine combined with antiserum application (antirabic equine immunoglobuline). Prevention: vaccination of exposed persons -several effective inactivated rabies vaccines are currently available worldwide (the virus is cultivated in human diploid cells); obligatory immunization of pet dogs, reduction of foxes or their vaccination (baited oral vaccine with strain SAD, suggested by George M. Baer); the latter method has 80% effectivity in the fox populations. Oral vaccination of foxes started in Europe in Switzerland (1978) , and it has then been used in France, Germany, Czechland and other countries. Geographical distribution: Lyssavirus s.s. occurs worldwide with the exception of Great Britain (the UK has applied a very strict policy since 1886: a 6-month quarantine for import or visit of dogs and cats), Ireland, Iceland, Japan, Australia, New Zealand and some other islands. The highest prevalence of the virus is in South and East Asia, and Central Africa.

Virions are similar to those of Lyssavirus s.s. aerogenic (by aerosol in caves populated by rabies-infected bats). Human disease: rabies (lyssa) -encephalomyelitis with excitation etc. Some of the bat lyssaviruses can kill humans (see above). Bio-containment: BSL-2/3. Diagnosis: anamnesis (animal bite); examination of the animal (histological slides of the brain and salivary glands -detection of antigen by IF or intracerebral inoculation of mouse); in the human patient, IF microscopy of corneal, mucosal and bioptic samples; also isolation on mice. Treatment: post-exposure prophylaxis is an immunization with several doses of vaccine combined with antiserum application (antirabic equine immunoglobuline). Geographical distribution: mainly in Europe and Africa, e.g. EBL1 in Poland, Czechland, Ukraine, Russia, Finland, France, Germany, Denmark, the Netherlands, former Yugoslavia, Spain; EBL2 in Great Britain, Finland, the Netherlands, Germany, Switzerland. However, some human pathogenic bat lyssaviruses occur also on other continents (see above).

Virions spherical to pleomorphic (85-130 nm), enveloped, contain two segments of ss(±) RNA sized 11 kbp. Interestingly, they also contain ribosomes (20-25 nm) that cause their "sandy" appearance under electron microscopy. Zoonotic arenaviruses belong to two complexes: (1) etc.), facial and neck oedema, tinnitus to deafness (common complication), hypovolaemia, abortion; fatality rate 10-50%, in severe cases up to 70%. In 1969-1975, a number of epidemics were recorded in tropical Africa (Nigeria, Liberia, Sierra Leone); hundreds of cases have been observed in northern Nigeria each year. 1996-1997 Sierra Leone: 823 cases, 53 died. In Sierra Leone, up to 40% of adult persons were found to be seropositive to Lassa virus in some areas (while the national mean seropositivity rate was 9%). It is estimated that 100,000-300,000 human infections per year occur in West Africa (with approximately 5,000 deaths). It is interesting that only 6-20% of persons infected with Lassa virus become clinically ill (according to serological survey in the latter two African countries). Imported cases of Lassa fever are occasionally reported in tourists and hunters returning from endemic regions. Bio-containment: BSL-4. Diagnosis: ELISA (IgM and IgG), IFA, RT-PCR, immunohistochemistry (postmortem). Treatment: ribavirin (helps only when applied in the first 3 or so days of disease: fatality rate decreases to 5-10%); immune serum; supportive care (e.g. fluid and electrolyte balance, oxygenation, blood pressure monitoring). Prevention: avoiding contact with Mastomys spp. rodents. Geographical distribution: western and central Africa (Nigeria, Liberia, Sierra Leone, DR Congo, Mali, Guinea, Senegal and the Central African Republic).

Source of infection (natural host range): rodents. Animal disease: unknown.

Transmission mode: contact or aerosol (highly contagious). Human disease: haemorrhagic fever with severe headache, myalgia, vomiting, chest pain, sorethroat (pharyngitis), thrombocytopenia, granulocytosis; acute respiratory distress syndrome, and renal dysfunction. Outbreak of disease involving 5 patients, 4 of whom died, occurred in South Africa, 2008 (the first patient had been transferred from Zambia to South Africa for medical management, 3 cases involved secondary spill over of infection from the first patient, and one was a tertiary infection). Bio-containment: BSL-4. Diagnosis: ELISA (IgM and IgG), RT-PCR, immunohistochemistry (post mortem). Treatment: ribavirin or immune plasma in the acute phase. Geographical distribution: Zambia (South Africa).

Source of infection (natural host range): drylands vesper mouse Calomys musculinus (reservoir) -chronic infection with a persistent viraemia and excretion of the virus by urine, saliva and faeces. Animal disease: inapparent course (but lethal in guinea pig). Transmission mode: alimentary, contact (percutaneously -bites), aerogenic (in farmers); high risk of laboratory infections (aerosol). Human disease: Argentine haemorrhagic fever -high fever, headaches, pain in abdomen and extremities, conjunctivitis, erythema on head and chest, petechial bleeding in the mouth, gastrointestinal and urogenital tracts, petechiae also in the skin, neurological defects (palsy, epilepsy), hypovolemic shock; fatality rate up to 30%, very long convalescence. Epidemics and cases have occurred in Argentina since 1958 (discovery date); up to now a total of at least 25,000 clinical cases. Bio-containment: BSL-4. Diagnosis: ELISA (IgM and IgG), RT-PCR, immunohistochemistry (post mortem). Treatment: should start early with immune serum (plasma) and ribavirin. Prevention: vaccine. Geographical distribution: South America (Argentina).

Source of infection (natural host range): rodents Calomys spp. (mainly C. callosus, reservoir) -chronic infection with persistent viraemia, excretion of the virus via urine, saliva and faeces. Animal disease: inapparent course (but lethal for guinea pig). Transmission mode: alimentary, contact (percutaneous -bites), aerogenic (in farmers); exceptionally high risk of laboratory infection (aerosol). Human disease: Bolivian haemorrhagic fever -high fever, headaches, pain in abdomen and extremities, conjunctivitis, erythema on head and chest, petechial bleeding in the skin, mouth, gastrointestinal and urogenital tracts, neurological defects (palsy, epilepsy), hypovolemic shock; fatality rate 10-30%; very long convalescence. Epidemics and sporadic cases have occurred in Bolivia since 1964 (discovery date), e.g. in 1994 or the latest in 2007 with 20 cases (3 fatal); in total, several thousand cases have been estimated to occur in Bolivia. Bio-containment: BSL-4. Diagnosis: ELISA (IgM and IgG), RT-PCR, immunohistochemistry (post mortem). Treatment: immunne serum (immediately after infection), ribavirin in the early phase. Prevention: vaccine (Junin, partially cross-protecting). Geographical distribution: South America (Bolivia).

Source of infection (natural host range): short-tailed cane mouse Zygodontomys brevicauda (reservoir), Sigmodon alstoni. Animal disease: unknown. Transmission mode: alimentary, contact (percutaneous), aerogenic (in farmers). Human disease: Venezuelan haemorrhagic fever with malaise, myalgia, anorexia, headache, back pain, dizziness, nausea, vomiting, prostration, petechiae, bleeding gums, later bleeding from mucous membranes, tremor, lethargy, convulsions, occasional coma and death. Bio-containment: BSL-4. Diagnosis: ELISA (IgM and IgG), RT-PCR, immunohistochemistry (post mortem). Treatment: immune plasma or ribavirin in the early phase. Geographical distribution: South America (Venezuela).

Closely related viruses, but distinct species.

Source of infection (natural host range): rodents (reservoir). Animal disease: unknown. Transmission mode: contact, alimentary, aerogenic. Human disease: haemorrhagic fever with a course similar to the other New World arenaviruses. First case of Sabiá virus disease (fatal) reported in Sao Paolo in 1990, and several laboratory infections have been also described. Chapare virus caused a small epidemic in Bolivia (2003 Bolivia ( /2004 ) with at least one fatal case. Bio-containment: BSL-4. Diagnosis: ELISA (IgM and IgG), RT-PCR, immunohistochemistry (post mortem). Treatment: immune plasma or ribavirin in the early phase. Geographical distribution: South America -Brazil (Sabiá) and Bolivia (Chapare).

Source of infection (natural host range): white-throated woodrat Neotoma albigula. Animal disease: unknown. Transmission mode: contact or aerosol. Human disease: haemorrhagic fever (3 fatal human cases reported in California). Bio-containment: BSL-2. Diagnosis: ELISA (IgM and IgG), RT-PCR, immunohistochemistry (post mortem). Treatment: ribavirin in the acute phase. Geographical distribution: Southwest USA.

Filoviruses are characteristic for their long filamentous virions (under electron microscopy, some of them appear ring-like, others in the shape of the figure "9", or even branching), 800-1000×80 nm or longer, up to 14 μm (!), enveloped, containing one molecule of ss(-) RNA sized 19 kbp.

Source of infection (natural host range): monkeys (Cercopithecus aethiops and C. ascanius), fruit bats (the reservoir -2007 Gabon, Uganda, Kenya: detection of the virus RNA in 1-5% of examined Rousettus aegyptiacus (Photo 5.28), several virus isolations from bat tissues, and IgG antibodies detected in 2-12% bat individuals), insectivorous bats Rhinolophus eloquens, Miniopterus inflatus in DR Congo; man. Animal disease: sometimes inapparent, but often fatal haemorrhagic disease in primates such as Cercopithecus aethiops or chimpanzee (up to 50% fatality rate) and also at experimental infection of some other monkey species of the Old World. Asymptomatic course in fruit bats. Transmission mode (Fig. 8.15 ): contact (primate saliva, blood and excreta; faeces of infected fruit bats: experimentally infected bats shed the virus for up to 3 weeks), iatrogenic (injections, blood transfusion), less often aerogenic; a high contagiosity -a number of nosocomial and several laboratory infections. Human disease: Marburg haemorrhagic fever, one of the most fatal infectious diseases, with chills, severe headaches, myalgia, pharyngitis, nausea, abdominal pain, diarrhoea, extreme fatigue, maculopapular rash most prominent on the trunk (chest, back, abdomen), skin hypersensitivity, neurological disturbances, conjunctivitis, lymphadenitis, splenomegaly, leucopenia, thrombocytopenia, massive haemorrhages -bleeding from nose, ears and eyes, bloody faeces and bloody (black) vomites, severe cachexia, multiorgan dysfunction However, the reservoir are bats including fruit bats (experimental viraemia lasted up to 21 days in some species -Tadarida condylura, T. pumila, Epomophorus wahlbergi); hunted fruit bats can also be the source of infection. Recently, Ebolavirus RNA was detected in visceral organs of fruit bats Hypsignathus monstrosus, Epomops franquetti, and Myonycteris torquata. Animal disease: usually inapparent except for chimpanzee (fatality rate up to 50%), but experimental infection of monkeys often fatal. Reston virus is pathogenic to pig. Transmission mode: contact and alimentary (saliva, blood and excretions of primates, hunter contacts with dead chimpanzees and monkeys and their meat; tree fruit contaminated with bat saliva and other excreta), iatrogenic (inoculation, transfusions), less often aerogenic; high contagiosity -nosocomial and laboratory infections occur quite frequently. Funeral rituals are also a common risk factor during the outbreaks. Human disease: Ebola haemorrhagic fever, one of the most fatal human infectious diseases, with acute and severe headaches, pharyngitis, pains of muscles, sore back, abdominal pain, hiccups, severe diarrhoea, nausea, vomiting, extreme fatigue and weakness, rash over whole body, neurological and psychotic disturbances (disorientation etc.), conjunctivitis, leucopenia, thrombocytopenia, effective blocking of interferon production, systemic haemorrhages, bloody faeces and bloody vomites, cachexia, hypovolemic shock and renal failure, the face looking as a mask; fatality rate 50-80%; a long-term convalescence. A number of mild or asymptomatic Ebolavirus infections have been observed in humans -in some enzootic areas (e.g., in Gabon) a relatively high proportion of population (about 10%) has antibodies to ebolavirus Zaire without being clinically ill before. Epidemics in the years 1976, 1979 and 1995 

Virions are spherical to pleomorphic 80-120 nm, enveloped, with 8 segments of ss(-)RNA sized 10-15 kbp and with two surface antigens (glycoproteins): haemagglutinin (16 H subtypes) and neuraminidase (nine N subtypes). All these antigenic subtypes have been detected in birds, while in mammals only some of them: for instance in humans they have been found only H1,2,3,5,7,9 and N1,2,7. Changes and evolution of influenza A viruses: antigenic "drift" (restricted mutations in H). . .antigenic "shift" (changes in H and N associated with recombinations or reassortement of individual subtypes in vertebrates (duck, pig) leading to appearance of new subtypes).

Source of infection (natural host range): man; in zoonotic influenza pig, horse, and fowl. Free-living waterfowl, gulls and shorebirds are the main reservoir of influenza A viruses in nature. Some wild anseriforms (swans, geese, ducks) also participate in the spread of highly pathogenic avian influenza (HPAI) viruses. Animal disease: inapparent (in a majority of waterbirds) or fever, sinusitis, bronchopneumonia, oedema of the face and neck, cyanosis -e.g., "fowl plague" in hens due to HPAI virus subtypes H5 and H7, with a fatality rate 70-100%; these subtypes may cause clinical disease also in some terrestrial and aquatic mammals. Transmission mode: aerogenic (a droplet infection), also by conjunctivae and contact. In the zoonotic HPAI H5N1 virus is the highest risk of human infection associated with processing of fowl (killing, removal of feather, cutting into portions), and in Asian animal markets with living fowl if it is infected. Human-to-human transmission of HPAI viruses has been absent or very rare. Close contacts of humans with domestic ducks, chickens and pigs (common dwellings) in southeastern Asia present a permanent epidemiological risk into the future. Bio-containment: BSL-2 (but HPAI H5N1: BSL-2/3). Diagnosis: isolation and cultivation in chick embryos or on cell cultures, detection of antigen or RNA in the samples, serology (HIT). Treatment: antivirotics amantadin, rimantadin, zanamivir (Relenza), oseltamivir (Tamiflu) might moderate the clinical course, but resistant strains of influenza A have already appeared. Prevention: vaccine (human and fowl), culling of infected animal breeds. Geographical distribution: worldwide; most strains of zoonotic influenza originate in Southeast Asia.

Virions are spherical, 80-120 nm, enveloped, contain ss(-)RNA arranged in 6 (Thogoto) or 7 (Dhori) segments with a total size of 10 kbp, and one surface glycoprotein.

Source of infection (natural host range): cattle, camel. Animal disease: inapparent course. 

Avulavirus Newcastle Disease (Avian Paramyxovirus 1)

Virions are spherical or pleomorphic, 150 nm or more, with one molecule ss(-)RNA sized 15 kbp.

Source of infection (natural host range): domestic, wild and pet birds. Animal disease: Newcastle disease (ND) of fowl and other birds, e.g. wild cormorants in North America, with the fatality rate of 10-90%. Transmission mode: contact, aerogenic (workers in fowl farms, laboratory accidents). Human disease: sporadic -painful conjunctivitis, regional lymphadenitis, pharyngitis, bronchitis, atypical pneumonia, affection of the CNS. Bio-containment: BSL-2/3. Diagnosis: isolation of the virus from ocular irrigations or from the blood and urine, serology (VNT, ELISA, HIT). Prevention: fowl vaccination. Geographical distribution: worldwide. and Mackay in 1994, and similar 7 cases of horse owners and attending veterinarians (two were fatal) were documented in 2008-2009. Bio-containment: BSL-4. Diagnosis: isolation (urine, CSF, throat swab, nasal secretions) -risky procedure, RT-PCR, ELISA, VNT, IFA, immunohistochemistry. Geographical distribution: Australia (Queensland), Papua New Guinea.

Antigenically closely related to Hendra virus, the difference in nucleotide sequence of the genome is only 10-20%. Animal disease: in pigs abortions and teratogenic defects; mummified and stillborn piglets with severe degeneration of the brain and spinal cord (almost absent in some piglets), arthrogryposis, brachygnathia, and occasionally fibrinous body cavity effusions and pulmonary hypoplasia, occasionally nonsuppurative myocarditis. Asymptomatic infection in fruit bats. Transmission mode: contact (wounds on hands and forearms) with bodily fluids from infected animals (blood and possibly foetal matter-e.g., amniotic fluid); aerogenic. Human disease: a febrile illness with chills, malaise, headache, and a measleslike rash; only two human cases have been described in Australia (1997 Australia ( -1998 . Bio-containment: BSL-3. Diagnosis: isolation (urine, CSF, throat swab, nasal secretions) -risky procedure, RT-PCR, ELISA, VNT, IFA, immunohistochemistry. Geographical distribution: Australia.

Spherical virions (85-125 nm) with one molecule of ss(-)RNA, unsegmented, 9 kbp in size.

Remark: many virologists do not regard that this is a zoonotic agent. Source of infection (natural host range): horse; sheep, goat, cattle, rabbit, and other mammals (unclear). The natural virus reservoir is unknown at present (rodents?). Animal disease: Borna disease, a fatal meningoencephalitis of horse and sheep (first epizootic described in Germany, 1885). Transmission mode: contact with animal excreta (saliva, tears, nasal discharge), possibly also aerogenic and alimentary. Tenacity of the virus in the dry state is exceptionally long (1-3 years). Human disease: neuropsychiatric disorders not sufficiently characterised, possibly also lymphocytic meningoencephalitis; bornavirus antibodies but also RNA were found in CSF and peripheral blood leucocytes of some psychiatric or immunocompromised patients in several studies. Bio-containment: BSL-2. Diagnosis: isolation in cell cultures; intracerebral inoculation of rabbit (fatal). Geographical distribution: Germany, Austria, Switzerland, France; infrequently it occurs in Japan and USA.

Coronavirus SARS Also called severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virions are spherical to oval (120-160 nm), enveloped, with a molecule of ss(+)RNA sized 28-31 kbp.

Source of infection (natural host range): civet Paguma larvata, raccoon-like dog (Nyctereutes procyonoides), Chinese ferret-badger (Melogale moschata) and other medium-sized carnivores on South-Asian animal markets; man. However, probable reservoir are bats (SARS-like coronaviruses have been isolated from Rhinolophus spp., Miniopterus magnater, and Pipistrellus spp.). Animal disease: asymptomatic infection. Transmission mode: aerosol and contact. Man-to-man transmission is common.

The virus has a considerable tenacity in environment -it survives up to 1 week on surface of various utensils, or in faeces. Human disease: severe acute respiratory syndrome (SARS), which also affects gastrointestinal tract, and has high fatality rate (40-50%). SARS in children has a less severe course than in adults. The proportion of asymptomatic infections in humans is low. First outbreak was reported from the Chinese province Guangdong in November 2002; the epidemic then jumped to Hongkong (hotel Metropol etc.) and to many other localities and countries over the world, becoming a dreadful pandemic. In the period to May 2003, a total of 20,791 patients were reported (9,662 of the cases were fatal) from 30 countries in 5 continents. One of the victims was also epidemiologist Carlo Urbani who put WHO on the alert at beginning of the epidemic. Bio-containment: BSL-3. Diagnosis: RT-PCR, isolation of the virus, serology (ELISA). Geographical distribution: China, Hongkong, Taiwan, Singapore; exported on airplanes also to Vietnam, Canada (Toronto), USA and 22 other countries.

Virions are spherical (30 nm), not enveloped, with one molecule ss(+)RNA sized 7-8 kbp.

Some virologists doubt that EMC virus is zoonotic in that an antigenically very similar Saffold cardiovirus is anthroponotic.

Source of infection (natural host range): rodents (reservoir -but it is uncertain whether EMC virus from rodents is transmissible to humans), pig and other domestic mammals, lagomorphs, non-human primates. Animal disease: encephalomyocarditis (EMC) or inapparent course; sporadic cases and outbreaks of myocarditis, encephalitis, and abortions in pigs. Transmission mode: aerogenic. Human disease: an uncommon disease with fever, headache, malaise, sweats, chills, myalgia, pallor, nausea, vomiting, and abdominal pain, weight loss, arthralgia, retro-ocular pain, photophobia, sometimes meningitis to encephalomyelitis; no mortality reported. Bio-containment: BSL-2. Geographical distribution: worldwide, but sporadic.

The virus is related to cardioviruses, it was isolated and named after a river in central Sweden in 1998. Scandinavian and American strains differ, and there are known three genotypes of Ljungan virus at present.

Source of infection (natural host range): rodents, especially voles (Myodes glareolus, Microtus montanus) -reservoir; also detected in Apodemus flavicollis. Animal disease: diabetes mellitus (usually during overpopulation; the virus attacks pancreas) and myocarditis in Myodes glareolus, or inapparent course. Transmission mode: probably aerogenic. Human disease: intrauterine foetal death (the virus infects the CNS of embryo) -2 cases have been described (Sweden, 2007, and USA 2008) . Ljungan virus is suspect of causing also sudden infant death syndrome, CNS embryonal malformations (hydrocephalus, anencephaly -which has been confirmed in mouse), and it has been detected in adult patients with diabetes and myocarditis. Bio-containment: BSL-2. Geographical distribution: Sweden, Denmark, Italy, USA, but probably worldwide.

Virions are spherical (30-40 nm), not enveloped, with one molecule ss(+)RNA sized 8 kbp.

Source of infection (natural host range): domestic pig (but only the strains of the genomic group II are zoonotic); oysters. Animal disease: gastroenteritis, or asymptomatic infection. 

Virions spherical (30 nm), not enveloped, with one molecule ss(+)RNA sized 7.2 kbp; antigenically uniform, but four genotypes (types I and II are anthroponotic, while the types III and IV are zoonotic).

Source of infection (natural host range): domestic pig, wild boar (reservoir), probably also red deer and rodents (brown rat, black rat); fowl, wild mongoose, horse, primates including man; shellfish. Animal disease: inapparent course (piglets 2-3 months old) or gastroenteritis.

Experimental infection successful in pig, monkey, sheep and rat. Transmission mode: alimentary (food-borne: raw or undercooked swine liver and intestine, deer liver meat contaminated with the virus; or water-borne: drinking of water contaminated with contaminated sewage disposal); personto-person transmission (among household members during outbreaks); parenteral (blood transfusion during a viraemic period), mother-to-child transmission (scarcely documented). 

Virions spherical (110 nm), enveloped, contain 2 identical molecules (dimer) ss(+)RNA, reverse transcriptase, and 2 surface proteins.

Source of infection (natural host range): man. HIV-1 ("human immunodeficiency virus") evolved from SIV ("simian immunodeficiency virus") of chimpanzee Pan troglodytes troglodytes (reservoir), and HIV-2 from SIV of sooty mangabey Cercocebus torquatus. HIV-1 and HIV-2 have therefore zoonotic origin, connected with crossing the species barrier (a host-jumping event). Animal disease: decreased immunity with a milder course than is AIDS in humans. Transmission mode: as the originating zoonosis by contact with the blood of killed wild primates ("cut-hunter hypothesis"); as anthroponosis transmitted sexually, by inoculation or transfusion (blood), transplantation of organs, and vertically from mother to child. Human disease: acquired immune deficiency syndrome (AIDS) -first infections demonstrated sporadically already before 1959 (DR Congo -antibodies); start of AIDS epidemics were revealed in homosexual communities of New York and California in 1981, the number of patients increased continuously resulting in a pandemic: in the year 2001, 40 million persons were infected with HIV or had symptoms of AIDS, of this number 28 million in sub-Saharan Africa (local HIV prevalence rate was in the age 15-25 years 10%, in adults 20%) and 8 million in southeast Asia; 3 million patients succumbed to AIDS worldwide in the same year. Bio-containment: BSL-2. Treatment: zidovudin, Retrovir, Combivir. Prevention: safe sexual behaviour, use of disposable injection syringes and needles in drug addicts. Geographical distribution: worldwide.

Virions approximately spherical (100-230 nm), enveloped, contain a linear molecule dsDNA 125-240 kbp. rhinoceros, felids -often fatal), wild rodents. Transmission mode: direct contact; infrequently also aerogenic and alimentary (risk -pet rodents). Human disease: cowpox (uncommon) -papulae and pustulae on the skin, lymphatic changes on the hands, lesions on eyelids (the Netherlands 2002); exceptionally a generalized illness. Several human cases of cowpox have been reported since 2008 as acquired from pet rats in Germany and France. Occupational disease in farmers, milkers and their close contacts, also in zoo and circus animal attendants. Bio-containment: BSL-2. Geographical distribution: worldwide.

Virions of parapoxviruses are oval, 220-300×140-170 nm. Size of DNA is 130-150 kbp.

Source of infection (natural host range): cattle. Animal disease: papular stomatitis (bovine pustular stomatitis) -papulae and pustulae on the muzzle and in oral cavity.

Transmission mode: direct contact (percutaneous). Human disease: not commonly, bovine papular dermatitis -red-violet papulae and pustulae on fingers and forearm, the course is protracted. Bio-containment: BSL-2. Diagnosis: symptoms; isolation on cell cultures, electron microscopy of the lesion samples. Geographical distribution: North America, Europe, Africa, Australia.

Source of infection (natural host range): cattle, sheep, pig. Animal disease: paravaccine (pseudocowpox) -lesions on the udder of cows (papulae to pustulae). Transmission mode: direct contact (percutaneously). Human disease: milkers' nod(ul)es, paravaccinia -a disease milder than cowpox: small painful not suppurative papulae and nodules on the hands and forearms for up to 6 weeks. Bio-containment: BSL-2. Diagnosis: isolation on cell cultures, electron microscopy. Geographical distribution: Europe, North America.

Source of infection (natural host range): sheep, goat. Animal disease: contagious ecthyma, "orf" -pustulae and papulae on the face and udder. Transmission mode: direct contact (percutaneous); the virus is resistant in the milieu (in scabs and crusts it can survive for years). Human disease: contagious pustular dermatitis -painful dermatitis (papulae to pustulae) on fingers and arms and in the oral cavity, the course is protracted. The disease is rare, it occurs in sheep breeders and among butchers. Bio-containment: BSL-2. Diagnosis: electron microscopy of the pus from pustules and scabs. Geographical distribution: worldwide.

Virions 200×300 nm, DNA size is 145 kbp.

Source of infection (natural host range): monkeys (possibly also other wild and domestic animals). Animal disease: papulae on the face. Transmission mode: mosquitoes (Mansonia) -a mechanical transmission. Human disease: fever with headaches and 1-2 pustular skin lesions for a period of up to 6 weeks. Bio-containment: BSL-2.

Diagnosis: electron microscopy, and virus isolation from skin lesions. Geographical distribution: tropical Africa (Kenya).

Chlamydiae]

Members of the order Chlamydiales are very small Gram-negative spherical bacteria with a diameter of 0.3-0.5 μm, obligate intracellular parasites preferentially of the mucosal epithelium. They do have solid cell wall but without muramic acid (in contrast to other bacteria peptidoglycan between the wall and plasmatic membrane is absent). They do not posses their own energetic metabolism and depend on the ATP system of the host cell (they are therefore called "energetic parasites"); thanks to this adaption, their genome is markedly reduced. The peculiar life cycle of chlamydiae differs greatly from that of other bacteria, and involves small extracellular non-metabolising but infectious elementary bodies (0.3-0.5 μm) that produce in the infected cell bigger and non-infectious reticulate bodies (also called "initial bodies", 0.7-1.1 μm); those divide by binary fission and form new elementary bodies which are able to survive extracellularly and also infect new hosts. Cell inclusions visible microscopically in chlamydial infections are, in fact, conglomerates (colonies) of replicating reticulate bodies together with the daughter elementary bodies. Finally, the infected cells crack or the bodies escape by exocytosis. Chlamydiae are well stained for microscopy according to Macchiavelli (initial bodies are stained blue, and reticulate bodies red) or Giemsa (blue and purple, respectively). The tenacity of chlamydiae in the milieu is very limited, especially for reticulate bodies (however, avian strains of Chlamydophila psittaci can survive in bird droppings for a long time). Chlamydiae are sensitive to diethyl ether because 50% of the cell wall content is formed by lipids, and are readily inactivated by certain antibiotics, largely those that inhibit proteosynthesis (chloramphenicol or tetracycline). The only typical zoonotic species among chlamydiae is Chlamydophila psittaci, while two other species cause anthroponotic infections: Chlamydophila pneumoniae causes respiratory infections (possibly also atherosclerosis and coronary disease), and Chlamydia trachomatis trachoma, but its serotypes D to K very frequent sexually transmissible infections of the human urogenital tract (and proctitis), and serotype L is the agent of lymphogranuloma venereum. In contrast to rickettsiae, chlamydiae are not transmitted by arthropod vectors.

A heterogenous species with a number of genotypes (A to F) differentiated according to the ompA gene (expressing outer membrane protein).

Source of infection (natural host range): domestic, wild and exotic (pet) birdsin psittacines genotype A -psittacosis; in other birds ornithosis: genotype C prevails in anseriforms; genotype B in fowl ((hens, turkeys), feral pigeons (but also the genotype E, at least 500 human cases reported) and passerines; further gulls, egretts etc. -the disease was observed in 230 avian species belonging to 10 orders). Animal disease: usually latent, sometimes subclinical or manifest -ornithosis of young fowl and pigeons, especially under stress conditions, with fluffed feathers, conjunctivitis (closed eyes), rhinitis, pneumonia, anorexia, lethargy, diarrhoea, pericarditis and enteritis, at a high fatality rate. Transmission mode: aerogenic (inhalation of dust containing infected avian droppings); often occupational infectious disease (breeders, fowl farmers, butchers). Tenacity of the elementary bodies is relatively high. Human disease: ornithosis/psittacosis ("parrot disease") -clinical symptoms are highly variable, from mild flu-like symptoms to severe pneumonia or systemic disease; the pneumonia is atypical (radiologic findings are substantially more pronounced than those physical -a nonproductive cough) with high prolonged fever that reveals relapses, headaches, myalgia and arthralgia, exhaustion, sometimes endocarditis, hepatosplenomegaly, encephalitis; fatality rate used to be high (e.g. it was 20% during the outbreaks transmitted by birds imported from Argentina in 1929/1930, but as high as 80% in pregnant women), today is only about 1%. The highest incidence rate of psittacosis is reported from Australia, UK, Denmark, Sweden and the Netherlands. Bio-containment: BSL-2/3. Diagnosis: anamnesis (contact with ill birds); serology (CFT, ELISA -there might occur cross-reactions with Q fever); isolation on chick embryo and McCoy cells, PCR, detection by microscopy of chlamydiae in sputum samples or in inoculated cells using IF or staining (Giemsa, Macchiavelli, Giménez, Lugol's iodine); PCR. Treatment: doxycycline, tetracycline (adults), erythromycin (children, 3 weeks). Geographical distribution: worldwide.

Source of infection: sheep, goat, cattle; occasionally pig, horse, deer. Animal disease: ovine enzootic abortion; in cattle, abortion, stillbirth, mastitis, metritis, epididymitis, orchitis, pneumonia, and occasionally encephalomyelitis (transplacental transmission of the bacteria to embryo); in young domestic animals (sheep, cattle, pig, horse) enteritis, conjunctivitis, pneumonia, and polyarthritis. This disease has very high economic impacts. Transmission mode: inhalation, less often by contact or alimentary. Human disease: mammalian chlamydiosis is milder than psittacosis, with fever, headache, conjunctivitis, arthralgia, affections of urogenital tract; in severe cases pneumonia, renal failure, miscarriage but also women sterility as a consequence; rarely fatal. Risk procedures: assistance with lambing (especially women). 

An obligate intracellular bacterium -endosymbiont of amoebae free-living in water.

Source of infection: river water, drinking water treatment plants, hospital water supplies. Animal disease: abortions in ruminants. Transmission mode: water-borne. Human disease: pneumonia (purulent and interstitial), miscarriage, stillbirth and premature birth. Bio-containment: BSL-2. Diagnosis: PCR, isolation on cell cultures or by amoebal co-culture, serology (ELISA). Treatment: specific treatment unknown, the bacterium is resistant to fluoroquinolones and other antibiotics. Geographical distribution: probably worldwide.

An endosymbiont of free-living amoebae.

Source of infection: river water, drinking water treatment plants. Animal disease: unknown. Transmission mode: water-borne.

Human disease: pneumonia. Bio-containment: BSL-2. Diagnosis: PCR, isolation on Vero cells or by amoebal co-culture, serology (ELISA). Treatment: specific treatment unknown, the bacterium is resistant to fluoroquinolones and other antibiotics. Geographical distribution: Israel, but probably worldwide.

Source of infection (natural host range): domestic ruminants. Animal disease: abortions. Transmission mode: aerogenic. Human disease: miscarriage (described in 2007). Bio-containment: BSL-2. Geographical distribution: USA, Germany.

Alphaproteobacteria]

Rickettsial microorganisms of the families Rickettsiaceae and Anaplasmataceae are very small Gram-negative bacteria, coccobacilli to short rods about 0.6×0.3 μm, intracellular parasites (in either nucleus -rickettsiae of spotted fever group, RSFGor cytoplasma of endothelial cells or leucocytes) and replicate by cross section. They possess most of enzymes the other bacteria have, form ATP (contrary to chlamydiae), exhibit a normal bacterial cell wall with muramic acid, and are stained with Giemsa, Giménez or Macchiavelli stains, poorly according to Gram. A natural reservoir of rickettsiae are arthropods of diverse systematic groups, in them they live usually as commensals, while in the organism of an "unnatural" host, e.g. man, they often cause an illness with fever, vasculitis (they attack selectively endothelial cells) and often also a rash or erythema (spotted fevers and typhus). According to the vector they can be divided into:

(a) louse-borne: Rickettsia prowazekii 

A SFG rickettsia with several subspecies: R. conorii conorii (its full genomic sequence is known), and closely related rickettsiae of Astrakhan fever (R. conorii caspia), Israeli tick typhus (R. conorii israelensis) and Indian tick typhus (R. conorii indica).

Source of infection (natural host range): dog and other canids; rodents, wild rabbit. Animal disease: usually inapparent course, but fever, anorexia, lethargy, splenomegaly, and polyneuritis in dogs. Transmission mode: ixodid ticks Rhipicephalus sanguineus (TOT), R. appendiculatus, R. pumilio (R. c. caspia), Haemaphysalis leachi (TOT), Hyalomma spp. Human disease: Mediterranean spotted fever, boutonneuse fever (French: "fievre boutonneuse") was first described in 1910 -an infiltrate in the place where the vector tick fed with a dark scar (primary necrotic skin lesion -"eschar", French "tache noir"), fever 1-2 weeks, headaches, arthralgia, myalgia, sometimes maculopapular rash, and regional lymphadenopathy in half of patients; increased transaminases AST and ALT; the complications might appear as pneumonia or intravenose coagulation; fatality rate is in untreated persons 1-5% but in places higher (e.g. in Portugal 32% in 1997 Human disease: Queensland tick typhus with fever up to 2 weeks, headache, eschar, regional lymphadenitis, and sometimes a generalized rash. Bio-containment: BSL-2/3. Diagnosis: isolation from the blood; serology (Weil-Felix AR, specific AR, CFT, RIHA). Treatment: tetracycline. Geographical distribution: Australia.

Genomically similar to R. felis and R. australis.

Source of infection (natural host range): rodents -synanthropic (Mus, Rattus), less exoanthropic species. Animal disease: lethal for mice. Transmission mode: the mite Liponyssoides (Allodermanyssus) sanguineus (a mouse ectoparasite occasionally feeding also on man); laboratory infections. Human disease: rickettsial-pox or vesicular rickettsiosis, with the course similar to African tick fever, but usually milder (however, sometimes lethal) -at first a primary ulcerating skin lesion (eschar) and regional lymphadenopathy, after a week follows fever with chills, headaches, myalgia, photophobia, and papulo-vesicular rash over the trunk and extremities (sometimes generalized) rash. Largely an urban zoonosis. Bio-containment: BSL-2/3. Diagnosis: symptoms, inoculaton of mice (the blood from febrile status), CFT, AR (Weil-Felix AR is negative). Treatment: doxycycline, tetracycline (chloremphenicol). Geographical distribution: towns in North America (New York: first described in 1946), Central America (Mexico), Eurasia (Russia, Ukraine, Croatia, southern Europe, Turkey, Korea) and South Africa.

A SFG rickettsia originally labeled as "ELB agent", known since 1994, genomically closely related to R. akari. 

Source of infection (natural host range): exoanthropic rodents (wild rats), insectivores and other small mammals. Animal disease: septicaemia in mice. Transmission mode: larvae ("chiggers") of the mites, especially of the genus Leptotrombidium (reservoir -TST as well as TOT): L. deliense (in the whole geographical range; also a non-bacteraemic transmission by co-feeding has been described), L. akamushi (in Japan), L. pallidum (Japan, Korea, Russian Far East), L. scutellare (Japan, China, Malaysia), L. pavlovsky (the Far East), L. imphalum, L. chiangraiensis, L. fletcheri, L. aernicola, etc. Human disease: scrub typhus, tsutsugamushi -sudden high fevers for up to 2 weeks, hyperhidrosis, severe headaches, lymphadenopathy, often eschar (e.g. in 90% of patients in China), macular rash on face, chest and abdomen, cough to pneumonia, gastrointestinal symptoms, splenomegaly, conjunctivitis, photophobia, CNS affection, often temporary deafness; average fatality rate 15% (range, 1-40%, but up to 60% in untreated cases); Allied troops recorded a total of 20,000 tsutsugamushi cases during operations in 2ndWW, with a fatality rate of 25%. In the 1970s, scrub typhus was a frequent infectious disease among American soldiers also in the Vietnamese War. In South Korea, a total of 23,930 cases (68% serologically confirmed) were reported between 2001 and 2006. Bio-containment: BSL-2/3. Diagnosis: mouse inoculation (blood samples), serology (Weil-Felix AR, CFT, IFA, ELISA). Treatment: tetracycline, doxycycline (chloramphenicol). Prevention: effectivity of inactivated vaccine is low, it is not used. Geographical distribution: southeastern, eastern and southern Asia (among others also the Himalayas in 2006), northern China, northern Australia, and Oceania, typically in grassy and bushy habitats that arose after cut down of tropical forests (Photo 5.32).

Genomic group E. canis s.l., also involves very similar E. muris and veterinary important Ehrlichia (Cowdria) ruminantium, the agent of heartwater disease of ruminants in Africa. with fever, headaches, myalgia, arthralgia, anorexia; bacteraemia, leucopenia, thrombocytopenia, increased levels of transaminases; fatality rate 5-10%; convalescence long, usually 1 month (total weakness, fatigue). In addition, infected persons are more susceptible to other infections (due to immunosuppression). The disease was first described and elucidated in USA, 1994. Probably a majority of A. phagocytophilum strains are nonpathogenic for man (they are endosymbionts of ticks and their host is deer, e.g. the variant Ap-1), and only some strains belong to the pathogenic genotype (e.g., the variant Ap-ha). The situation is confusing especially in Europe, where often disproportionately high prevalence rates (detected by PCR) of A. phagocytophilum have been reported in ixodid ticks approaching those of Borrelia burgdorferi s.l., whereas incidence of HGA in Europe is substantially lower than for instance that of LB. Bio-containment: BSL-2. Diagnosis: blood smear (Giemsa stain: the bacteria form micro-colonies visible as morulae in neutrophil granulocytes), serology (IFA, ELISA with the antigen from A. equi); PCR, cultivation in human leukemic cells HL-60, vertebrate endothelial cells or in tick cell lines. Treatment: doxycycline (or other oxytetracyclines) up to 3 weeks, children and pregnant women rifampicin. Geographical distribution: North America, Europe (Great Britain, Ireland, Scandinavia, Switzerland, Italy, Slovenia, the Netherlands, France, Spain, Germany, Austria, Poland, Denmark, Slovakia, Czechland), Madeira, Siberia, China, Japan.

First isolated in Japan, 2004.

Animal disease: unknown. Human disease: bartonellosis, in two clinical phases: (1) Oroya fever (Carrión's disease -acute form -anaemia, with fatality rate 10-40% when untreated);

(2) verruga peruana (Peruvian wart -papular to verrucose secondary cutaneous form, with a low mortality) [Daniel Carrión autoinfected himself with the blood of a patient, and documented the two stages in 1885; he succumbed to the disease]. A total of about 7,000 workers died due to this disease during the building of the railway connecting Lima with Oroya in 1870. Bio-containment: BSL-2. Diagnosis: blood smear -Giemsa (intraerythrocytic localisation) in acute phase; skin biopsy in the secondary phase; haemocultivation (chocolate BA or agar with rabbit serum, 5-10% CO 2 , the growth is slow); serology (CFT, AR). Treatment: chloramphenicol, ampicillin, penicillin, streptomycin, tetracycline (in verruga peruana mainly against secondary microflora). Geographical distribution: South America (valleys of the Cordillera mountains in Peru, Ecuador and Columbia).

B. henselae is genomically closely related to B. quintana, in fact its "ancestor".

Source of infection (natural host range): cat (reservoir, 10-25% of cats in USA and New Zealand are bacteraemic), rodents. In B. rochalimae, also red fox and gray fox (reservoir?), coyote, raccoon, rural domestic dogs. In B. alsatica, wild rabbit is a natural host. Animal disease: usually inapparent course, but may cause reproductive failure in female cats, and endocarditis in dog (B. rochalimae). Transmission mode: percutaneous by cats (scratching, biting); the cat flea Ctenocephalides felis (a competent vector, but flea-to-human transmission is obviously rare). [Often discussed possible transmission of B. henselae by ixodid ticks has not been proven, there are no clear supportive data]. Human disease: cat scratch disease (CSD) or felinosis, benign lymphoreticulosis, regional lymphadenopathy -especially in children, high fever with headaches, pharyngitis, exhaustion, sometimes conjunctivitis, nodular syndrome, arthralgia, a long-term rash (4-24 months), endocarditis, bacillary (epitheloid) angiomatosis (cutaneous, subcutaneous and other vascular lesions -especially in AIDS patients), persistent bacteraemia, infrequently chronic osteomyelitis, aseptic meningitis; no mortality. In the USA up to 20,000 cases annually, and from that number >2,000 need hospitalisation (mean incidence rate is 9/100,000 population annually). In the Netherlands, the CSD incidence estimates are 2,000 per year, and 12/100,000 population. B. alsatica was first identified in 1999 in Alsace, France, as an agent of bacteraemia in healthy wild rabbits. In 2006, interest in B. alsatica increased when it caused a blood culture-negative endocarditis in a patient with lymphadenopathy who had contact with rabbits. melophagi. Human disease: deer ked dermatitis (speculation at present, the aetiology has not yet been proved). B. melophagi was isolated from the blood of two women with skin lesion, myalgia, fatigue and dry cough (and pericarditis in one of them) in the USA. However, the clinical relevance of these findings remains to be established. Bio-containment: BSL-2. Diagnosis: serology (CFT), detection of antigen (IF, ELISA) or DNA (PCR) of the agent. Treatment: symptomatic; the effect of antibiotics is debatable. Geographical distribution: Germany and some other European countries, USA.

Non-motile Gram-negative coccobacilli or short small rods 0.6-1.5×0.5-0.7 μm without bipolar staining, not encapsulated. Several biotypes (biovars) in each species.

Source of infection (natural host range): domestic and wild ruminants -e.g., bison (B. abortus), elk (B. abortus), reindeer and caribou (B. suis biotype 4), domestic pig and wild boar (B. suis biotypes 1-3), brown hare (B. suis biotype 2), goat and sheep (B. melitensis), dog (B. canis). Animal disease: Bang disease, brucellosis (B. abortus) -infectious abortions of cattle; arthritis; orchitis and epididymitis, sterility; chronic forms (often inapparent infections). Also other wild ruminants involved in the disease: bison, elk, reindeer. Porcine brucellosis (B. suis biovars 1, 2, or 3) causes reproductive failure in domestic and wild sows, orchitis in boars, arthritis or paralysis. B. suis biovar 2 is also the agent of the hare brucellosis -necrosis of spleen, liver and genital organs. Newly described species of brucellae cause illness in marine mammals (B. pinnipedialis, B. ceti) or in terrestrial rodents (B. microti), but their pathogenicity for man is as yet unknown (although there are 3 reports on naturally acquired infection of humans with brucellae originating from marine mammals to date). Transmission mode: alimentary (unpasteurized milk and cheese), percutaneous, aerogenic, per conjunctivae, or by contact; quite high tenacity in animal products, but not in external milieu. A number of laboratory infections have been described. Human disease: brucellosis -a serious disease with acute or undulating fever (relapses are especially common with B. melitensis), hyperhidrosis, headaches, myalgia, arthralgia, lymphadenitis, hepatosplenomegaly, pericarditis, formation of granulomas, arthralgia, synovitis, myalgia, oedema of legs (B. melitensis), osteomyelitis, damage of kidneys and some other organs (orchitis, endocarditis); fatality rate in untreated cases is low, 2-5%. Relatively frequent are chronic forms leading to permanent disability. Occupational disease: veterinarians, animal keepers and attendants, meat industry workers, hunters, medical and veterinary microbiologists are at risk. Bio-containment: BSL-2/3. Diagnosis: cultivation of the blood and tissue samples (liver agar, glucose agar with serum, 5% CO 2 ), inoculation of guinea pig (increased laboratory risk), PCR, serology (AR -cross reactions with Francisella tularensis and Yersinia enterocolitica serovar O9, sometimes it occurs so-called prozonal effect -the serum sample does not react with the brucella antigen at low dilutions but starts to react at higher dilutions, Rose Bengal AR; CFT -specific, Coombs test for incomplete antibodies, etc.), intradermal test. Some species of the genus Brucella can be misidentified as Ochrobactrum (e.g., O. intermedium) when using commercial biochemical test kits because their reactions are similar. Treatment: difficult -doxycycline (tetracycline) + streptomycin; rifampicin + doxycycline combination for ≥6 weeks; cotrimoxazole. No steroid administration. Prevention: eradication programs in domestic animals (cattle), milk pasteurization. Geographical distribution: nearly worldwide (in Europe especially the Mediterranean), in some places Bang disease was eradicated (e.g. in Czechland).

Non-motile very small spherical to ovoid (0.3-1.0×0.2-0.5 μm) Gram-negative and facultatively intracellular bacteria. The species consists of several subspecies: F. tularensis tularensis (type A -"nearctica", the most virulent one for mammals), F. t. holarctica (type B), F. t. mediasiatica, and the low virulent F. t. novicida (only 5 patients with suspected infection with this subspecies have been reported). Another species of the genus Francisella is F. philomiragia, living saprophytically in water, being of low pathogenicity for man. There are also ichthyopathogenic francisellae recorded in marine fish farms in USA, Japan and Norway which are not pathogenic for endothermic vertebrates and are unable to grow at 37 • C. Very interesting are the francisellae living as endosymbionts in metastriate ixodid ticks especially of the genus Dermacentor in the Holarctis. The new findings indicate two probable trajectories of evolutionary adaptation from saprophytism to parasitism within the genus Francisella: (a) via water organisms; (b) via ixodid ticks.

Source of infection (natural host range): leporids, rodents (Microtus, Arvicola, Ondatra, in Canada also Castor -especially during overpopulation of the rodents and tularaemia epizootic in process within them); but never a tularaemic patient. Very recent data show that F. tularensis could also be an endosymbiont or commensal of water amoebae of the genus Acanthamoeba, the bacterium being able to replicate in these protozoa and survive in their cysts for several weeks. The interaction between aquatic and terrestrial cycles of F. tularensis is largely unknown. Animal disease: tularaemia (usually lethal epizootics of hares, rabbits and rodents; sometimes sheep -only with the type A; subcutaneous nodules in dogs). Transmission mode (Fig. 8.19 ): unusually varied -direct contact (e.g. skinning the infected animals); bites of ixodid ticks Dermacentor (reservoir, TST and TOT demonstrated) -D. variabilis, D. andersoni, D. reticulatus, Amblyomma americanum, rarely Ixodes ricinus complex, and in certain areas also mechanical transmission by bites of tabanids Chrysops spp. ("deerfly disease" -USA, Russia) while reports on transmission by mosquito bites are unsubstantiated at present (Scandinavia); alimentary (water or food contaminated by infected rodents); aerogenic (inhalation of contaminated aerosol or dust during the work with hay, straw or other agricultural products including sugar beet -outbreaks in sugar refineries in central and eastern Europe: Austria, Czechland, Slovakia, Ukraine). An unusual air-borne outbreak of tularaemia occurred among hunters (39 cases, 1 person died) in Hesse, Germany, 2005: the infection occurred when aerosol was generated during rinsing with a water hose of disemboweled hares (some of them being infected) after the hunt. High tenacity of the microbe at low temperaturesat 4 • C F. tularensis survives up to 4 months. Interestingly, F. tularensis survives in Acanthamoeba castellanii cysts for up to several weeks; trophozoites of this amoeba encyst rapidly in response to infection with F. tularensis. Human disease: tularaemia -sudden fever, chills, headache, backache, hyperhidrosis, diarrhoea, anorexia; then according to the entrance gate different clinical forms: (1) (ulcero-/oculo-)glandular (bubonic) with the primary ulcer on the skin and regional painful lymphadenitis; (2) pulmonary (pneumonia);

(3) abdominal (typhoid, oropharyngeal, gastrointestinal); or (4) generalized (septic); fatality rate is about 5% (but up to 30% in the typhoid form) in USA; while in Eurasia <3% (due to absence of the highly virulent type A tularaemia); convalescence is long (2-3 months or more), especially in improperly treated illness. Occupational disease: farmers, hunters or trappers of leporids and big rodents (caught for skin, e.g. muskrats), workers in veterinary laboratories. There was a big outbreak of hare/rodent-borne tularaemia in Central Europe (Austria, Czechoslovakia) in 1936/1937, with many hundreds of patients. A recent (1999) (2000) outbreak of largely alimentary tularaemia in Kosovo involved 327 confirmed cases; the main source were rodents, overpopulated during the Civil War in this region. The first two outbreaks of tularaemia in Spain occurred in 1997 and 1998, and were associated with hare hunting (585 patients) and crayfish (Procambarus clarkii) fishing in a contaminated freshwater stream, respectively. In the USA from 1990 to 2000, the average annual number of human cases of tularaemia was 124 (the range, 86-193); however, prior to 1950 there were many hundreds of cases annually (maximum in 1939: 2,291 reported patients). For comparison, in the Central-European Czechland (about 10 million population), the annual incidence averaged in the same decade 75 cases (the range, 12-225); an absolute maximum of tularaemia incidence in Czechland was recorded in 1962, with a total of 1,468 reported (serologically confirmed) patients. Diagnosis: symptomatology, anamnesis, serology (AR, ELISA etc. -possible cross-reactivity with brucellae), subcutaneous inoculation of adult laboratory mouse (MLD is 1 cell!), cultivation of the blood or ulcer secreta samples on TGKA (glucose BA with thioglycollate) or cysteine BA, PCR; past infection could well be detected by an intradermal test with tularin; IF microscopy of lesion secreta, immunohistochemistry. Bio-containment: BSL-2/3. (MID for man is as low as 10 viable cells applied intradermally or by inhalation). Considered as a bioterrorist agent (but only the type A tularaemia might be dangerous). Treatment: streptomycin, gentamicin (tetracycline, chloramphenicol); exstirpation of enlarged lymph nodes. Prevention: vaccination by scarification (the attentuated Russian strain, LVS)but routinely the vaccine is inaccessible. 

Poorly stainable Gram-negative aerobic rods 2-6(15)×0.3-0.9 μm, motile and facultatively intracellular. Up to now about 15 species (with a number of serotypes) of legionellae pathogenic to man have been described, the most important being the serotypes 1 and 6 of L. pneumoniae causing 80-90% of cases. The group of so-called "legionella-like amoebal pathogens" (LLAP) is formed by parasites of amoebae; interestingly, antibodies to LLAP were detected in up to 20% of patients hospitalized with pneumonia of unclear aetiology in USA and Canada in 1995.

Source of infection: water (for industrial purposes, heated water; water in air-conditioning systems, cooling towers in industrial plants, gas turbines, buildings' water systems, shower heads, whirlpools, warmwater mains, water sprayers, rainwater in puddles on asphalt roads during warm weather); a saprophytic and thermophilic microbe (the growth optimum is about 40 • C), often associated with other thermophilic bacteria and protozoa, e.g. cyanobacteria, Flavobacterium, amoebae (legionellae are endosymbionts of Acanthamoeba, capable to replicate in them). They often form biofilms in water habitats (water mains, cooling towers, etc.) and are resistant to standard disinfection compounds and measures. Potting soil is an alternative infections source of L. pneumophila and other Legionella species (especially in Australia and New Zealand, but rarely in Europe or North America). Transmission mode: aerogenic -inhalation of aerosol (water droplets) containing the bacteria. Human disease: two clinical forms -(1) legionellosis (Legionnaires' disease, LD) -pneumonia with high fever (up to 41 • C), chills and dry to spasmodic cough, headache, neurological and psychotic disturbances (confusion, anxiety), somnolence, vomiting, diarrhoea, damage to visceral organs (liver, kidneys); fatality rate 10-25%; the disease is most dangerous for smokers and immunosuppressed persons; (2) Pontiac fever (the agent is, e.g., L. anisa), a flu-like illness with a sudden onset, myalgia and headache, but without any pulmonary affliction; mortality has not been reported. (Germany) 65 patients (5 deaths; a community outbreak of LD associated with a water cooling system), and Barcelona (43 cases of Pontiac fever). Bio-containment: BSL-2. Diagnosis: serology (paired serum samples: IFA, AR, ELISA); detection of the agent in sputum and other excreta or by bronchoalveolar lavage (IF; PCR could detect viable, but non-cultivable cells); cultivation on a special BCYE agar medium containing yeast extract, cysteine, iron ionts and charcoal in 5% CO 2 (LLAP need the presence of amoebae for growth); antigen detection in urine (ELISA, PCR). Treatment: clarithromycin, erythromycin, tetracycline, levofloxacin, azithromycin, rifampicin (penicillin and ampicillin are ineffective). Geographical distribution: worldwide, but (surprisingly) mainly in the temperate zone. L.l. occurs in Australia and USA while in Europe sporadically.

Pleomorphic minute coccobacilli or short rods 0.4-1.0×0.2-0.4 μm. Obligate intracellular parasite with a greatly reduced genome, able to multiply also in phagolysosomes of vertebrates. It reveals a phase variation: virulent phase I (S), and avirulent II (R). During a passage in the chick embryo, the coxiellae undergo the transformation I → II (which corresponds to a deletion mutation expressed by a surface lipopolysaccharide change), but the reverse transformation II → I is possible by passaging through a mammal or a tick. Only the phase I occurs in nature. The strains of C. burnetii obviously differ substantially in their virulence. (In the past, the genus Coxiella was assigned to rickettsiae.)

Source of infection (natural host range): all domestic ruminants (cattle, sheep, goat), less rodents, insectivores, and other wild mammals (including ruminants, and marsupials -kangaroos in Australia), occasionally pigeons. Animal disease: coxiellosis -inapparent persistent infection; sometimes abortions or pneumonia. Transmission mode (Fig. 8.20) : aerogenic -by aerosol (foetal fluid and placenta of infected cows, ewes, and goats contain up to 109 coxiellae per gram -the infection exacerbates before delivery) and dust (straw, hay; dispersal by wind), often also alimentary (raw milk of goat and sheep: C. burnetii may resist even pasteurization 30 min/60 • C), percutaneous (by bites of metastriate ticks, e.g. Rhipicephalus sanguineus, Dermacentor marginatus, Hyalomma lusitaniae -more often in subtropical regions; tick excrements contain up to 1010 coxiellae per gram; TOT in the ticks was demonstrated).

C. burnetii has a very high tenacity in milieu: it resists drying and light exposure for many months: for instance on wool, cotton or in tick excrements it remains viable for a number of months, and in the soil for up to 20 days. The agent is extremely contagious and man is highly susceptible to infection. Exoanthropic cycle: rodents and wild ruminants (deer) + ixodid ticks (Metastriata). Synanthropic cycle: among domestic ruminants (contact). Some flies feeding on the faeces, milk, carcasses, or blood of infected domestic animals can spread C. burnetii mechanically. Human disease: Q fever (Q meaning "query"), first described (by Edward Derrick) in butchers working in a slaughterhouse in Brisbane (Queensland, Australia) in 1935-1937 -sudden fever and chills, often recurrent, hyperhidrosis, weakness, intense headaches, fatigue, myalgia, arthralgia, atypical pneumonia (infiltrate, but not always), weight loss, myo-and endocarditis, rash does not occur (contrary to rickettsioses), sometimes meningitis; hepatitis (increased levels of transaminases); fatality rate ≤1%; often inapparent or abortive infections (one-third to one-half of cases), on the other hand also chronical course occurs in 1-3% of cases, accompanied with a latency period of several years (the agent persists in liver and spleen) and a characteristic subsequent endocarditis, sometimes granulomatous hepatitis (granulomas could also appear in the bone marrow , several patients with Q fever endocarditis were described in a settlement in eastern Greenland -the likely animal source included sled dogs and seals. Q fever is an occupational disease with a risk for breeders and attendants of small domestic ruminants (goat, sheep), veterinarians (delivery in ruminants), butchers; also many laboratory infections are known. For instance, a teacher and 33 students (of 48 exposed) acquired Q fever during veterinary practice in a Slovenian sheep farm in 2007. Bio-containment: BSL-3. Diagnosis: serology (micro-AR, IFA, CFT; antigen phase II indicates acute infection, while antigen I confirms the chronic stage of Q fever; in ELISA there can occur cross-reactions with Chlamydophila psittaci), intraperitoneal inoculation of the blood sample in guinea pig, mouse or on chick embryo (patients have intense bacteraemia during acute phase of the illness, but the isolation is a risky operation); staining after Giménez or Giemsa, immunohistochemistry; PCR. Treatment: doxycycline, tetracycline, chloramphenicol (they shorten febrile period, but do not kill the intracellularly localized coxiellae), cotrimoxazole in children and pregnant women; a recommended combinations in chronic cases of Q fever are doxycycline with hydroxychloroquine, rifampicin or cotrimoxazole. Prevention: Australian vaccine is approved for humans (it is prepared from the phase I); the protection is assumed to last 10 years. Culling of infected small ruminant herds according to the "test (bulk milk samples tested by PCR) and slaughter" policy. In addition, mandatory vaccination of small ruminants started in the Netherlands in 2009. Geographical distribution: worldwide, most often in steppe habitats with brush of the Mediterranean and Black Sea regions (Photo 5.31), or in analogous Australian habitats.

Motile facultatively anaerobic Gram-negative rods not fermenting lactose and producing hydrogen sulphide; the only for man pathogenic species of the genus, with 6 subspecies; virtually all serovars pathogenic for man are in the subspecies S. e. enterica, including also anthroponotic S. Typhi and S. Paratyphi. The serovars (today a total of c. 2560 but those pathogenic for man are only about 100 from the groups B, C, D and E) are differentiated according to the Kauffmann-White scheme based on thermostable somatic antigens O (polysaccharides of cell wall) and thermolabile antigens H (from German "Hauch") of two phases (flagellar proteins); sometimes is also present thermolabile capsular Vi-antigen, masking the O antigen.

Source of infection (natural host range): fowl (especially S. Enteritidis: it contaminates the eggs in the ovary and sometimes even penetrates eggshell), rodents (S. Typhimurium), pig (S. Derby), cattle (S. Typhimurium, S. Dublin, S. Enteritidis), sheep (S. Montevideo), domestic mouse, synanthropic birds (gulls, house sparrow, collared dove, feral pigeon: S. Typhimurium, S. Enteritidis and other serovars), some ectothermic vertebrates. Animal disease: usually inapparent course, or enteritis acute (young animals) or chronic (adults); abortions. Salmonellae are able to persist for a long time in visceral organs of mammals (spleen, liver, kidney, biliary duct) and in oviducts of fowl. S. Dublin and S. Pullorum (both not transmissible to man) cause severe disease in cattle and in chickens, respectively. Transmission mode: alimentary -typical "food-borne disease" (mainly via contaminated eggs with S. Enteritidis and meat; MID for man is quite high, usually 106, exceptionally 102-103, but in some highly virulent strains allegedly 101 cells will do; some salmonellae easily replicate in foods at room temperature); direct contact (nosocomial infections). Great tenacity of S. Enteritidis (and other zoonotic salmonellae): e.g., in chicken droppings it survives viable ≥1 year. Human disease: salmonellosis, one of the most frequent and important zoonoses -gastroenteritis with a very short incubation period (6-48 h), watery diarrhoea (about 10 days), headache, abdominal pain, nausea, vomiting, fever, usually associated with haematogenic and lymphogenic dissemination of the agent, sometimes resulting in meningitis (especially in children); fatality rate is low, about 0.1% (mortality only occurs in toddlers and old patients -via critical dehydratation). The most frequent serovars are S. Enteritidis (frequent phagotypes are European PT4 and American PT8; -they have been panzootic and pandemic in the 1990s) and S. Typhimurium, less common are e.g. S. Virchow, S. Agona, and a number of others. Incidence of salmonellosis in the USA: 1956 reported 1,700 cases, while 1965 already 20,865. A similar increase of incidence was recorded in European countries; for instance in Czechland: 1,981 reported cases in 1955, 4,975 in 1965, 7,678 in 1975, 8,492 in 1985, and 52,588 in 1995. A considerable increase of the incidence in Czechland was reported in 1989, from 11 to 24 thousands of cases (it was caused by import of pandemic strain of the serovar S. Enteritidis from west Europe and USA), and the subsequent mean salmonella morbidity in the years 1990-2000 was 43,450 cases annually. While the incidence rate of salmonellosis per 100,000 population in Czechland was 385 in 1997, the average for Europe in the same year was 20-130, but it could be biased by underreporting (or no obligatory reporting) of the disease in some European countries. An instructive outbreak of salmonellosis occurred in Minnesota in 1994 with 224,000 patients (the largest salmonellosis outbreak in the U.S.A.): infective vehiculum was ice cream, and the mechanism was contamination with S. Enteritidis of a tank transporting egg melange used for preparation of that ice cream. The economical costs of salmonellosis can be high: it has been calculated that diagnosis and therapy of one human case of this disease in EU countries will cost on average 1,100C. [Remark: typhoid fever (typhus abdominalis) and paratyphoid fever, caused by S. Typhi and S. Paratyphi, respectively, are anthroponoses characteristic by a subsequent chronic asymptomatic carriership in 1-10% of patients]. Bio-containment: BSL-2. Diagnosis: cultivation of faecal samples in semiselective enrichment fluid media, e.g. tetrathionate or selenite enrichment broth, with a subsequent inoculation on selective solid agar media with deoxycholate, brilliant green etc. (MAL, XLD, SS, Rambach, Wilson-Blair and others); serotypization and phagotypization (PT), PCR (RFLP). Treatment: rehydration (antibiotics prolong the carriership stage; they are used only in necessary cases and after sensitivity testing, especially in toddlers); Endiaron N. Geographical distribution: worldwide.

Straight rods 1-6×0.3-1.0 μm with flagella (peritricha), fermenting lactose, with a number of serovars (160 antigenic types O, 56 types H, 80 types K/Vi). The strains pathogenic for man are labeled as E. coli enteropathogenic (EPEC), enterohaemorrhagic (EHEC), enterotoxigenic (ETEC), enteroinvasive (EIEC) or enteroaggregative (EAEC); usually formed toxins include verotoxin (VTEC: e.g. in O157) or thermostable "shiga-like toxin" Stx 1 and Stx 2 (STEC); the most frequent antigenic types of these bacteria are O157:H7, further O111 and O26.

Source of infection (natural host range): cattle (reservoir, about 1% of the animals has EHEC in faeces); less often sheep, goat, pig, domestic dog and cat (pet contact), game animals (deer); VTEC isolates O157 also found in fowl. Seagulls can be competent hosts of multi-drug resistant E. coli. In addition, asymptomatic human carriers of some of these pathogenic strains have been revealed. Animal disease: inapparent course or colibacillosis -diarrhoea in young domestic mammals (calf, lamb, piglet) and fowl. Bio-containment: BSL-2. Diagnosis: cultivation (faeces, pus from lymph nodes: selective media -e.g. CIN), serotypization, serology (AR, ELISA: serovar O9 of Y. enterocolitica cross-reacts with brucellae). Treatment: in septical forms tetracycline, cotrimoxazole, doxycycline, chloramphenicol, streptomycin (but not penicillin). Geographical distribution: largely holarctic, especially in the colder climatic zone (Scandinavia); incidence in Europe is moderately increasing.

Slowly motile (at 22-25 • C, but not at 37 • C) ovoid to short rod 0.6-1.2×0.4-0.8 μm with bipolar staining; 10 serovars.

Source of infection (natural host range): cat (carrier host), rodents (reservoir), leporids, dog, beaver (Canada), ruminants, bats, birds; also soil, water (it can replicate in water at 18-20 • C), foods, vegetables (Y. pseudotuberculosis replicates in vegetables at 4 • C). Animal disease: pseudotuberculosis (necroses and granulomas on liver, spleen, lymphatic nodes), especially in rabbit, sheep, birds; cattle, horse, dog. Transmission mode: alimentary, less often direct contact, via conjunctivae and aerogenic; the agent has considerable tenacity in external milieu. Human disease: pseudotuberculosis -fever, purpura, acute gastroenteritis, abdominal pain, mesenteric lymphadenitis, hepatosplenomegaly and abscesses in liver, sometimes pseudoappendicitis, bronchopneumonia; occasionally severe invasive septical illness with a considerable mortality. Bio-containment: BSL-2. Diagnosis: cultivation of the blood and pus from lymph nodes (at 22-25 • C), serology (AR), intradermal test. Treatment: only in severe forms -ampicillin, tetracycline, streptomycin. Geographical distribution: worldwide.

Short Gram-negative rods 1.5×0.5-0.7 μm with bipolar staining, pleomorphic (occasionally thread-like, large spherical and other involution forms), non-motile, producing a capsula. A facultative intracellular parasite. The whole genome of Y. pestis was sequenced in 2001: it contains 4.7 million nucleotides and 3 plasmids sized 96, 70, and 10 kbp. According to phylogenetic analyses Y. pestis originated from Y. pseudotuberculosis roughly 10,000 years ago as a clone capable of transmission by fleas and lost about 13% of the original genes. The biovars of Y. pestis Antiqua, Medievalis, Orientalis, and Microtus differ in the ability of nitrate reduction, and glycerol and arabinose fermentation. limits the ability of the flea of further blood feeding (Fig. 6.14) , and leads to regurgitation. TOT has not been demonstrated in fleas. Other means of plague transmission are aerogenic (person-to-person, droplets during cough) which results in the most feared epidemics, and alimentary -e.g. 18 plague cases were described after consumption of uncooked liver of infected camels in Libya and Saudi Arabia. The plague sometimes occurs as an occupational infectious disease -hunters of marmots and other rodents: e.g. 19 marmot hunters (handling infected animals or their carcasses) got plague in north China in 2004, and 8 died. An alternative (but speculative) mode for Y. pestis transmission during outbreaks might be via the body lice Pediculus humanus. Types of disease foci: (1) primary, natural, sylvatic (the hosts of the agent are exoanthropic rodents) in steppe, semidesert or tropical forest ecosystems;

(2) secondary, urban -largely in sea ports (the main hosts of the agent are rats -"urban" plague). Human disease: plague (pestis) starting with fever and fatigue. The clinical forms are bubonic (bubonic plague, with lymphadenitis: swollen and extremely painful lymph nodes called buboes), pulmonary (severe bronchopneumonia and respiratory distress syndrome -usually in the anthroponotic infection), oroglandular (after an alimentary infection, associated with abdominal pain and diarrhoea), and primarily septic (without lymphadenitis, but with meningitis, endotoxic shock, organ failure and a disseminated intravascular coagulation); occasional severe peripheral tissue necrosis and gangrene remind of medieval epithet ("Black Death"). Mean fatality rate is 2-10% in treated and 50-95% in untreated cases (the most lethal are septic and pulmonary forms). Historically, the first major epidemic of plague was reported in China in 224 BC. Later on, three pandemics of plague were recorded: (1) "Justinian's plague" in the sixth century (with roughly 100 million victims out of the 142 million infected); (2) "black death" in the fourteenth century killed nearly whole populations of Tatars and Saracens, then the disease encompassed nearly whole Europe where died one-fourth of the population (about 25 millions), and further roughly 25 millions died before in Asia and Africa; (3) "modern" plague in the nineteenth and twentieth centuries (30 million people got the disease, 12 millions of them died; the pandemic started in Hongkong after introduction from the continental China; rats and their fleas dispersed plague on ships to many seaports of Japan, India, Europe, Africa, America and Australia (2010) involved 31 cases including 3 deaths (the last outbreak of bubonic plague in northern Peru before was in 1994, which affected more than 1,100 persons and killed 35 of them). Bio-containment: BSL-3. Diagnosis: microscopy (methylene blue) and cultivation (BA, agar with gentianviolet at 27 • C) of the pus from enlarged lymph nodes, blood, CSF, bone marrow or sputum samples, subcutaneous inoculation of guinea pig, laboratory rat or mouse; serology (IFA, CFT, RIHA). Treatment: streptomycin, tetracycline, doxycycline, chloramphenicol, gentamicin. Prevention: vaccine (inactivated or attenuated -strain EV76 produced in the former Soviet Union, or heat-killed Y. pestis vaccine manufactured in Australia) produces a short-term protection; rat control in endemic areas. 

Short Gram-negative rods to coccobacilli 0.5-1.2×0.3-0.6 μm with a marked bipolar staining, facultatively anaerobic, non-motile, forming capsula; serovars A, B, D, E in P. multocida.

Source of infection (natural host range): serovar A birds, serovars B and D domestic (cattle, sheep, pig, dog, cat, rabbit) and wild (rodents, hare) mammals. Animal disease: pasteurellosis, called avian cholera in fowl -bronchopneumonia, haemorrhagic septicaemia. Asymptomatic in cats and dogs. Transmission mode: contact (percutaneous: biting or scratching by a cat, less often a dog; insect bite or sting), sporadically alimentary or aerogenically. Human disease: pasteurellosis (infrequent illness) -local inflammation, abscesses, lymphadenitis; respiratory illness; sometimes meningitis; rarely appendicitis. Bio-containment: BSL-2. Diagnosis: cultivation of pus or tissue samples (BA; does not grow on Endo agar), microscopy of the blood or tissue smears (methylene blue: bipolar staining; IF microscopy), inoculation of mouse or rabbit.

Treatment: penicillin (higher doses); ceftriaxone, ciprofloxacin, amoxicilin, doxycycline, tetracycline, chloramphenicol, erythromycin, cotrimoxazole, cefuroxim. Geographical distribution: worldwide, sporadic.

Gammaproteobacteria]

Short motile (monotricha) slightly crescent-shaped Gram-negative rods; facultatively anaerobic; one H antigen, but 80 somatic O-antigens. The serogroups pathogenic for man are O1 (with two biotypes: classical, and haemolytic "El Tor"; and with two main serotypes -Inaba and Ogawa), and O139 (Bengal); infrequently certain others called "non-O1/O139 V. cholerae".

Source of infection: man; brackish water and marine animals (crustaceansmainly Copepoda, shellfish including raw oysters, and fish) in endemic areas. Transmission mode: alimentary (municipal or surface water, food); V. cholerae non-O1 quite often after consumption of raw "seafood" or street vendors' beverage. The agent survives in water for up to several weeks. Human disease: cholera -sudden vomiting without nausea, intense longterm watery diarrhoea (excrements look like rice water and have fish odour) causing rapid dehydratation and hypovolemic shock, anuria, muscle cramps; death can occur in severe cases sometimes within 1 or 2 days. The cholera enterotoxin stimulates hyperproduction of cAMP that inhibits in the cells of intestinal villi influx of ions Na+ and Cl-and at the same time stimulates hypersecretion of Cl-and HCO 3 -causing a blockade of intestinal water influx. V. cholerae non-O1 causes less severe but sometimes bloody diarrhoea and abdominal spasms. A total of 10 explosive pandemics of cholera occurred in the nineteenth and twentieth century, and most of them were initiated in the Indian subcontinent. For instance the first known pandemic of cholera (1817) Diagnosis: microscopy (darkfield) and cultivation of faecal samples (enrichment in alkalic peptone water and a subsequent isolation on agar medium TCBS with thiosulphate, citrate, deoxycholate and saccharose), combined with agglutination of the grown colonies.

Prevention: inactivated oral vaccines (DUKORAL, OROCHOL); the use of packaged water in endemic areas, appropriate hygiene practices. Treatment: intense rehydration and influx of ions; antibiotics (gentamicin, chloramphenicol, tetracycline). Geographical distribution: tropics and subtropics. Endemic area is, e.g., Bangladesh. * Vibrio parahaemolyticus A halophilic marine bacterium, pathogen of fish. Pandemic strain (spreading since 1996) posses antigenic structure O3:K6.

Source of infection: marine coastal water (especially at higher temperatures, often coincidence with algal overpopulation), marine fish, crabs and oysters. Transmission mode: alimentary ("seafood-borne disease": oysters etc.). In addition, asymptomatic human carriers of these strains have been revealed. Human disease: vibrio gastroenteritis -an about 3-day, often bloody, diarrhoea, abdominal pains, nausea, vomiting. In Japan the agent causes about 50% of all patients with bacterial gastroenteritis. Sometimes epidemic occurrence. For instance, during a recent outbreak in Chile (2004) (2005) (2006) (2007) , the total number of reported cases was 10,783 (as of March 2005), making this the largest documented occurrence of V. parahaemolyticus diarrhoea in the world. The bacterium also causes ear and wound infections. Bio-containment: BSL-2. Diagnosis: cultivation of stools and food remnants (TCBS agar with 3% NaCl); serotypization, Kanagawa's test for detection of thermostable haemolysin. Treatment: rehydration. Geographical distribution: worldwide -coastal areas, very often in Japan and Singapore, but also other parts of southeast Asia, further India, Spain, USA and South America. * Vibrio vulnificus A halophilic bacterium, serious pathogen of eel.

Source of infection: coastal water, marine fish, crabs and oysters (a halophilic bacterium). Transmission mode: contact (skin injuries, especially with fish bones), alimentary (e.g., raw oysters, fish). Human disease: skin wound lesions with necrotizing fasciitis, primary septicaemia sometimes accompanied with a septic shock (fatality rate 30-50%); or acute diarrhoea (fatality rate low, but in the biotype 3 up to 10%). Usually sporadic cases, sometimes epidemics (e.g. in Israel, 1996 Israel, /1997 : 134 cases in fishers and fish consumers, biotype 3). In the Los Angeles area (California), a total 252 cases were reported between 1980 and 2004, and in Japan 94 cases between 1999 and 2003. Bio-containment: BSL-2. Diagnosis: cultivation (TCBS agar, with 3% NaCl). Treatment: rehydration in intestinal form of the disease, antibiotics in severe cases (cephotaxin + minocycline); surgery (amputation occasionally necessary in fasciitis cases). Geographical distribution: Mexico, southern USA, India, southeastern Asia (Taiwan), Japan, Israel, Baltic Sea, Spain. * Vibrio metschnikovii Source of infection: coastal marine or brackish water, fish, oysters (a halophilic microorganism). Animal disease: pathogenic for birds, illness in birds similar to cholera. Transmission mode: contact, alimentary. Human disease: diarrhoea, pneumonia, infection of wounds etc. -low incidence. Bio-containment: BSL-2. Geographical distribution: southern USA, Southeast Asia, Germany. * Other "Non-cholera" Vibrios Pathogenic for man (causing wound infections or gastroenteritis) but with a lower risk, they involve Vibrio mimicus, V. fluvialis, V. furnissii, V. alginolyticus, Grimontia hollisae, and Photobacterium damselae.

Gramnegative rods to coccobacilli, facultatively anaerobic, usually motile (with one terminal flagellum). Some human isolates posses Shiga toxin genes (stx1, stx2) similar to those in pathogenic Escherichia coli strains.

Animal disease: pathogenic for frogs and fish. Source of infection: water. Transmission mode: contact, alimentary (e.g., fish). Sometimes associated with disasters (hurricanes, tsunami, earthquakes). Human disease: gastroenteritis, bacteraemia, prostatitis, HUS. Usually sporadic cases. Bio-containment: BSL-2. Diagnosis: cultivation and biochemical tests. Treatment: antibiotics in severe cases. Geographical distribution: worldwide.

Class Epsilonproteobacteria]

Mildly bended, S-shaped to shortly screw-like Gram-negative rods 0.5-1.2×0.2-0.5 μm with two polar flagella (amphitricha), aerobic to microaerophilic, thermophilic (optimum growth temperature 42 • C, do not grow at <30 • C); 65 serovars differentiated according to O and H antigens.

Source of infection (natural host range): domestic fowl (>50% human cases; in broilers commonly up to 10 7 cells/g) and other birds (reservoir), mammals (cattle, sheep, pig -C. coli, dog, cat); man (about 1% asymptomatic carriers); oysters, crabs; surface water (contaminated by birds). Animal disease: usually asymptomatic, or diarrhoea (calves); fowl hepatitis.

C. foetus causes septic abortions and fertility disturbances in sheep and cows. Transmission mode: alimentary -e.g. grilled fowl (especially chicken broilers), hamburgers ("fast-food"), processing raw meat, drinking raw milk, eating fresh cheese, water (campylobacters survive in it for >4 months/5 • C); contact. Mechanical transmission by flies has been repeatedly recorded. MID for man is 500-800 cells. Human disease: campylobacterosis (commonly used term "campylobacteriosis" is imprecise because the agent is not a "Campylobacterium", but Campylobacter), together with salmonellosis probably the most frequent zoonosis and a major health problem worldwide. After a short incubation period (usually 3-5 days) appears fever (with chills), headache, myalgia, anorexia, nausea, acute enteritis (abdominal pains are stronger than in salmonellosis), prolonged diarrhoea (sometimes bloody) for up to 10 days, pseudoappendicitis, arthritis; sometimes meningoencephalitis (C. foetus). The arthritic and neurologic sequelae of infection with C. jejuni involve in <1% of patients Guillain-Barré syndrome (demyelinizing peripheral neuropathy with acute neuromuscular paralysis: symmetrical flaccid effect on limbs and loss of tendon reflexes; up to 30% cases of this polyradiculoneuritis syndrome is attributed to C. jejuni) or Reiter syndrome (reactive arthropathy); mortality is rare. Campylobacterosis, in contrast to salmonellosis, occurs more often sporadically than in epidemics. Incidence rate was 20-110 per 100,000 population in Europe in 1996-1999, while 7-32 in the USA (that of salmonellosis was 13-26 in the same period). In Great Britain the annual incidence of campylobacterosis attained 50,000 cases in the years 1997-1999 and surpassed that of salmonellosis (51,800 cases in 2007). A similar trend was observed in Czechland (EPIDAT Report on incidence of infectious diseases): while the mean annual incidence was 8,630 cases in the decade 1990-2000, as many as 23,480 cases (annual average; the range, 20-30 thousands) were reported in the period 2001-2008, i.e. not much less than in salmonellosis in the same period (annual average 25,800, the range 11,000-33,000 cases). However, this obviously increasing trend could be biased by a much better and more widespread laboratory diagnosis of campylobacterosis. Bio-containment: BSL-2. Diagnosis: microscopy of native stool samples in darkfield, cultivation of faeces (sampled in a special transport medium), blood or CSF on selective Preston agar with charcoal and cefoperazon or on other special agar media (Karmali; Butzler) at 42 • C in 5-10% CO 2 and 85% N 2 ; serology (ELISA, CFT), PCR. Treatment: rehydration; antibiotics should be used only in severe cases (erythromycin, tetracycline, azithromycin, clarithromycin, ciprofloxacin). Campylobacters are usually resistant to quinolones (these drugs used to be occasionally added to chicken food). Geographical distribution: worldwide.

Small, mildly bended and motile Gram-negative rods, microaerophilic. In the past, helicobacters were classified in the genus Campylobacter, and the two mentioned species formed a group Helicobacter "heilmannii", observed in animals and man. [Anthroponotic species is H. pylori, causing gastritis and peptic ulceration].

Source of infection (natural host range): dog (H. bizzozeronii), cat (H. felis), pig. Animal disease: probably usually asymptomatic. Transmission mode: alimentary or contact. Human disease: gastritis, severe dyspeptic symptoms. Only few cases have been described (e.g., one in Finland recently). Bio-containment: BSL-2. Diagnosis: microscopy of native stool specimens in darkfield, cultivation from faeces (very difficult). Treatment: unknown (metronidazole unsuccessful). Geographical distribution: Europe, possibly worldwide.

Spirochaetes]

In addition to saprophytic leptospirae (e.g., L. biflexa, L. parva) living in water, 13 spp. are regarded as pathogenic, with more than 260 serovars at present. However, the most important is one species -L. interrogans.

A very motile obligately aerobic spirochaete 6-20×0.1-0.2 μm with many dense coils, two periplasmic flagella and usually hooked ends. Twenty-three serogroups with more than 200 serovars have been described in this species.

Source of infection (reservoirs) with particular serovars: brown rat (Icterohaemorrhagiae), voles and other rodents (Grippotyphosa, e.g., Microtus agrestis, M. arvalis: persistent infection in these species, the agent lives in renal tubules and is excreted in urine that contains up to 106 leptospirae per ml) and Sejroe (largely Mus musculus); pig (Pomona -also Apodemus agrarius, and Australis), cattle (Tarassovi, Hardjoe), dog (Canicola), hedgehog and horse (Bratislava). Leptospirae are very resistant in water milieu; they can also be transported by waterbirds (from and to rice fields etc.). Animal disease: inapparent, or (cattle, pig) abortions, meningitis and dying of some young animals. Transmission mode: contact (percutaneous; bathing, water sports, work in water or in sewers), alimentary (water or food contaminated with rodent urine, e.g. after floods; uncooked meat of infected animals). Human disease: leptospirosis is one of the most widespread zoonoses in the world -a flu-like illness, often with biphasic body temperature curve, aseptic meningitis and nephritis (albuminuria). The course of the disease varies according to serovar; the most severe is Weil's disease (L. interrogans Icterohaemorrhagiae) with hepatitis, icterus, myalgia, necroses, cardiac and ocular involvement, nephritis (damage to glomerulae; leptospiruria), haemorrhagies, encephalitis, and fatality rate in untreated cases 10-20%; milder but most frequent is the "harvest fever" in central Europe (caused by L. interrogans Grippotyphosa); also other anicteric leptospiroses usually have milder symptoms, e.g. "fever of swine breeders" (L. interrogans Pomona). The incidence of leptospirosis is not very high in most countries; for instance in Czechland, on the average 82 (the range, 12-226) cases were reported annually in the years 1970-1999, while 38 (the range, 11-88) in the decade 1990-2000 (0.4 cases per 100,000 population); in France, an average of about 250 cases annually have been reported since 1980 (0.5 cases/100,000). Occupational disease: up to 30% of cases form butchers in slaughterhouses, farmers, meat inspectors, workers in sewerage system, miners, soldiers, gamekeepers, hunters, rodent control workers, sugar cane cutters, ricefield workers, animal attendants in zoological gardens and workers in sewerage system; leptospirosis also often occurs as a "recreational" (leisure time) infectious disease (about 30% of all cases) -during outdoor activities like water sports (canoeing, swimming), or camping. Epidemics also follow natural disasters, such as floods, hurricanes or earthquakes. For instance, 167 Philippinos died from leptospirosis after storm Ondoy flooded Manila and Rizal in 2009. Bio-containment: BSL-2.

Diagnosis: microscopy (darkfield or phase contrast) and cultivation (EMJH [Ellinghausen-McCullough-Johnson-Harris] medium, Korthoff's fluid peptone medium supplemented with rabbit serum or bovine albumin and Tween 80, or Fletcher, Noguchi and Stuart liquid media; however, the growth of leptospirae is slow) of the blood (acute stadium) or urine (convalescence) samples; intraperitoneal inoculation of young guinea pig or hamster; serology (CFT, slide AR, IHA, ELISA; the most specific is the microagglutination-lysis test, when a viable culture is mixed with antiserum, and then observed under darkfield microscope); RFLP, ribotyping, PFGE. Treatment: penicillin, ampicillin, doxycycline, tetracycline, streptomycin, erythromycin, ceftriaxone, cefotaxime, ciprofloxacin; haemodialysis is sometimes necessary during renal insufficiency. Prevention: vaccination of domestic animals (cattle, pigs, dogs) is possible with serovar-specific vaccines. Vaccines for humans are produced in France (serovar Icterohaemorrhagiae), China and Japan (serovars Canicola, Icterohaemorrhagiae and Pomona). Geographical distribution: worldwide (mainly humid ecosystems: Photo 5.38).

A spirochaete up to 30 μm long, genomically very closely related to B. duttonii as found by DNA sequencing and molecular phylogenetic analyses. In fact, it should be regarded as a population subset or an ecotype of B. duttonii rather than a separate species.

Source of infection (natural host range): man. Transmission mode: body louse (Pediculus humanus; the lice, when infected, remain infectious longlife) -by swating and rubbing in skin (or conjunctiva). Human disease: epidemic louse-borne relapsing fever (typhus recurrens) -high fever for 3-9 days with 1-5 relapses (they are associated with the change of surface antigens of the spirochaetes and their reappearance in the blood; afebrile intervals use to be 5-10 days), chills, severe headaches, myalgia, arthralgia, abdominal pain, anorexia, hepatosplenomegaly, sometimes icterus, CNS affection (photophobia, dizziness); fatality rate in untreated cases up to 40%, in treated patients 4-7%. The spirochaetes in the human blood first observed and described Obermaier in 1867. Epidemic of recurrent typhus (on many occasions together with rickettsial epidemic typhus) are determined by socioeconomic factors, they occur during wars, famine and big disasters, usually in winter and early spring. Examples: in 1919-1923, epidemics in southern Europe (the Balkans) and Russia (5 million victims); recent cases and outbreaks have been reported in Ethiopia (1,000-5,000 cases annually), Sudan, Burundi, Rwanda, Uganda, China, Peru, and Russia.

Bio-containment: BSL-2. Diagnosis: darkfield microscopy of the blood (in the acute phase patients have up to 106 spirochaetes/ml blood), blood smear or thick drop (stained by Giemsa, IF); inoculation on suckling mice or chick embryo; cultivation in vitro is difficult (fluid BSK medium); serology (Weil-Felix reaction with antigen Proteus OXK). Treatment: tetracycline, erythromycin, doxycycline, penicillin. Geographical distribution: Africa (Ethiopia, Rwanda, Senegal), Asia Minor and Central Asia, foothills of the Andes .   Borrelia duttonii, B. hispanica, B. crocidurae, B. persica, B. caucasica,  B. latyschevi, B. hermsii, B. parkeri, B. turicatae, B. theileri, B. coriaceae,  B. venezuelensis, B. mazzottii, B. 

A large group of relapsing fever zoonotic borreliae. B. duttonii is phylogenetically closely related to B. recurrentis (even more than to B. hispanica) and B. crocidurae.

Source of infection (natural host range): rodents (mice, hamsters, gerbils), porcupine, hedgehogs, canids and other wild mammals (armadillo, opossum, bats), and some reptiles (agama); man (B. duttonii). Animal disease: usually inapparent course (arthritis in dogs). Human disease: endemic tick-borne relapsing fever (endemic recurrens)papula, rash (in half of patients), recurrent fever with chills (2-10 relapses going on for 2-7 days as a reaction to the antigenic "shift" of the agent, afebrile periods last 2-5 days or up to several weeks), hyperhidrosis, headaches, myalgia, arthralgia, abdominal pain, cough, conjunctivitis, lymphadenopathy, miscarriage, in a part of patients also affection of CNS, myocarditis, hepatosplenomegaly; fatality rate 2-10%. Bio-containment: BSL-2. Diagnosis: darkfield microscopy of the blood smear or a thick drop from the febrile phase (Giemsa or Wright staining, IF); intranasal (or conjunctival) inoculation of guinea pig or intraperitoneal inoculation of suckling mouse; serology (CFT), detection of the antigen (immunohistochemistry), cultivation (BSK medium). Treatment:

penicillin, tetracycline, erythromycin, doxycycline, chloramphenicol. Geographical distribution: subtropics and tropics (steppe to semidesert habitats) -the Mediterranean ( 

A spirochaete belonging to the group of relapsing fever zoonotic borreliae.

Source of infection (natural host range): rodents. Animal disease: not observed. Transmission mode: bites of the Lone Star tick Amblyomma americanum. Human disease: Southern tick associated rash illness (STARI) -similar to erythema migrans in Lyme borreliosis (see below). Bio-containment: BSL-2. Diagnosis: similar as in the previous borreliae, but cultivation in vitro is difficult. Treatment: antibiotics. Geographical distribution: southern USA.

Spirochaetes 4-25×0.2-0.3 μm with 3-10 coils and 7-11 periplasmic flagella. Genomic species ("genomovars", called often "genospecies" in discrepancy with standard bacteriological nomenclature) of B. burgdorferi s.l. (described as late as 1982), pathogenic for man, are B. burdorferi s.s. (its full genome was already sequenced), B. afzelii and B. garinii, less often B. valaisiana, B. lusitaniae, while genomic species with not yet sufficiently demonstrated pathogenicity are B. bissetii, B. spielmanii and a few others. In the host, some borreliae are able to produce persisting 'cystic forms' or 'blebs'.

and Myodes spp. -competent hosts and the reservoir especially for B. afzelii; in America Peromyscus leucopus), squirrels, chipmunks (e.g., Tamias striatus), leporids, turdid and other ground-foraging forest birds (the reservoir for B. garinii); also lizards (B. lusitaniae).

Animal disease (dog, ruminants, horse): borreliosis with arthritis, affection of the kidneys and CNS. Transmission mode: ixodid ticks of the Ixodes ricinus complex (reservoir -TOT, TST): I. ricinus, I. persulcatus, I. pavlovskyi, I. scapularis, I. pacificus, also I. uriae (B. garinii, in seabird colonies: Photos 5.37, 7.77). Human disease: Lyme borreliosis (LB, or Lyme disease in America, described in Old Lyme, Connecticut, in 1975) -a multisystem illness with 3 clinical phases (the course of untreated LB can remind that of the syphilis): (1) in 60-90% of infected persons appears a localized erythema (erythema migrans, EM) that was already described by Afzelius (1910) and Lipschütz (1913) ; (2) when not treated with antibiotics, the spirochaetes disseminate and secondary lesions may appear such as new EM lesions or lymphocytoma (lymphadenosis benigna cutis), sometimes increased temperature, headaches and myalgia, fatigue, regional lymphadenopathy, conjunctivitis, affection of CNS (meningitis), polyneuritis (n. facialis -Bell's palsy, radiculoneuritis), arthralgia and carditis;

(3) the late phase (usually after 2-3 years) is manifested by chronic relapsing polyarthritis affecting big joints (synovitis, erosion of cartilage), chronic neuroborreliosis (peripheral neuropathies, affection of CNS), chronic affection of the skin (acrodermatitis chronica atrophicans, ACA: described by Buchwald already in 1883). B. burgdorferi can sometimes persist in the human body for long periods (up to 10 years), e.g. in synovial fluid or in the CNS (often in changed morphological forms -cystic, circular or granular). LB is the most frequent ixodid tick-borne human disease in the world, with an estimated 85,000 patients annually (Europe 65,000, North America 16,500, Asia 3,500). For instance in Czechland was reported on average 3,330 (the range, 1,446-6,302) cases annually in the years 1990-2006, which presents an incidence rate of 32 (the range, 16-61) per 100,000 population (EPIDAT). Bio-containment: BSL-2. Diagnosis: symptoms (EM) and anamnesis (tick bites), serology (ELISA IgM and IgG, optimally with confirmation using WB; IF); isolation of spirochaetes from the skin biopsy or from CSF fluid complex BSK (or MPK) medium at 33 • C (the growth is very slow); also electron or IF microscopy of CSF; PCR. The 'cystic forms' or 'blebs' are impossible to diagnose in darkfield microscopy. Treatment: doxycycline, amoxicilin, penicillin, tetracycline, erythromycin, deoxymykoin in the acute phase; in the chronic phase cephalosporins (cefotaxim, ceftriaxon), or big doses of penicillin. Prevention: suitable human vaccine against LB does not exist at present. The lately released US vaccine "LYMErix" was removed from the market several years ago. Examination by darkfield microscopy or PCR of ixodid ticks feeding on a person may be helpful -in positive cases, prophylactic treatment of the person with one or few doses of doxycycline should be recommended. Geographical distribution: holarctic (Europe; northern Asia -including Siberia, China, Japan, Korea; and North America). For different habitats of LB agents, see Photos 5.33 to 5.37.

An anaerobic spirochaete.

Source of infection (natural host range): pig -some strains of swine brachyspirae are pathogenic for man. Animal disease: enteritis. Transmission mode: contact, alimentary. Human disease: enteritis, intestinal spirochaetosis (colon epithelium is affected) -abdominal pain, chronic (sometimes bloody) diarrhoea; the illness occurs mainly in immunosuppressed persons. In Bangladesh, often associated with cholera. Occupational risk (butchers, vets, animal breeders). Bio-containment: BSL-2. Diagnosis: cultivation in vitro is difficult. Treatment: antibiotics (optimally after differential susceptibility test). Geographical distribution: worldwide.

Flavobacteria]

Motile (gliding) Gram-negative fusiform rods to filaments, facultatively anaerobic, and fastidious.

Source of infection (natural host range): dog (a commensal in the oral cavity), less often cat, and rodents. Animal disease: usually asymptomatic infection. Transmission mode: percutaneous (by bites, scratches, or licking of scratched skin by pet animals). Human disease: fever, chills, myalgia, vomiting, septicaemia (disseminated) intravascular coagulation, peripheral gangrene, purulent meningitis, endocarditis. Infection can be fatal (sepsis) especially in immunosuppressed individuals. Since the first description in 1976, about 200 human cases have been reported. Risk groups are animal keepers, breeders, veterinarians and pet owners. Bio-containment: BSL-2. Diagnosis: cultivation in vitro is difficult (BA or chocolate agar in the atmosphere of 5% CO 2 , or anaerobically), the growth is slow; microscopy (bacteria present within neutrophils). Treatment: penicillin G, doxycycline, imipenem, clindamycin (or other antibiotics optimally after differential susceptibility test).

Geographical distribution: worldwide (North America, Australia, South Africa, Europe).

A non-motile, slightly bended, strictly aerobic, polymorphic Gram-negative rod 2-5×0.5-1 μm.

Source of infection (natural host range): equids (horse, donkey, mule), rodents (Rattus), cat, dog; man. Animal disease: glanders (malleus) -very dangerous, acute (donkey, mule) or also chronic (horse -carriers) infectious illness of odd-toed ungulates, producing nodules and ulcerations in the respiratory tract, occasionally also skin ulcerative lesions called "farcy". Transmission mode: percutaneous (skin abrasions) or aerogenic, less frequently alimentary, via conjunctiva. The agent is highly contagious, but its tenacity is low. Human disease: glanders (malleus) -multiple nodules, abscesses or flat ulcers in subcutis, muscles, visceral organs and on mucosa, high fever with headaches, photophobia, lacrimation, lymphadenitis, purulent haemorrhagic bronchopneumonia and septicaemia with a high fatality rate (40-100%) in untreated cases; less common is a chronic form. Bio-containment: BSL-3. Considered to be a serious bioterrorist threat (against animals and humans; it was used during the WWI and WWII against military horses). Diagnosis: microscopy and cultivation (media with 3-5% glycerol) of the pus from scars and nasal secret; intraperitoneal inoculation of male hamster or guinea pig (scrotal oedema -so-called Strauss effect), serology (CFT, ELISA, RIHA, AR), intradermal test for hypersensitivity (malein), PCR. Treatment: streptomycin, tetracycline, chloramphenicol, gentamicin; sulphonamides sulphadiazin, cephtazidim, carbapenem. Geographical distribution: Asia (Mongolia, Turkey, Middle East, Iran, Pakistan), north and eastern Africa, Mexico, South America (Brazil). In the past worldwide, but eradicated from most countries, lately reemerging in some areas (e.g., Arab Peninsula). * Burkholderia pseudomallei A motile polymorphic aerobic rod 1.5-6×0.5-1 μm with bipolar staining, growing also at 42 • C.

Source of infection: stagnant water (in rice fields, wetlands), potable water, soil/mud (a soil-borne bacterium); infrequently it occurs in rodents, sheep, cattle, pig, horse, leporids; occasionally primates, deer, dogs, cats, koalas, kangaroos, camels, crocodiles. Animal disease: inapparent course, or acute melioidosis (in sheep). Transmission mode: percutaneous (traumatic inoculation from the soil), less often aerogenic (inhalation of contaminated dust or water droplets, with a severe course) or alimentary (e.g. water ingested or swallowed during swimming); the agent has considerable tenacity in the milieu. Human disease: melioidosis (pseudomalleus, also called Whitmore disease or Nightcliff gardener's disease in Australia) -fever, a fierce diarrhoea of an extraordinary frequency (20 per h), disseminated disease with multiple abscesses and granulomas (similar to those in tuberculosis) in different organs (liver, lungs, spleen, kidney, prostate) and also in subcutis, lymphadenopathy, pneumonia, sometimes also septicaemia with a very high fatality rate (80-95%); also chronic forms occur with relapses even after a number of years (despite therapy). It is primarily an infection of humans with underlying diseases such as alcoholism, malnutrition, cirrhosis, and immunosuppression, but can also affect healthy individuals. An increased incidence of melioidosis is usually recorded in endemic areas after cyclones, heavy rains or floods. This is also a "tourist infectious disease" during the travel or adrenaline sports in wet tropical areas (importation to e.g. Europe has been repeatedly recorded). Bio-containment: BSL-2/3. Diagnosis: cultivation of the blood, sputum, urine and pus samples, inoculation of young male hamster or guinea pig (scrotal reaction), serology (HA, IFA, CFT, AR, ELISA). Treatment: long-term (6-12 months) application of doxycycline + amoxicilin, or large doses of sulphonamides (cephtazidim, cotrimoxazole, imipenem, meropenem, carbapenem). Geographical distribution: tropics and subtropics (largely wetland habitats) -Southeast Asia (Singapore, Indonesia) and northern Australia; also China, Taiwan, India, Bangladesh, Iran, Madagascar, Ecuador, Peru, Brazil, and Central America (Caribbean islands 

Betaproteobacteria] * Chromobacterium violaceum

Gram-negative, facultatively anaerobic rods.

Source of infection: soil and water (saprophytic growth). Animal disease: pathogenic for birds, their illness reminds cholera. Transmission mode: contact, alimentary. Human disease: chromobacteriosis with fever, headache, vomiting, cutaneous, hepatic and pulmonary abscesses, sometimes fatal septicaemia. The illness is infrequent (about 150 cases have been described), but serious. Bio-containment: BSL-2. Diagnosis: cultivation -the bacterium produces violet pigment due to tryptofan oxidation on usual agar media. Treatment: gentamicin, trimethoprim + sulphamethoxazole, meropenem, ciprofloxacin, chloramphenicol. Geographical distribution: (sub)tropical regions -Asia, Australia, USA, South America (Argentina, Brazil), Africa.

A short coiled pleomorphic Gram-negative rod 2-5×0.2-1 μm, with several (up to 7) polar flagellas (amphitricha); sometimes it forms long and disintegrating filaments.

Source of infection (natural host range): rodents (largely Rattus spp.) -they excrete the agent by saliva. Animal disease: inapparent course. Transmission mode: percutaneous (biting).

Human disease: sodoku [Japanese "so" = black rat; "doku" = poison], rat-bite fever -papular rash (on face and arms), ulceration, regional lymphadenitis, high recurrent fever (usually 6-8 relapses within 2 months, but sometimes prolonged over a number of months or even years), without arthritis; fatality rate 5-10%. Bio-containment: BSL-2. Diagnosis: intraperitoneal inoculation of laboratory rat, mouse or guinea pig (bacteraemia); darkfield microscopy, thick drop or blood smear (Giemsa stain); non-cultivable in vitro. Treatment: penicillin, aureomycin. Geographical distribution: eastern Asia (Japan), Australia.

Fusobacteria]

A non-motile pleomorphic Gram-negative rod 1-3 μm long, sometimes producing very long and disintegrating filaments up to 100 μm; facultatively anaerobic.

Source of infection (natural host range): rodents (Rattus etc. -S. moniliformis is a part of their oral microflora; it is excreted via saliva and urine); cat. Animal disease: usually asymptomatic infection, but sometimes polyarthritis, oedema of limbs and fingers. Transmission mode: percutaneous (bites); alimentary (ingesting food or drink such as milk or water contaminated with rat excrement). Human disease: Haverhill fever (rat-bite fever, streptobacillosis) with headache, sometimes rash of rubella type, photophobia, lymphadenitis, pharyngitis, septic mono-or polyarthritis, occasionally endocarditis and pneumonia; fevers can be recurrent for a period of months; fatality rate 10% in untreated cases. Bio-containment: BSL-2. Diagnosis: cultivation of the blood or synovial fluid samples (BA with serum or ascitic fluid, 5-10% CO 2 ), intraperitoneal inoculation of mouse, agglutination. Treatment: large doses of penicillin, tetracycline (streptomycin). Geographical distribution: worldwide but sporadic.

Anaerobic non-motile Gram-negative rods 2-5×0.5-1.5 μm or filaments up to 80-100 μm long.

Source of infection (natural host range): domestic ruminants.

Animal disease: necrobacillosis (necrotic lesions on limbs, diphteroid stomatitis, arthritis, abscesses on liver) in calves, lambs, piglets and young rabbits, with a high fatality rate; necrosis of genital organs in male bisons (Bialowieža, Poland). Transmission mode: contact; tenacity of the agent is low. Human disease: necrobacillosis -necrotic ulcers and regional lymphadenitis. Bio-containment: BSL-2. Diagnosis: cultivation (BA, 5% CO 2 ), intradermal inoculation of laboratory animals (mouse in the tail, rabbit in the auricle). Treatment: penicillin + streptomycin, tetracycline, chloramphenicol, sulphonamides, locally potassium iodide; surgery. Geographical distribution: worldwide, sporadic.

Non-motile pleomorphic non-sporulating Gram-positive rods 0.8-2.5×0.1-0.3 μm.

Source of infection (natural host range): pig (E. rhusiopathiae var. suis) and other domestic and wild mammals (especially rodents -E. rhusiopathiae var. murisepticum), also domestic birds (turkey, chickens), fish, cuttlefish, molluscs, crabs, lobsters; water. Animal disease: swine erysipelas with acute or chronic course (rash, septicaemia, endocarditis, arthritis), sometimes clinical disease in domestic and wild birds. Transmission mode: contact (percutaneous at injury: occupational disease in butchers, veterinarians, fishers, pickers and shope assistants of seafood, farmers); exceptionally haematophagous arthropods (isolation of E. rhusiopathiae from ixodid ticks -experimentally confirmed mechanical (?) transmission by Ixodes persulcatus, mites, fleas and flies); considerable tenacity of the agent (in water and soil it survives at 5 • C up to 970 days, in animal cadavers up to 9 months, it also resists higher concentrations of NaCl). Human disease: erysipeloid [vs. erysipel caused by Streptococcus pyogenes]characteristic erythema on hands, oedema of finger joints; infrequently a generalized (septic) form with polyarthritis and endocarditis (in that case the fatality rate is high). Bio-containment: BSL-2. Diagnosis: symptoms and anamnesis (haemo)cultivation (BA with glucose, 5-10% CO 2 ), subcutaneous inoculation of mouse. Treatment: penicillin, erythromycin (tetracyclines).

Prevention: vaccination of animals. Geographical distribution: worldwide. Short, motile ("tumbling" at lower temperatures of 20-25 • C), non-sporulating aerobic Gram-positive rods 0.5-2×0.4-0.6 μm. A total of 13 serotypes have been described, in humans occur most frequently the serovars 1/2a, 1/2b, and 4b.

Source of infection (natural host range): (1) domestic and wild mammals (sheep, goat, cattle, pig, rodents) , birds (corvids, gulls, fowl), and man (up to 5% of the human population are asymptomatic carriers); (2) soil, water, fodder, silage, household rubbish (L. monocytogenes grows even in fridge at 4 • C). Animal disease: often inapparent infection, sometimes encephalitis, abortions (especially in sheep), and fatal septicaemia in young fowl, lambs and calves. Transmission mode: nearly exclusively alimentary ("food-borne" infection: soft maturing cheese sorts, raw milk, smoked tongue, ham, paté, raw cabbage, salads, sea fish and other seafood), less often contact (farmers, fishers), aerogenic, via conjunctivae, and transplacentary. The agent's tenacity is remarkable: it survives at a lower temperature 1 year or more, and tolerates, e.g., 10% NaCl. L. monocytogenes also survives in macrophages, and its virulence is activated by contact with gastric fluid of the host. Human disease: listeriosis -often inapparent infection. Incubation period of listeriosis is very long, on the average one month but sometimes up to 70 days. The symptoms of listeriosis are fever, headaches, chills, pharyngitis, nausea, mononucleosis, purulent meningitis (in up to a quarter of cases), encephalitis, endocarditis, granulomas and abscesses in liver, subcutis and other organs, septicaemia (bacteraemia) in half of the cases; fatality rate is up to 20-30% (mortality usually occurs in old persons, at immunosuppression or at a large infectious dose 

Greek "ανθραξ" (anthrax) means "glowing coal" (cutaneous form of the disease is characterized by a black skin lesion). An aerobic, non-motile Gram-positive rod 4-8×1-1.5 μm with a mucous polyglutamate capsule and a spore located in the cell centrally, as observed already by Robert Koch in 1876 who cultivated the anthrax bacillus first. Virulence is determined by a plasmid.

Source of infection (natural host range): domestic and wild ruminants (especially cattle, sheep and goat), equids; soil (on pastures contaminated with the agent or its spores mainly in alluvial areas of rivers, or in deltas), animal products (manure, skins, fur, wool). Animal disease: anthrax (herbivores, much less pigs and carnivores) -a peracute septic illness with a sudden death. For instance, ten thousands of livestock died in Zimbabwe in 1979-1982; about abdominal; and septic. The number of anthrax cases in the world varies between 5 and 100,000 yearly (WHO), with a considerable mortality (25-100%) especially in non-cutaneous forms of the disease with septicaemia (the fatality rate in cutaneous forms is 5-20%). Epidemics: e.g., Zimbabwe c. 10,000 cases in 1979-1985 (the source: infected cattle); 64 persons died in Yekaterinburg (former Sverdlovsk) after an unintentional release of B. anthracis spores in 1979 from a plant producing bacteriological weapons; 2000 Volgograd: 25 persons were infected after consuming infected meat; 2000 Romanian Danube delta: 2 persons died. In 2001, anthrax spores were used as a bacteriological weapon in letters in USA: 22 persons were infected, and 5 of them died (11 cases were the inhalational clinical form, and 11 were the cutaneous form). Occupational disease: the wool, skin and fur proceeding workers (carpets etc.), veterinarians, butchers, farmers, diggers in burial ground with the anthrax contaminated bodies. Bio-containment: BSL-2/3. Potential bioterrorist agent (used, e.g., in USA). Diagnosis: symptoms (in cutaneous form), blood smear (Gram, IF) with detection of capsules (Giemsa or polychromic methylene blue stain, or phase contrast); cultivation (MPA, BA: colonies have a characteristic shape caput Medusae, without haemolysis; selective media such as PLET agar inhibiting Bacillus cereus); inoculation of laboratory mouse (or guinea pig, rabbit); Ascoli's precipitation reaction (overlaying of anti-anthrax precipitation serum with the filtered extract of the tested organ); serology (IFA), PCR. Treatment: large doses of penicillin, amoxicilin, ampicillin, penicillin combined with streptomycin; tetracycline, chloramphenicol, erythromycin. Prevention: vaccine (immunization with a toxoid; for humans and animals, a non-virulent strain; developed Louis Pasteur in 1880, who cultivated the strain for 6 weeks/42-43 • C); (a vaccine licensed in USA -AVA/Biothraxis applied by skin scarification). In leather manufacture, inactivation of B. anthracis spores with peracetic acid (Persteril) is used for raw materials (skins). Geographical distribution: worldwide, but sporadic (enzootic foci) -Asia (Siberia, Turkey, Iran, Iraq), Europe (Romania, southern Russia, Hungary), Africa, South America.

Non-motile Gram-positive cocci of about 1 μm, in clusters, facultatively anaerobic and producing catalase. S. aureus and S. intermedius also produce plasmacoagulase, haemolysin, and ferment mannitol. NaCl), coagulase test, phagotypization, molecular typization; serological detection of toxin. Treatment: antibiotics (optimally after the susceptibility testing) -oxacilin, methicillin (but some strains are MRSA -methicillin resistant S. aureus), chloramphenicol, tetracycline, ampicillin, erythromycin; junction of abscesses. There is no specific therapy for staphylococcal enterotoxicosis. Geographical distribution: worldwide.

Bacilli]

Pyogenic streptococci of the α-haemolytic group D (S. suis), and β-haemolytic group C (S. equi ssp. zooepidemicus). Non-motile cocci 1 μm, arranged in chains, do not produce catalase.

Animal disease: fish pathogen (sporadic infections in tilapia, yellowtail, rainbow trout, and coho salmon as well as disease outbreaks with high mortality rates in aquaculture farms) -skin lesions, necrotizing myositis, meningoencephalitis, panophthalmitis; sometimes asymptomatical course. Transmission mode: percutaneous (throw soft tissue injuries that may occur during the preparation of fresh fish from wet markets). Human disease: streptococcosis, usually results in bacteraemic cellulitis of the hand, accompanied with one or more of these symptoms: endocarditis, meningitis, arthritis, sepsis, pneumonia, osteomyelitis, and toxic shock. First human case of S. iniae infection was reported in 1996, and since 2000, hundreds of cases have been reported from southern Asia and Australia.

Most of infections occur in elderly people who commonly have underlying conditions such as diabetes mellitus, chronic rheumatic heart disease, cirrhosis, etc. Bio-containment: BSL-2. Diagnosis: anamnesis, cultivation (BA), PFGE, MLST (multi-locus sequence typing). Treatment: penicillin, ampicilin, cloxacillin, cefazolin, and/or gentamycin, doxycycline, and trimethoprim/sulphamethoxazole. Geographical distribution: probably worldwide (global distribution among fish population), largely North America, Israel, and Asia (Japan, Taiwan, China).

Enterococci are gut commensals in humans and other endothermic vertebrates. But the emerging vancomycin-resistant (VRE) and high-level gentamicin-resistant (HLGRE) enterococci (multilocus sequence type 16) can cause serious diseases, e.g. endocarditis.

Source of infection: some HLGRE and VRE isolates from pigs are identical with those from humans sufferring from endocarditis. Animal disease: not observed. Transmission mode: alimentary, by contact. Nosocomial infections. Human disease: endocarditis, sometimes severe. Bio-containment: BSL-2. Diagnosis: by cultivation (BA, Slanetz-Bartley or kanamycin-aesculin-azid medium) and antibiotic sensitivity testing. Treatment: normally combinations of antibiotic such as one affecting cell wall of bacteria (ampicillin, penicillin, or vancomycin) plus gentamicin or vancomycin. But the HLGRE and VRE strains pose now great problems. The alternative use is linesolid, quinupristin or some fluoroquinolones. Geographical distribution: USA, Europe (e.g., Denmark), but probably also many other geographic areas.

Anaerobic slim Gram-positive rod 4-8×0.4-0.8 μm with a terminal spore of the plectridium type.

Source of infection: soil (especially manured); horse and other mammals. Animal disease: tetanus (dogs, cats and birds are resistant). Transmission mode: by contact (percutaneous -injury: e.g., farmers, gardeners); spores are very resistant, they survive (e.g. in soil >10 years, and in boiling water up to 3 h). Human disease: tetanus (lockjaw); classical neurotoxicosis (main toxin is tetanospasmin, its MLD for mouse is 0.0001 μg; another one is tetanolysin), with the fatality rate of 30-70%; first clinical signs are the blockade (painful contraction) of maxillary muscles, trismus (sardonic grimace) and abdominal rigidity, later convulsions of back muscles (opisthotonus: bow-shaped deflection of body to the back, leading sometimes to fractures of vertebrae and muscles), respiratory and other muscles; no fever, consciousness is conserved. Bio-containment: BSL-2/3. Diagnosis: clinical symptoms (tonic spasms); microscopy and anaerobic cultivation of wounded tissue, subcutaneous inoculation of mice (combined with toxin neutralization test). Treatment: surgical treatment of the wound, application of specific human (TEGA) or horse immunoglobulin (antitoxin, antitetanic serum) within 24 h; pulmonary ventillation or tracheotomy, myorelaxants and sedatives; penicillin and metronidazole. Prevention: immunization with anatoxin (toxoid). Geographical distribution: worldwide (less frequent in cold areas). * Clostridium perfringens Type A, C. septicum, C. novyi etc.

Anaerobic Gram-positive rods 4-6×0.6-1 μm, non-motile (C. perfringens) or motile (C. septicum, C. novyi).

Source of infection: soil (contaminated with animal excrements). Animal disease: gastritis in lambs (C. septicum); necrotic hepatitis in sheep (C. novyi). Transmission mode: by contact (injury, trauma -car accidents and other harms; iatrogenic). Human disease: gas gangrene -cellulititis, myositis, fasciitis, necrosis of tissue with gas production (main toxin is lecithinase -phospholipase C); fatality rate is 30-90%. A total of 35 (out of 104 infected drug-users) died of sepsis after syringe application of contaminated drugs in Great Britain in 2000 (C. novyi, C. perfringens). Bio-containment: BSL-2/3. Diagnosis: clinical symptoms, microscopy and anaerobic cultivation of the tissue, detection of lecithinase. Treatment: surgical treatment of wounds; antibiotics (penicillins) in high doses; hyperbaric box. Geographical distribution: worldwide.

Anaerobic Gram-positive rods. Highly virulent ribotypes O17, O27, and O78 of C. difficile emerged lately.

Source of infection: soil, water, digestive tract of vertebrates (pig, cattle, poultry); man. Ribotypes of many human isolates have been shown to be identical with bovine strains. Animal disease: calf diarrhoea, infectious enterotoxemia of domestic animals. Transmission mode: alimentary (food-borne: e.g., undercooked and longer weaned meat, salads); nosocomial -man to man transmission (about 5% of adults act as carriers of C. difficile occurring in the gut). Human disease: intestinal clostridiosis -infection or intoxication (toxin production in the gut -enterotoxins A and B) -pseudomembraneous colitis with diarrhoea, occasionally occurrence of megacolon with risk of gut perforation and subsequent peritonitis; gastroenteritis with diarrhoea and abdomen convulsions, and quite high lethality. The disease frequently occurs after long-term treatment with various antibiotics (so-called "post-antibiotic colitis"), when C. difficile replicates abundantly in the gut and produces toxins (the most virulent are the strains with type V toxin). C. difficile forms considerable portion of bacterial enteric infections in old peoples' homes, hospices and some clinics (a hospital ecological niche); the incidence rate of this disease, sometimes called CDAD (C. difficile-associated disease) has increased tenfold recently -it is an emerging nosocomial infectious disease, spreading as anthroponosis especially in North America, Europe and Singapore. People older than 65 years are very susceptible to this illness. Bio-containment: BSL-2. Diagnosis: anaerobic cultivation of stool samples and foods (selective media with cefoxitin and cycloserine), detection of enterotoxin in the stool and blood specimens on tissue cultures or by ELISA. Treatment: rehydration, vancomycin, metronidazole. However antibiotic treatment increases incidence of C. difficile infections in healthcare settings. Geographical distribution: worldwide, with increasing incidence in countries associated with high hygienic standard (Canada, Great Britain, Belgium, Netherlands, France, Austria).

An anaerobic motile rod 4-6(10)×1 μm, with a subterminal spore.

Source of infection (natural host range): pig, ruminants, horse, poultry; fish (type E); soil, vegetables, fruit, silage. Animal disease: botulism (death caused by diaphragm paralysis) in mammals and birds (chicken, wild waterfowl). Transmission mode: alimentary (gastric trypsin activates the toxin) -ham, sausages, home-made tins of meat, vegetable (green beans, peas, root vegetables) and fish origin, liver pate; wound botulism (drug users). Human disease: botulism (alimentary intoxication of humans by the types A, B, E, F and G, the most effective neurotoxins at all causing after an incubation period of 12 h to several days irreversible neuromotoric paralysis by blockade of acetylcholine release on synapses, with loss of motility, diplopia, strabism, paralysis of respiratory muscles); fatality rate 15-75%. MLD of botulinum toxin ("sausage poison") for man is 0.0625 μg. Very dangerous is infant botulism with replication of clostridia and toxin production in the gut of babies (honey as an addition to baby food is the most frequent source of C. botulinum). Bio-containment: BSL-2. Diagnosis: detection of botulotoxin in serum, faeces, vomitus or food residues by toxin-neutralization test on mice (ELISA is 10-100× less sensitive); cultivation of the stool or of food residues is less important. Treatment: stomach and intestine lavage; botulinum antitoxin poly-or monovalent. Prevention: vaccination with toxoid (in occupations with risk, and animals). Geographical distribution: worldwide.

Actinobacteria] Diagnosis: see other mycobacteria; the optimum temperature for its in vitro isolation ranges between 30 and 33 • C. Treatment: clarithromycin + ciprofloxacin. Geographical distribution: worldwide. * Mycobacterium xenopi "Atypical", mostly slow-growing "non-tuberculous" saprophytic mycobacteria, however potentially pathogenic for human; maximum growth temperature is between 42 and 45 • C. M. xenopi was found to be more heat-resistant than Legionella pneumophila.

Source of infection: potable warm water systems (households, hospitals, dental units), animals (domestic and wild pig, cat, cattle), soil (?). Transmission mode: aerogenic, alimentary.

Human disease: mycobacteriosis -chronic pulmonary and extrapulmonary disease, especially in immunocompromised persons (AIDS). Usually sporadic disease, but outbreaks of pulmonary mycobacteriosis due to M. xenopi may rarely occur. Bio-containment: BSL-2. Diagnosis: see other mycobacteria. Treatment: clarithromycin + ciprofloxacin. Geographical distribution: worldwide. * M. marinum, M. haemophilum "Atypical" photochromogenic (M. haemophilum is not photochromogenic), mostly slow-growing "non-tuberculous" saprophytic mycobacteria, however potentially pathogenic for human. M. haemophilum demands special growth conditions (ferric ions).

Source of infection: water (aquaria -water, plants, sediment, biofilm, aquatic invertebrates, swimming pools, coal mine water, surface water, sewage, drinking water systems, soil, peat); fish (M. marinum -this species is also ichtyopathogenic); fish (zebrafish), insects, reptiles in M. haemophilum. Transmission mode: by contact -skin injury. Human disease: mycobacteriosis -skin disease characterized by rash, tubercles and raddish scabs 2 weeks after infection, then granulomas, nodules and ulceration evolve (M. marinum: "swimming pool granuloma" or "fish tank granuloma"); often in fish breeders and aquarists -usually after injuryalso M. haemophilum. Typical location of skin lesions are elbows, knees, lower legs, hands and fingers in amateur fishermen and aquarists; cervical lymphadenitis was recorded mostly in Dutch children (M. haemophilum). Bio-containment: BSL-2. Diagnosis and therapy: biopsy of damaged tissue for laboratory testing (culture, histology); optimum growth temperature for in vitro isolation ranges between 30 and 33 • C; for other methods see previous species. Geographical distribution: worldwide. * Mycobacterium abscessus, M. chelonae, M. fortuitum, M. phocaicum "Atypical", mostly fast-growing "non-tuberculous" saprophytic mycobacteria, however potentially pathogenic for human; optimum temperature growth usually at 28-30 • C.

Source of infection: drinking water (hospital water supplies, showers, cooling towers, consumption of ice, ground water (M. chelonae, M. fortuitum), treated surface water, biofilms (bronchoscopes, dialysers)). Transmission mode: aerogenic, alimentary, iatrogenic. Some of these mycobacteria can survive in amoebae. 

This microbe has lost at least 2,000 genes after adaptation to human host (drastic reduction of genome, whose complete sequence of nucleotides has been described recently).

Source of infection: human; water (peatbogs and bryophytes growing in the surroundings of waterfalls and on fiord slopes with south exposition in Norway, Portugal, southern USA etc.), open water bodies (bathing) and contamination of clothes by washing in streams in endemic regions; systemic leprosy occurs occasionally in feral ninebanded armadillos. Transmission mode: airborne -human to human transmission (thus anthroponosis); according to J. Kazda a L.W. Irgens transmission from environment either by ingestion of infected water (conducted by wood pipe-lines downhills in Norway) or by direct contact (scratches, from mother to child) is also possible. Human disease: leprosy (Hansen's disease) -a chronic infection characteristic by skin, nervous or even general manifestations, without appropriate treatment leading in mutilations. Bio-containment: BSL-2. Treatment: long-term (6-12 months), with a combination of rifampicin, Dapsone, and clofazimine. Diagnosis: microscopy of skin scrapings (staining according to Ziehl-Neelsen); it does not grow in vitro, while replicating in armadillo Didelphis and "nude" laboratory mice. Geographical distribution: formerly worldwide, very limited at present.

Corynebacterium ulcerans, C. pseudotuberculosis Short irregular Gram-positive rods 1-3×0.4 μm, aerobic and non-motile.

Source of infection (natural host range): cattle, sheep, horse, dog, cat, pig and monkey (only C. ulcerans), occasionally other mammals; human. Animal disease: pneumonia, abscesses and lymphadenitis. Transmission mode: alimentary (raw milk), percutaneous (biting by monkey), by contact. Occupational risk in farmers and vets. Human disease: pharyngitis (C. ulcerans) similar to diphtheria, wound infections (C. pseudotuberculosis) and regional lymphadenitis, pneumonia; a rare disease. Bio-containment: BSL-2. Diagnosis: cultivation of swabs (resp. smears) originated from wounds, milk (BA, selective agar with tellurate, Loeffler medium slants, Lowenstein-Jensen agar, some other media for isolation of mycobacteria); inoculation of guinea pigs; detection of toxin. Treatment: erythromycin, antitoxin. Prevention: vaccination (diphtheric toxoid). Geographical distribution: Great Britain, but obviously worldwide.

Syn. Corynebacterium pyogenes. Slim Gram-positive rods fragmenting gradually into small coccobacilli, aerobic and non-motile.

Source of infection (natural host range): cattle, sheep, goat, pig, horse and other mammals; human. Animal disease: abscesses, polyarthritis, lymphadenitis. Transmission mode: by contact (via biting). Human disease: purulent wound infections after biting and painful regional lymphadenitis, arthritis, sometimes sepsis; a quite rare disease. Bio-containment: BSL-2. Diagnosis: cultivation of scumming from wounds (BA, selective agar with tellurate); inoculation of guinea pig; detection of toxin. Treatment: erythromycin. Geographical distribution: probably worldwide.

Synonym Corynebacterium equi. Pleomorphic coryneform Gram-positive, partially acidoresistant, aerobic cocci to rods (coccobacilli), forming short filaments with symptoms of branching.

Source of infection: soil enriched with faeces of domestic mammals (R. equi is a commensal of their gastrointestinal tract), in which is the rhodococcus able to replicate. Animal disease: acute or chronic bronchopneumonia with lung abscesses (sometimes lethal) of foals; lymphadenopathy in pigs. Transmission mode: aerogenic, less often alimentary, contact with horses. Human disease: rhodococcosis -fever, nausea, vomiting, diarrhoea, dizziness, granulomatous bronchopneumonia (opportunistic infection in immunocompromised patients), often lethal (fatality rate about 50%); sometimes lymphadenitis and abscesses in the CNS, liver, kidneys and other organs, skin lesions in immunocompetent persons (mainly childrens) after injury may also occur. In patients with AIDS, the disease is often chronic and recurrent, because R. equi can survive intracellularly in macrophages. Incidence is quite low, about 200 cases have been described since the disease description in 1967. Bio-containment: BSL-2. Diagnosis: cultivation of blood, sputum, bronchial and tissue samples (BA,

Czapek-Dox agar; pink colonies) and detection of "equi" factor (CAMP test: synergistic haemolysis against Staphylococcus aureus and other bacteria: partial haemolysis of S.a. turns into complete in proximity of R.e. colonies due to the effect of rhodococcal cholesteroloxidase); histopathology, acidoresistant staining (partially acidoresistant). Treatment: long-term (2-9 months or even lifelong treatment) -rifampicin, vancomycin, erythromycin, gentamicin, imipenem, carbapenem, meropenem (often in combination of two drugs, e.g. sulbactam + cefoperazone; confirmation of in vitro sensitivity is needed). Geographical distribution: probably worldwide. * Nocardia asteroides, N. brasiliensis Aerobic filaments of mycelial character, fragmenting into pleomorphic Grampositive rods to cocci, forming also aerial mycelium on solid substrates.

Source of infection: soil, plant remnants. Animal disease: nocardiosis -infection of subcutis and lymph nodes (dog, cat), sporadically mastitis and pneumonia in cattle. Transmission mode: aerogenic, percutaneous. Human disease: nocardiosis pulmonary, cutaneous (actinomycetoma), visceral, even CNS affection (by dissemination from lungs, about 30% of cases); fatality rate 80% in CNS forms. Bio-containment: BSL-2. Diagnosis: microscopy of sputum, pus or CSF (Gram and acidophilic staining), cultivation (BA etc.); X-ray computed tomography. Treatment: cotrimoxazole, sulphonamides in long-term usage; some strains sensitive to ampicilin, amikacin, cephalosporines and other antibiotics; surgical intervention (abscesses). Geographical distribution: worldwide, however sporadic; N. brasiliensis occurs more frequently in (sub)tropics.

Source of infection: soil, vegetation. Animal disease: (actino)mycetoma.

In this chapter filamentous (with mycelium) and yeastlike eukaryotic microorganisms are dealt with. The taxonomic nomenclature of fungi differentiates two forms according to their life cycle: the anamorph is the asexual phase with asexual spores (conidia), or sterile; the teleomorph is the sexual phase with fruiting bodies and sexual spores (ascospores, basidiospores or zygospores). The complex of all developmental forms of the fungus (i.e., the teleomorph including all its anamorphs) is regarded as a holomorph, the binomical determination of which is identical with a teleomorph.

Fungi (micromycetes) that are pathogenic for vertebrates cause two basic clinical syndromes of mycoses: (1) superficial diseases with lesions on the skin and its adnexes (nails, hairs etc.), and (2) visceral (deep, organ, systemic) diseases. Among the most common agents causing skin mycoses belong dermatophytes of the teleomorph genus Arthroderma (with the anamorphs Trichophyton, Epidermophyton and Microsporum); these dermatomycoses are differentiated according to the source of infection being antropophilic (corresponding to the adjective "anthroponotic" used throughout this book), zoophilic (corresponding to the adjective "zoonotic"), and geophilic (corresponding to the adjective "sapronotic"). Noteworthy, many agents causing visceral mycoses are dimorphic: their saprophytic phase is filamentous, but the parasitic phase appearing in tissues of warm-blooded vertebrates is morphologically entirely different -most often yeast-like, or spheruliform.

Among the first signs indicating that a patient could be suffering from a visceral mycosis is usually failure of antibiotic therapy (especially when virus infections have been excluded). Immunocompromised patients (AIDS, cancer, malnutrition, post-transplantal and post-operation stages are among the main risk factors) present the highest risk of acquiring visceral mycoses.

Several microfungi (especially of the genera Aspergillus, Fusarium, etc.) produce mycotoxins often causing dangerous mycotoxicoses affecting diverse organs of vertebrates (including man): liver, intestine, CNS, kidneys or the reproductive system.

The traditional diagnosis of fungal diseases is based on microscopic examination of samples originating from lesions (crusts, scrapings, scales of skin and nails) after their partial digestion in 10% KOH. The microscopy is supplemented with cultivation of the samples, frequently on Sabouraud agar (SGA) with chloramphenicol and cykloheximide simultaneously at temperatures 25-30 • C and 37 • C for up to 2-3 weeks; some yeasts or visceral fungi require richer media such as BA or BHI agar. The macroscopic pattern of the fungal colony and microscopic morphology of the fungus is evaluated. In addition, biochemical identification sets are generally used for the determination of pathogenic yeasts (Candida spp., Cryptococcus neoformans). Histological examinations are also applied in invasive visceral mycoses (e.g. histoplasmosis, blastomycosis) -the sections are usually stained according to Schiff's or the more specific Grocott and Gomori methods. Serological examinations of the patients include RDPA, counter immunoelectrophoresis, agglutination and ELISA. Latex agglutination or ELISA is generally used for the detection of antigen. Molecular biology methods (PCR) have evolved into progressive diagnostic tools in recent years.

Ascomycetes]

Teleomorph: Arthroderma benhamiae.

Source of infection: soil in arid and semi-arid areas (mainly in and around rodent burrows). Animal disease: inapparent course or bronchopneumonia. of old buildings, visits of caves contaminated with bat and oilbird droppings). Human disease: histoplasmosis -primarily a pulmonary disease characterized with pneumonia and lymphadenopathy, similar to tuberculosis (lung calcification), with a good prognosis; however, generalized or progressive clinical forms (approximately 1% of all cases) may result in hepatosplenomegaly, the CNS infection, ulceration of digestive tract and other severe manifestations with high lethality. Pulmonary histoplasmosis might be chronic, and with relapses. The course of disease is severe in immunocompromised patients (e.g., AIDS) as well. H.d. is the agent of African histoplasmosis with predominantly subacute course and formation of cutaneous or bone granulomas without lung affection. Bio-containment: BSL-3. Diagnosis: chest X-ray, microscopy (Gram and Giemsa staining) and cultivation of sputum or tissue lesions (SGA, 25-30 • C: production of characteristic conidia, and demonstration of conversion of isolate M → Y at 37 • C), liver or lung biopsy in severe forms (microscopy-silver stain); serology (RDPA, ELISA, CFT, IFA, latex agglutination), intradermal test (histoplasminretrospective demonstration of exposition). Treatment: amphotericin B, ketoconazole itraconazole. Geographical distribution: nearly worldwide. H. capsulatum is relatively frequent in the USA (natural foci are present in e.g. the basin of Mississippi and Ohio rivers), Central and South America, Africa, India and southeastern Asia (e.g., first indigenous case reported in Taiwan in 2005), while infrequent occurrence has been reported in Europe where, e.g., 118 cases were documented in 1995-1999 (but only eight obviously autochthonous in Italy, UK, Turkey and Germany); H. duboisii has been recorded in Africa only. * Blastomyces dermatitidis

Teleomorph: Ajellomyces dermatitidis. A dimorphic fungus: normally filamentous, but yeast-like forms are produced in the tissue at 37 • C.

Source of infection: soil; dog (equids). The specific reservoir (ecological niche) unknown, but the fungus habitat seems to be associated with waterways in North America. Animal disease: ulcerative changes. Transmission mode: aerogenic, by contact.

Human disease: (North American) blastomycosis -pulmonary, occasionally cutaneous, mucocutaneous as well as generalized (disseminated) forms with high lethality. Bio-containment: BSL-2/3. Diagnosis: chest X-ray, microscopy of sputum, pus and biopsy (yeast-like forms), cultivation (SGA), serology (RDPA, ELISA). Treatment: amphotericin B, ketoconazole itraconazole. Geographical distribution: North America. Some cases reported in Africa, Asia and Europe. * Emmonsia crescens

Teleomorph: Ajellomyces crescens. A dimorphic fungus, very closely related to genera Histoplasma and Blastomyces (based on 18S rRNA sequences), with small spherical to oval conidia (2-3 μm) in saprophytic phase, and with thick-walled spherules called adiaspores with a diameter up to 500 (700) μm (whereas close species Emmonsia parva, with unproven pathogenicity for man, has spherules only up to 40-50 μm) in the lung tissue; granulomas.

Source of infection: soil (rhizosphere), burrows of mammals. Animal disease: pulmonary emmonsiosis (adiasporomycosis, adiaspiromycosis) of mammals, mainly in rodents. Emmonsiosis caused by E. parva occurs in steppe and desert rodents. Transmission mode: aerogenic (from the soil). Enhanced occupational risk of infection (farmers and persons handling with soil-diggers). Human disease: pulmonary emmonsiosis (adiasporomycosis, adiaspiromycosis), occasionally with fever, cough, dyspnoea, exceptionally with lethal course. A number of severe cases of the disease have been recorded in Brazil and Argentina. Several benign cases have been documented in the former Czechoslovakia. Bio-containment: BSL-2. Diagnosis: chest X-ray, lung biopsy (adiaspores), cultivation (SGA). Treatment: amphotericin B, ketoconazole. Geographical distribution: worldwide (E. crescens). * Paracoccidioides brasiliensis Teleomorph: supposedly Ajellomyces (based on 18S rRNA sequences of the anamorph). A dimorphic fungus: filamentous, but multipolarily budding yeast-like form in the tissue.

Source of infection: soil, plant substrates. A number of isolates have been obtained from the armadillo Dasypus novemcinctus in Brazil; armadillos obviously play an important role in the ecology of this fungus (hosts, reservoir?), but they are uncertain as the source of human infection.

Teleomorph: Filobasidiella neoformans. C. neoformans complex produces spherical yeast-like cells 2-10 μm with a mucopolysaccharide capsule; serotypes A to D.

Columbia and northwestern USA, occasionally southern and central Europe (Spain, France, Italy, Greece, Austria, Germany).

( * * ) Pneumocystis jirovecii (Synonym P. carinii)

Formerly classified within Protozoa, but the rRNA analysis revealed close similarity with smut fungi.

Source of infection (natural host range): brown rat and other rodents, domestic animals (dog); man (there are anthroponotic and zoonotic strains of this species). Animal disease: inapparent course (sometimes massive findings of cysts in lungs of rabbits and rodents). Transmission mode: aerogenic, by contact. Human disease: pneumocystosis, often in immunocompromised persons (leukaemia, AIDS, malnutrition); generally subfebrile. [Interstitial pneumonia of newborns is an anthroponosis with fatality rate 0-40% (aetiology of this disease was elucidated by Vaněk and Jírovec in 1952)]. Bio-containment: BSL-2. Diagnosis: microscopy of sputum (IF determination of antigen), bronchoalveolar lavage, lung biopsy. Giemsa or silver staining of the samples: mature "cysts" (in fact basidia) are 5-8 μm in diameter with double wall and contain eight uninuclear bodies, "sporozoites" (in fact basidiospores), and spots of eosinophilic substance with aggregations of very small spherical forms 1-4 μm, called "trophozoites"; PCR, sometimes serology (CFT, IFA). Treatment: cotrimoxazole, trimethoprim + sulphamethoxazole, pentamidine, sulphadiazine + pyrimethamine. Geographical distribution: worldwide.

Oomycetes] * Pythium insidiosum A plant pathogen (in nature, biflagellate zoospores attach the water plants), not a true fungus.

Source of infection: water. Animal disease: a cutaneous and pulmonary disease in domestic mammals (cat, dog, horse, cattle), with chronic ulcerated lesions on the limbs, chest, and abdomen.

Transmission mode: by contact (skin abrasions -e.g., in rice fields). Human disease: pythiosis -ocular form (keratitis), cutaneous and subcutaneous form, and arterial form with chronic ulcers on the legs, ischaemia, thrombosis of major arteries, and necrosis (fatality rate of c. 40% in the arterial form). Bio-containment: BSL-2. Diagnosis: microscopy (biopsy: hyaline, thin-walled hyphae and hyphal fragments resembling zygomycetes -the cell walls are non-parallel), cultivation (e.g., SGA), serology (IFA, immunodiffusion). Treatment: surgery combined with antifungal compounds (amphotericin B, azoles); in ocular pythiosis, keratoplasty is usually necessary but not always it is successful. Geographical distribution: tropical and subtropical regions (reported from Thailand, Malaysia, Australia, New Zealand, Haiti).

Flagellates of two genotypes (I and II), and two life forms: trypomastigotes 15-20×2 μm with an undulating membrane (operates as a traction propeller) and kinetoplast (a specialized mitochondrium near the base of flagellum); replicating spherical amastigotes (2-6 μm) occur in the tissue (RES and muscle cells) most of them generate new trypomastigotes that disseminate via the blood.

Source of infection (natural host range): dog, cat, pig, goat, cattle, rabbit, rodents (Neotoma spp. woodrats, guinea pig), armadillo (Dasypus), opossum (Didelphis albiventris, reservoir), punaré (Trichomys apereoides, reservoir), racoon (Procyon), bats, monkeys; man (sporadically). Animal disease (dog): chronic myocarditis, meningoencephalitis, anaemia. Transmission mode: bites of tropical haematophagous insects -kissing bugs (Reduviidae): Triatoma infestans, T. sanguisuga, Rhodnius prolixus, Meccus longipennis, T. rubida (USA), etc. (trypanosomes develop in their gut and are rubbed with the bugs' excrements into wounds or conjunctiva). Other means of transmission include blood transfusion, organ transplantation, or congenital infection in childbirth, and also alimentary route -58 food-borne human cases were reported in Brazil in 2007 and 2009, after eating "acai", a food prepared from palm tree of the family Aracaceae (fruit, juice). A similar large outbreak also occurred in children from a school in Venezuela: the palm

Flagellates (15)20-30(40) × 1.5-3 μm with an undulating membrane. Two subspecies: zoonotic T. b. rhodesiense, and anthroponotic * * T. b. gambiense, formerly classified as two separate species. They are characteristic by their "immune evasion" strategy due to antigenic variation within a host, caused by switching of surface glycoproteins (VSG genes are responsible). (40) days. Human disease: African sleeping disease, African trypanosomiasis (East-African -T. b. rhodesiense, or West-African -T. b. gambiense) -irregular high fever attacks without chills, hyperhidrosis, headache, tachycardia, respiratory distress, skin rash, anaemia at the beginning, later lymphadenitis (swollen lymph nodes in the hind trianguloid part of the neck and axillae, called Winterbottom's sign), swollen eyelids, oliguria, neurologic signs (hypersensitivity for touch, hypersomnia, meningoencephalitis); hepatosplenomegaly; acute course (2-4 months: T. b. rhodesiense) or chronic (1-6 years: T. b. gambiense). Fatality rate is high (90%), 1-2 years after primary infection without specific therapy the patient dies. Re-emergence of the disease has occurred during last years (DR Congo etc.: T. b. gambiense). The annual incidence of sleeping sickness in sub-Saharan Africa is estimated as 50,000-70,000 cases. Bio-containment: BSL-2. Diagnosis: microscopy -thick drop, blood smear, smear of punctate from swollen lymphatic nodes or from CSF (native preparation, Giemsa, IF), serology (IFA, CFT, AR, RDPA, ELISA, RIHA), cultivation (agar), inoculation of laboratory rat or mouse (T. b. rhodesiense); novel molecular techniques such as PCR and proteome fingerprinting. Treatment: pentamidine (ineffective in late-stage of disease, less effective against T. b. rhodesiense) in acute phase or as a prophylaxis; suramin (a trypanocidal agent that is however toxic, causing degeneration of the liver, kidney and adrenal glands), arsenic preparates (toxic) in chronic phase (CNS affection) such as melarsoprol (the effectivity of this drug has been reduced by some 20% in the last years as demonstrated in DR Congo), tryparsamide, and the latest α-difluoromethylornithine (DFMO), being relatively nontoxic and effective in combination with nifurtimox even in therapy of the CNS phase of the disease. Geographical distribution: tropics of East Africa -savannah (T. b. rhodesiense),

West and Central Africa -river basins (T. b. gambiense); both subspecies occur simultaneously only in Uganda. Source of infection (natural host range): in cutaneous leishmaniasis rodents (gerbils Rhombomys, Meriones, Psammomys in desert; rats Mastomys, Arvicanthis, etc. in savannah; punaré Trichomys apereoides in Brazil, hyrax Procavia capensis in Jordan, Israel and Kenya), sloth, kinkajou, also dog, jackal, fox, goat, buffalo, cattle, horse and human in urban cycle; in visceral leishmaniasis canines, rats (Rattus rattus), opposums and man in the urban cycle. Animal disease: ulcerative inflammations accompanied with changes on skin and mucosa; in dogs also marked cachexia, alopecia, depigmentation of nose and overgrown claws in the cutaneous form, and swollen lymph nodes, ocular signs, epistaxis and kidney failure in the visceral form; canine leishmaniasis is an emerging zoonotic infection in the Mediterranean region, and in North America. Transmission mode: sandflies (Phlebotomus in the Old World; Lutzomyia in the Americas) -by biting and infectious excrements; in the vector, there are flagellar forms (leptomonas), replicating in its midgut. Within the human host, the promastigote forms are ingested by macrophages where they change into amastigote forms. Main vectors of leishmaniasis in the Mediterranean region are e.g., P. neglectus, P. perfilievi, P. perniciosus, P. papatasi (L. major), P. arabicus; elsewhere in the world P. martini, P. orientalis, P. chinensis, P. sergenti (L. tropica), P. duboscqui (L. major), P. alexandri, P. argentipes,

Trepomonadea] ( * * ) Giardia lamblia (Synonyms G. intestinalis, G. duodenalis)

The two life forms are an inactive ovoid cyst (8-15×7-10 μm) and active trophozoite -bilaterally symmetrical pyrifom-shaped flagellate 9-21×6-12 μm with four pairs of flagella, two nuclei and an adhesive disc. Several genomic types: A (anthroponotic), B (zoonotic), and C-G (animal types probably not transmissible to humans). The protozoan was first described by Lambl in 1859, as Cercomonas.

Source of infection (natural host range): human; less often rodents (castor, muskrat etc.), dog; rabbit, sheep; contaminated water (e.g., swimming pools). However, the importance of zoonotic transmission in human giardiosis is not clear. Animal disease: inapparent course. Transmission mode: alimentary (water contaminated with resistant cysts of rodents), by contact, mechanically via houseflies (Musca domestica) and cockroaches; high contagiosity. The cysts have considerable tenacity, and are resistant even to common disinfectants. Human disease: giardiosis -intestinal form (giardiae adhere on intestine and duodenum mucosa): enteritis with abdominal pain, nausea, fatigue, diarrhoea, loss of weight and hepatobiliary damage. Extensive epidemics occurred in the 1970s (St. Petersburg, New York, Colorado). Giardiosis is a quite frequent human disease. For instance, the average annual incidence of giardiosis in Czechland was 645 in the period of 1990-2000, and Giardia was prevalent in about 1% adults and 4-5% children at the same time. Bio-containment: BSL-2. Diagnosis: microscopy of fresh stool using flotation method (4-nucleic cysts; flagellar trophozoites are usually present only in watery stool or in duodenal fluid), enteroscopy. Treatment: albendazole, metronidazole, mepakrin, furazolidone; acridine dihydrochloride, paromomycin. Geographical distribution: worldwide.

Heterolobosea] * Naegleria fowleri

Amoeabe free-living in warm water, e.g. in indoor warmed swimming pools (the amoebae are able of replication in sand filters of the pool system). One isolate was recovered from a hot geyser in Yellowstone Park (USA), and a number of others from artesian wells in Arizona. They have two morphological forms: amoeba (a trophozoite) and a dormant cyst stage.

Source of infection: water (warm or warmed-up surface and well water). Transmission mode: inhalatory -throw nasopharynx mucosa (amoeabe invade into brain along the olfactory nerves, and divide rapidly in the CNS); the cysts are extremely resistant in external milieu. Human disease: primary amoebic meningoencephalitis (naegleriosis) -purulent, acute (3-10 days), causing haemorrhagic necrosis of the brain; the fatality rate is up to 100% even in young, immunocompetent persons. First epidemics have been observed in Australia in 1965 and also in Czechland in 1962 -1965  in the latter country, 16 swimmers died, and other two fatal cases were recorded until 1984. Bio-containment: BSL-2. Diagnosis: microscopy of CSF under warm conditions (motility of trophozoites with a diameter of 7-20 μm) or smear (IF), cultivation. Often misdiagnosed as a bacterial meningoencephalitis. Treatment: amphotericin B (intravenously or intrathecally administered), in combination with fluconazole (or ketoconazole) and rifampicin. Geographical distribution: probably worldwide, but only sporadic cases (Australia, New Zealand, USA, Czechland, Great Britain, Belgium).

Transmission mode: inhalatory (nasal mucosa, airways), percutaneously (skin scratches), organ (kidney) transplantation (2 cases in USA); cysts are very resistant in external milieu. Human disease: granulomatous amoebic encephalitis, a rare infection with lesions on skin and in nasopharynx, further hemipareses, ataxia, seizures, personality disturbances. A total of about 150 cases have been reported (half of them in the USA -predisposition was found in Hispanic and immunocompromised persons) since discovery of the disease in 1990, usually fatal. First case in Europe: Czechland, 1995. Bio-containment: BSL-2. Diagnosis: CT scan of the brain, microscopy of CSF, print (scraping, rinsing) of lesions (IF), cultivation, PCR; often post mortem. Treatment: amphotericin B, sulphonamides, dibromopropamide (ointment), neomycin, itraconazole. Geographical distribution: worldwide, sporadic.

Two morphological forms as in other free-living amoebae (trophozoite and cyst stage).

Source of infection: soil contaminated with ruminant faeces. Transmission mode: probably inhalatory. Human disease: amoebic encephalitis, a rare infection (only one case has been described -in USA, 2001 -the patient was an immunocompetent and previously healthy man). Bio-containment: BSL-2. Diagnosis: as with other free-living amoebae. Treatment: the patient survived after surgical excision of the tumour-like mass in the brain, and subsequent treatment with azithromycin, itraconazole, flucytosine and pentamidine. Geographical distribution: worldwide.

Phyllum Apicomplexa] * Cyclospora cayetanensis Source of infection: vegetables, herbs, strawberries, lettuce, red pepper, garlic, basil etc.

Treatment: cotrimoxazole, furazolidone, albendazole, sulphonamides (Biseptol) + pyrimethamine (but with unclear outcomes sometimes), anti-inflammatories; no specific treatment in muscle coccidiosis. Geographical distribution: worldwide, endemic, with predominance in the tropical areas.

Forms: (1) (acute stage) vegetative crescent-shaped trophozoites (endo-or tachyzoites) 4-7×2-4 μm; in cell vacuoles often 2-32 together, forming "pseudocysts";

(2) (chronic stage) spherical tissue cysts 50-300 μm with thick membrane in muscles, heart, diaphragma and brain, with 1,000-60,000 crescent-shaped bradyzoites (cystozoites); (3) oocysts (10-12 μm) discovered in the 1970s, result of sexual reproduction of gametocytes (gametogony) occurring only in the gut epithelium of definitive, final host. Sporulation (excitation) occurs only after excretion of immature oocysts, 2 sporocysts with 4 sporozoites 8×2 μm may be released from each oocyst. There are four genomic lineages of T. gondii.

Source of infection (natural host range): cat and other felids (Felis, Lynx) are definitive hosts of T. gondii (they become infected with meat of intermediate host such as rodents containing bradyzoites, and excrete oocysts in faeces during 1-3 weeks: about 1% of cats in Europe); intermediate hosts (only with asexual stages of parasite, cysts) are rodents (reservoir: TOT), lagomorphs (e.g., 80% of domestic rabbits in Czechland have antibodies to T. gondii and 25% cysts), pig (cysts in 1-2%, antibodies in 10%), sheep (cysts in 5%, antibodies in 40-60%), cattle, and occasionally birds. In addition to the domestic cycle (domestic cat -mouse) there is a sylvatic cycle, observed e.g. in French Guyana: highly virulent strains of T. gondii circulate between free-living jaguars (Panthera onca, the definitive host) and their prey (intermediate hostsdeer, armadillos, pacas, peccaries). Sources of human infection is undercooked meat from hunted game and water containing oocysts excreted by wild cats. Animal disease: inapparent course, sometimes fever or even fatal infection (hen, pig, rabbit, hare in winter, rarely cat); abortions in sheep, goats, and pigs (Japan). Transmission mode: alimentary (rare meat: bloody steaks or slightly smoked meat with tissue cysts, fruit, vegetables, water and soil contaminated with cat excrements containing oocysts, which are very resistant -they survive in cat faeces and water for up to 17 months); transplacentary. Among risk areas are children playgrounds with sand, which are visited by cats excreting the oocysts. Human disease: toxoplasmosis -pantropic chronic disease: (1) congenital toxoplasmosis (infection of foetus → pathologic gravidity [acquiring infection during second trimester seems to be critical], miscarriage, chorioretinitis + hydrocephalus, microcephalia + CNS calcification of the foetus); (2) postnatal or acquired toxoplasmosis (lymphadenopathy, cough, fever, headache, fatigue, sometimes meningoencephalitis, chorioretinitis, various mental disorders), often latent (activation in AIDS patients etc.; 80-90% of infection cases are asymptomatic). Toxoplasmosis is a common zoonosis in many countries. For instance, on average 1,008 (range, 670-2,049) clinical cases were reported annually in Czechland in the years 1990-2000, and about 30% population revealed antibodies to T. gondii. Diagnosis: serology (CFT, ELISA, Sabin-Feldman's test, which encompasses staining of trophozoites with alkaline methylen blue in the presence of examined sample and so-called activator, that is accesoric factor of native human serum; in the presence of antibodies have trophozoites characteristic original crescent-like shape with uncoloured plasma and blue nucleus, while without presence of antibodies they round off and stain deep blue; further serological tests include IFA, RDPA, RIHA etc.), intraperitoneal inoculation of mouse (and histology of its brain), biopsy of lymph nodes (IF, Giemsa: trophozoites have blue plasma, nucleus is red, plasmatic granula are red-brown); X-ray examination (calcification of the brain in newborns). Bio-containment: BSL-2. Treatment: sulphonamides for long-term usage, sulphadiazine (sulphamethoxydin) + pyrimethamine (Daraprim); antibiotics -spiramycin (during gravidity), clindamycin and doxycycline. Prevention: necessary in pregnant women (avoid contact with raw or undercooked meat, cats). Vaccine unavailable. Geographical distribution: worldwide (very often in tropics).

Coccidea]

Cryptosporidium parvum, C. felis, C. canis, C. muris, C. suis, C. meleagridis

Forms: oval trophocytes 2-4 μm in the epithelial cells of respiratory and gastrointestinal tract of vertebrates including man. One-host developmental cycle (monoxenic), the host excretes oval thick-walled oocysts (sporocysts, with 4 sporozoites) about 5 μm.

Source of infection (natural host range): cattle (C. parvum bovine genotype II -a number of cases: e.g. major part of human isolates from Switzerland, also occurrence in Great Britain and Czechland), deer (C. parvum deer genotype), horse, sheep, cat (C. felis >30 cases), pig (C. parvum pig genotype), rodents (C. parvum, C. muris -sporadic cases), rabbit (C. parvum rabbit genotype), dog (C. canis), birds (C. meleagridis -several human cases); oysters and sea mussels; water -even after sand filtration. [Anthroponotic C. parvum genotype I, nowadays classified as a separate species C. hominis, is the principal causative agent of human cryptosporidiosis]. Animal disease: enteritis mainly in young animals (e.g., calves). Pathogenicity for animals was proven only in 1955, earlier the cryptosporidia were regarded as nonpathogenic, commensal species of many animals. Transmission mode: alimentary (ingestion of oocysts excreted in faeces) mainly by water "water-borne" -largely the C. parvum bovine genotype 2, but also food-borne; several epidemics reported after swimming in a pool (source: swimming pool filter backwash -2000 Columbus, Ohio: 137 sick persons, 2000 Mallorca -a hotel swimming pool: 50 British tourists) or water parks. MID for man is only 30 oocysts, which are extremely resistant to chlorine (they survive at least 2 h in 5% of hypochlorite), they also survive in rotifers (Rotifera), and could be mechanically transmitted by house-flies. Many outbreaks of cryptosporidiosis occur in North America and Europe, and it is often unclear whether humans or animals are the source of contamination. Human disease: cryptosporidiosis -enteritis lasting 1-2 weeks with fever, headache, abdominal pain, vomiting and diarrhoea (up to 20 times daily); relapses may occur. Disease was first described in 1976, it is common in immunocompromised persons e.g., with HIV infection (C. parvum, C. felis, C. canis, C. meleagridis, C. muris). A huge epidemic was recorded in Milwaukee (Wisconsin) in 1993: 403,000 persons were affected, 4,000 of them had to be hospitalised; the infection was spread by municipal water supply, which was contaminated by excrements of cattle. Bio-containment: BSL-2. Diagnosis: flotation of stool (in saturated solution of saccharose) and microscopy (oocysts), staining of stool specimens according to Miláček, or IF; serology (ELISA), PCR-RFLP. Treatment: less effective -sulphonamides (trimethoprim + sulphomethoxazole, pyrimethamine), spiramycin, paromomycin; symptomatic treatment (Endiaron, Reasec). Geographical distribution: worldwide.

Haematozoea, Phyllum Apicomplexa] * * Plasmodium falciparum, P. vivax, P. ovale, P. malariae

The developmental cycle is complicated, it involves alteration of asexual replication (schizogony) and sexual development (sporogony). From a mosquito female, where sporogony takes place, sporozoites migrate into vertebrate blood during mosquito feeding, and in liver (cells of the RES) they change to cryptozoites (EE stadium, exoerythrocytic), and by schizogony into merozoites; the latter are released into blood and form trophozoites (ring-like forms) in erythrocytes; new merozoites arise by schizogony (simultaneously with disruption of erythrocytes, clinically associated

of infection (natural host range): domestic and wild swine (S. suis, reservoir, the agent occurs mainly on tonsils and in vagina), horse (S. equi ssp. zooepidemicus)

vaginitis and uterus inflammation (mare, S. equi ssp. zooepidemicus), less often mastitis in cattle and arthritis in lambs (S. equi ssp. zooepidemicus); bronchopneumonia, endocarditis, polyarthritis, septicaemia and meningitis in swine with fatality rate up to 50% (S. suis, mainly serotype 2). Transmission mode: alimentary (raw milk and cheese, undercooked pork -S. suis) or aerogenic (S. equi ssp. zooepidemicus), contact (percutaneousskin injury)

(poly)arthritis, uveitis, diplopia, endocarditis, pneumonia, peritonitis, septicaemia, ataxia, toxic shock syndrome, with the fatality rate about 8-20%. The first case of human infection with S. suis was described in Denmark in 1968, later a few cases in other European countries (the Netherlands

Diagnosis: anamnesis; cultivation (BA) of throat swabs, CSF and blood samples; biochemical tests (API 20 Strep System); serotypisation; MLST. S. suis might be misidentified as a member of the viridans group streptococci. Treatment: penicillin. Geographical distribution: worldwide, S. suis is more common in southeast Asia, and China sporadic in mild climatic zone

Streptococcus iniae

Non-motile streptococci 1 μm in diametre, do not produce catalase. Virulence factors similar to those found in group A streptococci

M. a. paratuberculosis (99.9% similarity of 16S rRNA with M. a. avium, causative agent of paratuberculosis in ruminants and other mammals), and probably non-zoonotic M. a. hominissuis (causes avian mycobacteriosis in pigs, cattle and other animals including human) and M. a. intracellulare (the latter is sometimes recognized as distinct species because DNA-DNA hybridization studies demonstrate that M. avium and M. intracellulare strains only share approximately 50% similarity). A new, sapronotic mycobacterium species is * M. chimaera, closely related to M. intracellulare. Source of infection (natural host range): poultry (M. a. avium) and other birds (rook, pheasant, sparrow, woodpigeon, feral pigeon -M. a. avium, M. a. silvaticum), pig

Johne's disease (M. a. paratuberculosis) -paratuberculosis, a veterinary important chronic hypertrophic enterititis in cattle with diarrhoea and anorexia, leading to death. Transmission mode: alimentary (milk, less often meat), aerogenic; high tenacity of the agent in environment (M. a. avium is viable in water for about 113-417 days

Human disease: avian tuberculosis -pulmonary lesions, lymphadenitis, gastrointestinal lesions, after dissemination even fatal; incidence is increasing (frequent in immunocompromised persons with AIDS, etc.). Lesions are typically without necroses, calcification and fibroses. M. a. paratuberculosis: paratuberculosis, perhaps also Crohn's disease (multifactorial chronic granulomatous enteritis or ulcerative colitis with relapses)

Human disease: actinomycetoma predominantly on lower extremities. It is distinguishable from (eu)mycetoma caused by fungi

Diagnosis: microscopy of pus or biopsy (Gram and acidophilic staining), cultivation, X-ray examination. Treatment: cotrimoxazole, streptomycin, amikacin; surgical intervention. Geographical distribution: America, Africa, Arabic Peninsula -semiarid habitats in areas with dry and warm climate

Facultatively anaerobic microbe with heavily septate hyphae, dividing both transversally and longitudinaly, forming characteristic packages of Gram-positive coccoid cells; motile cells (spores) are also recognized, 0.3-0.5 μm. Source of infection (natural host range): cattle, sheep, horse, mammals in ZOO, less often dog and cat

Animal disease: dermatophilosis (cutaneous streptothrichosis, sometimes falsely regarded as mycotic dermatitis) -pustules and papules, occasionally lethal (mainly in tropics)

Human disease: dermatophilosis -acute to chronic pustules and ulcers on hands

Diagnosis: microscopy of epidermal scales (Giemsa staining), histology, cultivation (without antibiotics -BHI, BA, while SGA not)

Animal disease: inapparent course, or trichophytia (favus) in some animals. Transmission mode: by direct or indirect contact (zoophilic dermatophytes)

Diagnosis: symptoms; microscopy of affected epidermis, hair and nails samples (preparate in 10% KOH), cultivation (SGA with chloramphenicol and cykloheximide)

Treatment: topical fungicide ointments; oral fungicides (griseofulvin, itraconazole). Prevention: vaccine for animals

Trichophyton verrucosum Source of infection (natural host range): cattle (a typical zoophilic dermatophyte)

Transmission mode: by contact (arthrospores in hairs may be viable for more than 1 year)

Treatment: griseofulvin perorally, topically imidazoles (econazole, ketoconazole etc.), Hexadecyl spray. Prevention: vaccine Trichoben (Bioveta) for calves. Geographical distribution: worldwide. Trichophyton simii Teleomorph: Arthroderma simii. Source of infection (natural host range): primates, occasionally domestic fowl

Bio-containment: BSL-2. Diagnosis and therapy: see prior species. Geographical distribution: India

Geographical distribution: worldwide. Microsporum persicolor Teleomorph: Arthroderma persicolor. Source of infection (natural host range): rodents, insectivores (hedgehog)

Bio-containment: BSL-2. Diagnosis and therapy: see prior species. Geographical distribution

Animal disease: sporadic dermatophytosis. Transmission mode: contact with contaminated soil

Bio-containment: BSL-2. Diagnosis and therapy -see prior species. Geographical distribution: worldwide

Closely related species. The teleomorph has not yet been recognized, but according to recent molecular studies of the anamorph it could belong to this family (because the close genomic relationship with Uncinocarpus reessi

A dimorphic fungus: filamentous form with arthrospores 4-6×2-3 μm; but spherules with diameter 20-60 μm containing endospores 2-5 μm in the tissues. Transmission mode: aerogenic (farmers), by contact, alimentary. Human disease: paracoccidioidomycosis (South American blastomycosis) -the fungus invades either nasal and oral mucosa and skin (mucocutaneous form: ulcerative granulomas) or predominantly lymphatic system (the lymphatic form)

Diagnosis: microscopy (tissue, pus, sputum), biopsy, cultivation (SGA)

Treatment: amphotericin B, ketoconazole. Geographical distribution: South and Central America

Source of infection: marine ecosystem -vegetation, soil; dolphins (?). Transmission mode: contact -percutaneous (skin traumatized by plant thorns or insect bites)

Animal disease: lobomycosis in bottlenose dolphins (Tursiops truncatus, T. aduncus) and Guiana dolphin

Bio-containment: BSL-2. Diagnosis: microscopy (biopsy and histopathology: spherical, thick-walled and yeast-like cells in the tissue); the organism has not yet been cultured in vitro. Treatment: surgery

Geographical distribution: coastal areas in the South and Central America, less common in southern USA (Florida, Carolina), South Africa, and exceptionally in Europe

Source of infection: soil, plant remnants, cornstalks, woody plants; sphagnum moss, less often cat

Systematic Survey of Zoonotic and Sapronotic Microbial Agents Transmission mode: by contact (injury by thorns and splinters; or scratching/biting by infected cats: 24 cases in Brazil)

Human disease: sporotrichosis -chronic pyogenic granulomatous disease of the skin, subcutis, mucosa and lymph nodes. A number of cases of miners in South African (diamond and gold) mines (occupational disease). A total of 41 human cases have been reported in Australia between 2000 and 2003 (the source was contaminated hay)

Bio-containment: BSL-2. Diagnosis: microscopy (biopsy), cultivation (SGA)

Treatment: potassium iodide (very effective by local use), amphotericin B (in disseminated forms, i.v. application)

Geographical distribution: mainly (sub)tropics

It is the only dimorphic (yeast-like arthrospores in the tissue) and pathogenic species of Penicillium. Source of infection (natural host range): large bamboo rat (Rhizomys sumatrensis) and lesser bamboo rat

Transmission mode: aerogenic. Human disease: disseminated penicillosis (high fever, skin lesions, intestinal, pulmonary etc. symptoms), more often in immunocompromised patients (HIV); very high fatality rate -75% in treated patients, 100% in untreated cases. Bio-containment: BSL-2/3, highly contagious. Diagnosis: microscopy and cultivation of samples from biopsy

flavus Source of infection: plant remnants, hay, compost (thermotolerant fungi)

Transmission mode: aerogenic; alimentary intoxicosis (aflatoxins: A. flavuscontaminated nuts, dried tropical fruit, succade etc

or aspergilloma (colonization of lung cavities with mycelium, encapsulation); secondary dissemination and invasion of the kidney, heart (endocarditis), CNS and paranasal cavities (granulomas), spleen, liver, stomach, mainly in immunocompromised persons (e.g., with tuberculosis, AIDS or cancer); allergic aspergillosis (hypersensitivity in persons with atopic eczema and asthma, then "syndrome of maltster's lungs" -infection originates from barley); aspergillosis is the most frequent human visceral mycosis, with fatality rate of about 10%

Diagnosis: microscopy (sputum, biopsy), cultivation (SGA without cycloheximide, Czapek-Dox agar), serology (RDPA, latex agglutination, electrophoresis, ELISA), intradermal test. Treatment: potassium iodide, amphotericin B, ketoconazole, itraconazole, voriconazole and newly posaconazole

Human disease: fusariosis -keratomycosis (ocular infection), onychomycosis. For instance, about 100 cases of Fusarium keratitis were reported in people using contact lenses from Singapore and Hongkong in 2005-2006, and a similar disease (130 cases) was notified in USA in the same 2 years

Order Dothideales

Teleomorph of L. senegalensis belongs to Dothideales. Source of infection: soil, plants. Animal disease: maduromycosis. Transmission mode: by contact, percutaneously (injury) -people working on fields (farmers)

Human disease: maduromycetoma, eumycetoma (mycotic mycetoma) -granulomas and abscesses with fistula in skin and subcutis, rarely on bones, sometimes dissemination

Bio-containment: BSL-2. Diagnosis: microscopy (pus from fistula, biopsy), cultivation (SGA without cycloheximide etc

Therapy (less effective): ketoconazole, amphotericin B; resection of the affected tissue

Teleomorphs mostly unknown at present

Rhinocladiella aquaspersa Teleomorphs unknown at present. Source of infection: plant remnants. Animal disease: chromoblastomycosis. Transmission mode: by contact (percutaneously) -farmers. Human disease: chromoblastomycosis (chromomycosis) -chronic disease of skin and subcutis characterized by verrucose lesions covered with scurfs

Diagnosis: microscopy of the tissue (typical brown spherical multiseptate cells and brown hyphae), cultivation (SGA)

Treatment: amphotericin B, fluorocytosine. Geographical distribution: worldwide, predominantly areas with warm climate

Source of infection: plant remnants. Animal disease: phaeohyphomycosis. Transmission mode: percutaneous. Human disease: phaeohyphomycosis -nonspecific solitary lesions in subcutis

Treatment: amphotericin B, ketoconazole; surgical intervention (excision)

Animal disease: unknown. Transmission mode: percutaneous. Human disease: tinea nigra palmaris -dark lesions localized on the palm of one or both hands, occasionally on the sole. Bio-containment: BSL-2. Diagnosis: microscopy of wounded tissue, cultivation (SGA)

Scytalidium hyalinum Source of infection: plant remnants. Animal disease: hyalohyphomycosis. Transmission mode: percutaneous. Human disease: hyalohyphomycosis -usually ulceratose and nodulose lesions in skin and subcutis

Diagnosis: microscopy of wounded tissue, cultivation (SGA). Treatment: ketoconazole. Geographical distribution: worldwide

Animal disease: mucormycosis of gastrointestinal tract, abortion. Transmission mode: alimentary, aerogenic. Human disease: mucormycosis (zygomycosis) -cutaneous (wound infections), gastrointestinal, cranial, pulmonary or disseminated; the most serious and often fatal is rhinocerebral zygomycosis (spreading from nasal mucosa through nasal cavities and orbit into the brain

Diagnosis: microscopy (biopsy: wide non-septate hyphae), cultivation (SGA); often diagnosed only post mortem at autopsy. Treatment: amphotericin B (itraconazole, posaconazole, caspofungin); iron chelation, hyperbaric oxygen, cytokine therapy

Transmission mode: by contact (traumatic inoculation), exceptionally also alimentary. Human disease: entomophthoromycosis (phycomycosis) -subcutaneous and mucosal (nasal) tumor-like changes. Bio-containment: BSL-2. Diagnosis: microscopy (biopsy: hyphal elements sparse and often fragmentary; occasional septations within hyphae -contrary to mucormycosis), cultivation. Treatment: potassium iodide, amphotericin B. Geographical distribution: worldwide, but mostly in Africa

Earlier regarded as two closely related subspecies of C. neoformans, today they are treated as separate species; C. gattii corresponds to the serotypes B and C. The species C. neoformans is now differentiated into two variants: C. neoformans var. grubyi (serotype A), and C. neoformans var. neoformans (serotype D, and hybrid serotype AD)

Source of infection: soil contaminated with bird droppings in C. neoformans (faeces of pigeons and some ornamental birds present a nutritive substrate for the growth of serotypes A, D, and AD; pigeon excreta may contain as many as about 5.10 7 of C. neoformans cells per gram). In C. gattii, some species of trees (mainly eucalyptus) -leaves, bark, wood chips, decaying wood or rhizosphere present the fungus habitat, i.e. reservoir of infection. Animal disease: cryptococcosis -pneumonia, meningitis; C. gattii: disease in koalas, cats, dogs, ferrets, and other mammals. Transmission mode: aerogenic by inhalation; less often by contact. Increased risk of transmission in persons

Human disease: cryptococcosis -chronic to subacute pulmonary, skin or disseminated form (meningoencephalitis), with the fatality rate about

While cryptococcosis caused by C. neoformans commonly occurs in immunocompromised patients, the disease due to C. gattii largely occurs in immunocompetent persons and causes headache, persistent cough, shortness of breath, and the case fatality rate is about 9%. For instance, 272 cases (as of July 2010) of predominantly pulmonary cryptococcosis caused by C. gattii highly virulent genotype VGII have been reported on the Vancouver Island and adjacent inland areas in British Columbia (Canada) since 1999; and after 2003, the disease has spread to northwest

Diagnosis: microscopy (Indian ink negative preparation for detection of capsula) and cultivation (SGA or selective agar with Guizotia) of CSF, pus, urine, prostatic excretion; serological demonstration of polysaccharide anti

Human disease: Chagas disease, American trypanosomiasis -a chronic general disease with cardiomyopathy and CNS affection, it starts after an 1-2 week incubation period; initial symptoms include occuloglandular syndrome called Romaña's sign in 50% of infected people (one-sided conjuctivitis and swelling of the eyelid), enlargement of regional lymph nodes, irregular febrile periods, myalgia; the fatality rate is about 8% in children (myocarditis, meningoencephalitis), lower lethality in adults. Chronic forms (sometimes latent period of 10-20 years): heart arhythmia, dilatation of heart, esophagus ("megaoesoophagus"), gut ("megacolon"), and hepatosplenomegaly; the death usually occurs after perforation ("explosion") of the dilated gut or heart. An estimated 18 million persons are infected in Central and South America, and 15,000-50,000 of them die annually. For example, an average of 50% of Bolivian population was infected in 1994, while the infection rate in endemic areas was as high as 80-90%. Morbidity due to Chagas disease in Honduras was estimated as 5,172/100,000 population in 1996

Treatment (difficult -no satisfactory drugs are available): nitrofurfuryliden (Nifurtimox), benzonidazole, isometamidium derivates. Prevention: vaccine unavailable. Control of triatomine bugs (spraying the walls and roofs of houses, self-protection)

USA (a rare human disease in Arizona -a total of 7 cases were reported, but 41% of kissing bugs collected in Tucson were found infected with T

New experimental molecular data surprisingly indicate possible transmission of L. infanti by the dog tick Rhipicephalus sanguineus, including TOT in the tick

000. However, 100,000 persons died during a massive outbreak of visceral leishmaniasis in south Sudan between the years 1985 and 1987. Ninety percent of visceral leishmaniasis cases occur in Bangladesh, Brazil, India, Nepal and Sudan; 90% of mucocutaneous leishmaniasis occurs in Bolivia, Brazil and Peru; and 90% of cutaneous leishmaniasis occur in Afghanistan, Iran, Saudi Arabia, Syria, Brazil and Peru. The annual incidence in Europe (southern only) is much lower, about 750 cases. Asymptomatic infections of humans with Leishmania are 30−100 times more frequent than the clinical cases. DNA of L. donovani was amplified from ancient Egyptian and Nubian mummies 4,000 years old. Bio-containment: BSL-2. Diagnosis: microscopy of amastigotes (biopsy -lymph nodes, scrapings, smears: amastigote forms 2.5-5×2 μm, replicating in monocytes, macrophages; punctate from spleen or sternum in visceral leishmaniasis), cultivation (NNN agar), inoculation of mouse or Syrian hamster (ears, tail), serology (IFA, ELISA or haemagglutination test in visceral and mucocutaneous leishmaniasis), intradermal test, PCR. Treatment: derivatives of pentavalent antimony (natrium stilbogluconate, megluminantimonate, pentamidine), pyrimethamine (Daraprim), amphotericin B (the most effective in liposomal form in visceral leishmaniasis: AmBiosome) or ketoconazole (in cutaneous leishmaniasis), cycloguanyl, miltefosine, N-chlorotaurin (L. donovani); local injections of ulcers, cryotherapy. Prevention and risk avoidance: human vaccine unavailable at present. LEISHMUNE vaccine is the first licensed vaccine against canine visceral leishmaniasis caused by L. donovani in Brazil. Skin collar with deltametrine can be helpful in dogs. Dog travel to and from endemic areas poses a risk of introducing L. infantum to other areas. Geographical distribution: (semi)arid areas -steppe and savannah in Asia (L. tropica, L. major, L. donovani), Africa (L. tropica, L. aethiopica, L. donovani) and the Mediterranean (L. tropica, L. infantum); forest ecosystems in Central and South America

Amoebae (trophozoites c. 30 μm; cysts 10 μm) free-living in soil and water (cooling, waste, or contaminated seawater -these amoebae are frequently used as waste indicators in polluted water, sometimes they are more specific indicators of pollution than coliform bacteria or Clostridium perfringens). Interestingly, these protozoa may serve as obligatory hosts of legionellae and novel endosymbiont species Protochlamydia naegleriophila

Source of infection: water (thermal, polluted), soil. Transmission mode: inhalatory (nasal mucosa, airways), per conjuctivae (contact lenses), even percutaneously (skin scratches). The cysts are very resistant to dessication, freeze and most disinfectants

Francisella tularensis survives in the cysts of A. castellanii for at least 3 weeks, and this amoeba can also harbour Legionella pneumophila for a long period or may serve as obligatory host of this bacterium. Human disease: two main clinical forms -amoebic keratitis (usually in carriers of contact lenses), and chronic granulomatous amoebic meningoencephalitis (dissemination of the agent into CNS; most frequently in immunocompromised patients -e.g., with AIDS). Cutaneous lesions (hard erythematous nodules, papules or ulcers) caused by Acanthamoeba have also been described in immunocompromised persons

confocal microscopy of corneal tissue, serology (IFA), cultivation (on 1.5% non-nutrient agar plates with a growth of e.g. Escherichia coliamoebae feed on the bacteria, or on cell cultures -amoebae cause cytopathic effect), PCR. Treatment: amphotericin B, sulphonamides, dibromopropamide (liniment), izothionate (eye drops), neomycin, itraconazole, miltefosine (alcylphosphocholin)

Transmission mode: food-borne and water-borne. Human disease: protracted and relapsing diarrhoea (incubation period about 7 days) in children and adults; often as a traveller diarrhoea. First cases were diagnosed in the late 1970s, and the first outbreak was reported from USA and Canada in 1995. Recently, a total of 29 cases were described in British Columbia (Canada

Diagnosis: microscopy of oocysts in stool samples (staining by Lugol's iodine, safranin, or Ziehl-Neelsen), PCR. Treatment: cotrimoxazole (sulphamethoxazole + trimethoprim), pyrimethamine, ciprofloxacin. Geographical distribution: probably worldwide

They have a two-host parasitic cycle: intermediate hosts are herbivores, with the tissue cysts (sarcocysts) containing thousands of cystozoites (merozoites, bradyzoites) in muscles; sexual stage of the cycle occurs in definitive (final) hosts -carnivores (gametogony generates oocysts with sporocysts and sporozoites)

Animal disease: whitish cysts in muscles, called Miescher's vesicles; in rodents so-called M-organism in the brain. Transmission mode: alimentary (water or food contaminated faeces from unknown carnivore or omnivore in muscular form of infection; or raw or undercooked meat in intestinal form of infection)

Human disease: sarcosporidiosis (sarcocystosis) with two clinical forms: intestinal coccidiosis, when human serves as the definitive host (S. bovihominis, S. suihominis), with nausea, anorexia, vomiting, abdominal pain, diarrhoea, tachycardia; and infrequent muscular coccidiosis (human serves as the intermediate host), with fever, musculoskeletal pain, rash, subcutaneous swelling, cardiomyopathy, occasional necrosis and atrophia of muscles

Diagnosis: flotation of stool and microscopy (oocysts 20-33×10-16 μm with 2 sporocysts 15×9 μm each, containing 4 sporozoites) in intestinal form

Only these last stages could infect the vector mosquito again, where they transform in micro-and macrogametes, which form ookinete (zygota) after copulation that penetrates the mosquito midgut and produce oocysts in body cavity; sporozoites then form in the oocysts and migrate into salivary glands. Gametogony and sporogony occur thus exclusively in the mosquito vector. Source of infection (natural host range): man (thus de facto anthroponosis). Transmission mode: anopheline mosquitoes Anopheles maculipennis s.l. (south Europe -An. atroparvus, An. labranchiae), An. sacharovi (Asia Minor and Turkey), An. gambiae (Africa), An. darlingi and An. albimanus (South and Central America)

4-day malaria"); frequent relapses. Symptoms: chills, fever, hyperhidrosis, splenomegaly, sometimes affection of CNS (then often fatal course). WHO 1990: a total of 270 million people affected worldwide, approximately 1 million of which die annually. A total of about 20,000 cases of malaria are imported annually to Europe of them about 8,000 caused by P. falciparum. For example 918 cases in Germany in 1999 (60% formed tourists travelling to endemic areas). Air carriage of infected mosquitoes in airplanes can result in "airport malaria" (infection of human via mosquito biting in the surroundings of airport or during intermediate landing

Treatment: chloroquine (P. falciparum nowadays generally resistant; meflochine is an alternative), amodiachin, quinine + doxycycline, atebrin (uneffective on gametocytes); primaquine (only against parasites in liver and gametocytes); clindamycin, tetracycline. Prophylaxis and prevention: proguanil, meflochine, chloroquine (resistance), pyrimethamine; repellents, and mosquito bed nets. Effective vaccine unavailable at present. Geographical distribution: tropics and subtropics. Malaria has been extensively spreaded in Europe before WWR2 (commonly found in Mediterranean and Balkan) as well as in North America. Some hypotheses reveal that malaria could be one of the major causes of the fall of Roman Empire in fifth century. Italians controlled malaria in the neighbourhood of Rome by desiccation of lowland wetlands only in 1929

Up to 2004, only 5 cases (P. knowlesi) were reliably described. However, a number of additional cases have been reported since 2004 (at least 7, a few fatal) and it seems that simian malaria is an underdiagnosed (or misdiagnosed as classical human malaria)

OptiMAL-IT for detection of parasite lactate dehydrogenase, or even PCR) could produce cross-reactive or nonspecific results and miss P. knowlesi in the blood samples. Treatment: identical to human malaria. Geographical distribution: largely in forested areas of southeast Asia

Family Babesiidae [Order Piroplasmida, Class Haematozoea

According to up-to-date molecular studies (based on 18S rRNA gene sequencing) it has been shown that mentioned species are phylogenetically related more closely to the genus Theileria than to typical representatives of the genus Babesia, so we could expect some nomenclatural changes in foreseeable future. Source of infection (natural host range): rodents of the genera Microtus and Peromyscus (B. microti), cattle (B. divergens), roe deer (B. microti, B. venatorum), and some other mammals. Animal disease: piroplasmosis (babesiosis) with fever, haemoglobinuria, icterus, and haemolytic anaemia causing major losses in cattle

Transmission mode: ixodid ticks Ixodes scapularis (B. microti), I. ricinus (B. microti, B. venatorum -TST and TOT confirmed, B. divergens, B. duncani), further Rhipicephalus, Dermacentor, Haemaphysalis, mainly by nymphs (inside them are present "vermicules" up to 16 μm long)

Human disease: babesiosis -the course similar to malaria, with incubation period about 1-12 months: high fever (chronic in untreated patient) with chills, hyperhidrosis, exudation, fatigue, anorexia, headache, myalgia, cough, arthralgia, hepatosplenomegaly, icterus, haemolytic anaemia, thrombocytopenia, increased level of lactate dehydrogenase and bilirubin, haemoglobinuria, kidney failure. The most susceptible are splenectomized or otherwise immunocompromised people (B. divergens -c. 40 fatal cases in Europe: the former Yugoslavia

Only few cases of the disease caused by B. venatorum have been recorded recently in Europe (Italy, Austria, Germany -all in splenectomized persons), and two symptomatic infections with B. microti (Switzerland -autochthonous

sometimes in characteristic shape of Maltese cross); intraperitoneal inoculation of golden hamster; serology (IFA, ELISA; cross-reaction with Plasmodium), PCR of blood samples. Treatment: a combination of quinine + clindamycin, the alternative is atovaquone + azithromycin; blood transfusion if necessary. Geographical distribution: North America (except of B. divergens; B. duncani in west USA)

Family Balantidiidae [Order Trichostomatida, Class Litostomatea

Balantidium coli

The largest pathogenic protozoan and only one medically important ciliate: it forms motile trophozoites 50-300×40-70 μm, and spherical cysts 50-65 μm. Source of infection (natural host range): pig, wild boar (reservoir: a commensal of the swine intestine); occasionally rats, monkeys, dog. Animal disease: inapparent course. Transmission mode: alimentary (cysts from pigs present in water). Human disease: balantidiosis-chronic dysenteria, abdomen colics

Diagnosis: microscopy of stool (motile trophozoites, less often cysts), biopsy (scraping of intestinal mucosa), serology (IFA, immobilization)

Treatment: tetracycline, metronidazole, hydroxychinolin, sulphaguanidine. Geographical distribution: worldwide (more frequently in tropics and subtropics), a sporadic occurrence

Source of infection: river water. Animal disease: unknown. Transmission mode: by contact with traumatized skin. Human disease: chlorellosis -a rare disease (only one case has been described up to now) with wound lesion draining a greenish-yellow exudate

Diagnosis: microscopy of the tissue (endosporulating cells 6-9 μm, with bright green granules), culture. Treatment: surgical, amphotericin B

Human disease: protothecosis -an uncommon disease (but more frequent than chlorellosis), with skin lesions (nodules, papules), occasionally disseminated (algaemia demonstrated) and then fatal

Diagnosis: microscopy of the tissue (endosporulating hyaline cells 5-15 μm), culture. Treatment: surgical excision of localized lesions

Four morphologic forms (ontogenetic phases) are present: vacuolar form (2-200 μm, with central vacuole); granular form (forming of granules in central vacuole); amoebic form (motile, with pseudopodia)

Source of infection (natural host range): human; less often pig, horse, cattle, brown rat, opossum, chickens (some animal genotypes have zoonotic potential

Transmission mode: alimentary (ingestion -water, food), tenacity of cysts is quite high -they resist even gastric fluid. Human disease: blastocystosis -usually an acute gastrointestinal disease with diarrhoea, anorexia, abdominal pains and convulsions, sometimes with fever and fatigue

Diagnosis: microscopy, serology (ELISA), PCR, cultivation is also possible. Treatment: metronidazole. Geographical distribution: worldwide

They are obligate intracellular parasites of invertebrates (especially arthropods) and vertebrates (mainly fishes) with ontogenic phases: schizogony (by another name merogony: binary fission in so-called parasitophoric vacuoles of host cells) and sporogony, followed by the release of spores from split host cell. Ovoid to pyriform small spores are very characteristic (1.5-4.0×1.0-3.0 μm) and contain one (Encephalitozoon, Enterocytozoon etc.) or two nuclei (binucleate), a posterior vacuole (polaroplast) and ejection apparatus (a tubulous fibre, which is in the caudal part of spores helically stranded into 4-8 coils and after swelling of the polaroplast ejectable throw frontal polar cap); sporoplasma with nucleus is dislodged into host cell after the fibre ejection. Microsporidia do not contain mitochondria, only their residua (called mitosomes). The microsporidian Nosema bombycis is the first discovered microbial parasite of insects, namely of silkworm Bombyx mori (Louis Pasteur studied this disease). Except for the species mentioned below, zoonotic transmission of other microsporidia to man has been demonstrated only rarely, especially in the genera Pleistophora, Tachipleistophora, Brachiola and Vittaforma. ( * * ) Encephalitozoon cuniculi, E. intestinalis, E. hellem Source of infection (natural host range): human

Sometimes clinical illness can be observed in rabbits, rodents (laboratory), carnivores (canine encephalitis-nephritis syndrome), and monkeys (usually in young animals)

Tenacity of spores, which are excreted via urine and by expectorating, is quite high. The parasite can naturally persist in the human population and environment (even for several months under humid conditions)

Human disease: microsporidiosis (intestinal, respiratory and ocular form) -chronic diarrhoea, frequently in immunocompromised persons (AIDS, organ transplantations), occasionally even necrosis of intestine, gallbladder, liver, kidney, pancreas, paranasal cavities and respiratory tract may evolve in these patients. Ocular microsporidiosis may occur in patients which were exposed to pet birds

Diagnosis: light and transmission electron microscopy, IF and histochemical staining of samples (urine, stool and sputum), PCR, RFLP, sequencing

A number of genotypes have been distinguished (A to K at present), and some of them are zoonotic. Source of infection (natural host range): man (the genotype B); zoonotic transmission of some genotypes to humans has been occasionally confirmed e.g., from cat, pig, dog, rabbit, rhesus monkey, cattle, goat, llama, wild mammals (beavers, foxes, muskrats, otters, raccoons

Bio-containment: BSL-2. Diagnosis and treatment: similar as for Encephalitozoon. Geographical distribution: worldwide, sporadic. Brachiola (Nosema) algerae A microsporidian parasite of anopheline mosquitoes. Source of infection (natural host range): probably infected mosquitoes and other insects. Transmission mode: mosquito bites? Human disease: 3 human cases have been described, also in immunocompetent persons: corneal lesions; a cutaneous nodule

* Rhinosporidium seeberi Systematic classification of this species was unclear for long times. However, it was found (based on 18S rRNA analyses) that rhinosporidia do not belong either to fungi, where were assigned formerly, or to typical protozoa; they are more closely related to animals. From phylogenetic point of view they are very close to the genera Dermocystidium and Amphibiocystidium, whose representatives are parasites of fishes and amphibians; corresponding order Dermocystida belongs to microbial Protista of the class Mesomycetozoea (earlier Ichthyosporea)

Bio-containment: BSL-2. Diagnosis: macro-and microscopy, biopsy, histology (R. seeberi forms big thick-walled spherical sporangia in the affected tissue with diameter 50-1,000 μm containing endospores 5-10 μm); cultivation impossible. Treatment: surgical excision of the lesions, but recurrences are common. Geographical distribution: tropical areas